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Summary 
 
This thesis presents DNA binding studies and our work to develop a double competition 
dialysis assay. 
Chapter 1 describes DNA structure, including duplex, triplex and quadruplex structures, and 
functioning in storing the genetic code. This Chapter also presents an overview of the 
interactions of small molecules with nucleic acids structures. Moreover, the chapter describes 
the techniques that have been used for our DNA-binding studies, viz, UV - visible 
spectroscopy, circular dichroism spectroscopy and isothermal titration calorimetry. The 
chapter also describes potential applictions of small molecule DNA binders. Finally, we 
describe the competition dialysis in this chapter.  
Chapter 2 describes the determination of extinction coefficients for selected 
optoelectronically active π-conjugated molecules in aqueous buffers. Furthermore, we 
established the light sensitivity of the compounds. In addition, the chapter describes the 
binding studies of nucleic acid binders from a library of available ligands using UV-visible, 
circular dichroism, and isothermal titration calorimetry. 
Chapter 3 describes the development of a custom competition dialysis device. We test this 
device to determine affinity and selectivity of ligands for nucleic acids structures. We 
analysed the affinity and selectivity of a single ligand for FS-DNA, specific duplex sequences 
(dAdT)12●(dAdT)12 and (dGdC)12●(dGdC)12, and different quadruplex structures such as c-
myc, 22AG and EAD2. The data agree with the results from UV-vis titrations. 
In Chapter 4 we explore how double competition dialysis allows screening of two ligands 
against an array of nucleic acids structures. Several compounds were tested showing that our 
assay deals reasonably well with fading unless the latter progresses to the extent when 
absorbance is too low to measure reliably. Although we have identified compounds with 
promising affinity profiles, even in the presence of a second binder we are yet to identify 
binders with an orthogonal selectivity profile. 
In Chapter 5 we present general conclusions and suggestions for future work. 
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Abstract 
DNA, the molecule of life, plays a key role in many important fields, for instance medical and 
pharmaceutical science. Moreover, DNA is also used as a building block in directed 
assembly. This chapter provides a brief overview of the importance of DNA in life. 
Furthermore, we present an overview of the binding of small molecules with nucleic acid 
structures such as duplex and quadruplex DNA. The Chapter also describes the typical 
binding modes with duplex DNA, which are electrostatic, intercalation and groove 
interactions. The second part of this chapter describes briefly selected established techniques 
that have been used for DNA-binding studies, viz UV-visible, circular dichroism spectroscopy 
(CD), isothermal titration calorimetry (ITC), fluorescence resonance energy transfer (FRET) 
and competition dialysis. The Chapter finishes with the aim of this project, which is the 
development of an assay that allows the identification of orthogonal recognition elements for 
the directed assembly of functional nanostructures.  
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1.1. DNA structure and functions 
Nucleic acids are one of the most important biomacromolecules. They are vital to all known 
forms of life. All living cells contain both DNA and RNA, except some cells such as red 
blood cells, while viruses contain either DNA or RNA, but usually not both. The function of 
nucleic acids is to encode, store, transmit and express genetic information to the benefit of the 
cell itself and ultimately to pass the information onto the next generation of each organism.1  
In 1869 Johann Friedrich Miescher reported discovering a weakly acidic substance in the 
nuclei of human white blood cells and named the substance "nuclein". He subsequently 
separated nuclein into protein and nucleic acid components. This is known to be the first 
isolation of what we now refer to as deoxyribonucleic acid (DNA).2  
In the 1920's nucleic acids were reported to be major components of chromosomes, gene-
carrying structures in the nuclei of most living cells. Further analysis of nucleic acids showed 
the presence of phosphorus, in addition to carbon, hydrogen, oxygen and nitrogen, but no 
sulphur, unlike proteins.3  
Most scientists, however, remained convinced that the more complex proteins must be the 
carriers of genetic information as DNA is made up of only four different nucleotides – not 
enough, it was believed, to store the huge amount of genetic information. Extensive interest 
in nucleic acids was not rekindled until the 1940-1950s, when in classical experiments it was 
unequivocally demonstrated that DNA is the carrier of genetic information. This culminated 
in creation of the now iconic three-dimensional model of DNA, which was worked out by 
Watson and Crick using the X-ray diffraction photographs taken by Franklin and Wilkins.3-5  
Nucleic acids are linear biopolymers. Their monomers are nucleotides, hence the other name 
of nucleic acids, polynucleotides.6 Each nucleotide consists of three components: a 
nitrogenous base (also known as a nucleobase, or simply as a base), a pentose (5-carbon) 
sugar (ribose in RNA and deoxyribose in DNA) and a phosphate group, associated with the 
acidic nature of the nucleic acid (Figure 1.1).7  
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Figure 1.1 Comparison of DNA and RNA nucleotides. 
Different genes have different sequences of these four nucleotides.8 Since the 
deoxynucleotides differ only in the bases they carry, this sequence can be recorded simply as 
a base sequence. The substructure of a nucleotide, which consists of a nitrogenous base and a 
sugar, is known as nucleoside (Figure 1.2); we find ribonucleosides are found in RNA and 
deoxynucleosides in DNA. In chemical terms therefore, a nucleotide is a phosphate ester of a 
nucleoside.9   
 
Figure 1.2 The structures of the nucleosides. 
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The five nitrogenous bases – Adenine (A), Guanine (G), Cytosine (C), Thymine (T) and 
Uracil (U) - are the fundamental units of the genetic code. The bases A, G, C, and T are 
characteristic for DNA while A, G, C, and U are found in RNA. These bases belong to two 
chemical classes: pyrimidines (C, T, U) are composed of a single carbon-nitrogen ring, while 
purines (A and G) are double-ring structures with two joined carbon-nitrogen rings, but with 
different side-chains (Figure 1.3).6 Thymine and uracil have an identical structure except for 
a methyl group, which is present in T but not in U (Figure 1.3).10  
 
Figure 1.3 The purines and the pyrimidines.  
Several structures can be distinguished for DNA and the structure is described on different 
levels viz. primary, tertiary and quaternary (Figure 1.4).11 
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Figure 1.4 Nucleic acid structures (primary, secondary, tertiary, and quaternary) using DNA 
helices and examples from the VS ribozyme and telomerase and nucleosome. 
1.2. Primary structure of DNA 
The primary structure of DNA consists of the linear sequence of nucleotides that are linked 
together. The different nucleotides are covalently joined to form a long polymer chain by 
covalent bonding between the phosphates and sugars. For any one nucleotide, the phosphate 
attached to the -OH group at the 5’ position of the sugar is in turn bonded to the -OH group 
on the 3’ carbon of the sugar of the of the next nucleotide. As each phosphate-hydroxyl bond 
is an ester bond, the linkage between two deoxynucleotides is a 3’5’ phosphodiester bond 
(Figure 1.5). Thus, in a DNA chain, all of the 3’ and 5’ hydroxyl groups are involved in 
phosphodiester bonds except for the first and the last nucleotide in the chain. The first 
nucleotide has a free 5’ phosphate and the last nucleotide has a free 3’ hydroxyl.12 Therefore, 
each DNA chain has polarity; it has a 5’ end and a 3’ end. Traditionally the base sequence is 
written in the order from the 5’ end of the DNA chain to the 3’ end. 13-15    
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Figure 1.5 3’5’ phosphodiester bonds formed between nucleotides in a DNA molecule. 
1.3. Secondary and tertiary structure of duplex DNA 
Secondary structure is determined by the set of interactions between bases which form the 
primary structure. These interactions are called base pairing and can occur within a single 
polynucleotide chain or between two polynucleotide chains.  
Two nucleotides on opposite complementary DNA strands that are connected through 
hydrogen bonds are called a base pair (bp). In DNA adenine forms a base pair with thymine 
and guanine forms one with cytosine (Figure 1.6).  
 
Figure 1.6 DNA complementary base pairs. (Left), a GC base pair demonstrating three 
intermolecular hydrogen bonds; (Right), an AT base pair demonstrating two intermolecular 
hydrogen bonds shown in green. 
As a result of base pairing, DNA typically exists in the double-stranded helical form ( a 
tertiary structure) proposed by James Watson and Francis Crick in 1953 on the basis of X-ray 
diffraction data by Rosalind Franklin and colleagues.16, 17 The double helix is composed of 
two anti-parallel strands of DNA that contain a phosphate-linked deoxyribose sugar backbone 
with pendant nucleotide bases.18 The two anti-parallel strands of DNA are held together by 
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hydrogen bonds between the adjacent nucleotide bases, where adenine pairs with thymine 
and guanine pairs with cytosine as shown above. Adenine and thymine form a double 
hydrogen bond, whereas between cytosine and guanine there is a triple hydrogen bond. The 
uniquely selective interactions between strands of DNA underpin both the storage of genetic 
information in biological systems and the use of DNA in the directed assembly. The 
hydrogen bonds formed between the two nucleotide bases in a base pair force π–π interaction 
(also called π stacking) between consecutive base pairs. A key driving force for the formation 
of the double helix is provided by the hydrophobic interaction between the stacked base pairs. 
The two anti-parallel strands form a helical structure in which the strands are closer at one 
side than on the other side. The region where the backbones are far apart is called the major 
groove and the region where they are close is called the minor groove.19 The grooves are thus 
unequal in size, the major groove is 22 Ångstrom wide, and the minor groove is 12 Ångstrom 
wide.20 The double helix of DNA is shown in Figure 1.7.   
 
Figure 1.7 B-DNA double helix (Nucleic acid database (NDB) ID: BD0003). 
Many double-helical forms are possible; for DNA the three biologically relevant forms are A-
DNA, B-DNA, and Z-DNA (Figure 1.8 and Table 1.1). The Watson-Crick structure is B-
DNA. The B form is the most stable structure for a random-sequence DNA molecule under 
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physiological conditions and is therefore the standard point of reference in any study of the 
properties of DNA. 21, 22, 23 
 
 
 
 
 
 
 
Figure 1.8 The main DNA conformations (left to right): (A) A-DNA (NDB ID: AD0003), 
(B) B-DNA (NDB ID: BD0003) and (C) Z-DNA (NDB ID: ZD0008). A-DNA, B-DNA, and 
Z-DNA conformations of DNA. 22, 24 
 
Table 1.1. Comparisons of B-form, A-form and Z-DNA.22  
Property A-DNA B-DNA Z-DNA 
Helix handedness Right-handed Right-handed Left-handed 
Repeating helix unit one base pair one base pair two base pair 
Diameter ~23 Å ~20 Å ~ 18 Å 
Rotation per base pair 33.6° 36° 30° 
Base pairs per turn 10.7 10.0 12 
Helix rise per base pair 2.3 Å 3.32 Å 3.8 Å 
Sugar pucker C3’-endo C2’-endo C2’ -endo at C    C3’ -endo at G 
Major groove Narrow and deep Wide and deep Narrow and deep 
Minor groove Wide and shallow Narrow and deep Narrow and deep 
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1.4. Triplex DNA 
 
Nucleic acids can also form triplex structures (Figure 1.9).  
 
Figure 1.9 DNA triplex structure (NDB ID: BD0017). 
The DNA triplex structure consists of three strands of DNA, one of which is wound around 
two other strands (which are in a B-form) through so-called Hoogsteen hydrogen bonds 
(Figure 1.10), hence allowing the formation of triplex DNA. The non-Watson-Crick pairing 
is called Hoogsteen pairing after Karst Hoogsteen, who in 1963 first recognized the potential 
for these unusual pairings.25 The triplex shown is most stable at low pH because the C ≡ G * 
C+ triplet requires a protonated cytosine.26 In Hoogsteen hydrogen bonding, there is pairing 
between two homopyrimidines and one homopurine, where one homopurine in the third 
strand runs parallel to the second homopyrimidine.27, 28  
 
Introduction 
 
11 
 
Figure 1.10. Schematic illustration of the A: T and G:C Watson-Crick and Hoogsteen base 
pairs. Hydrogen bonds are shown as dashed lines. 
1.5. Quadruplex DNA 
G-quadruplexes (G4s) are formed by DNA sequences that are rich in guanosine nucleotides 
and form four-stranded secondary structures of DNA. Guanosine bases are important for the 
formation of the quadruplex structure,29 where four guanosine nucleotides group together 
through Hoogsteen hydrogen bonding to form a planar quad-structure known as the guanine 
tetrad (G-tetrad) (Figure 1.11). The quadruplex structure is further stabilized by the presence 
of a cation, especially potassium, which sits in a central channel between each pair of 
tetrads.30  
While metal atoms plays largely a structural role in most G4 binders, there are also examples 
where they interact directly with G4s by electrostatic interactions or direct coordination with 
nucleobases (Figure 1.11).31  
  
Figure 1.11 (G-tetrad) as the basis for quadruplex DNA formation. 
The orientation of strands in the tetraplex can vary, as shown in Figure 1.12.   
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Figure 1.12 the several common topologies found in G-quadruplex.32  
‘If G-quadruplexes form so readily in vitro, Nature will have found a way of using them in 
vivo’, said Aaron Klug, British chemist over thirty years ago.33 The evidence emerges that 
their location is non-random, correlating with functionally important genomic regions and 
that they play an impotant role in various cellular pathways including DNA replication, gene 
expression and telomere maintenance.34, 35  
Only a small part of the genome is responsible for coding proteins (for example, only 2% of 
the human genome encode protein sequences), but a rising percentage is being shown to have 
regulatory functions, including most sequences within introns. When there is much non-
coding DNA, a large proportion appears to have no biological function, as predicted in the 
1960s.36, 37 
Telomeres [5′-(TTAGGG)n-3′] and associated proteins form a unique DNA–protein structure 
located at the ends of linear chromosomes.38 These structures are required for capping the 
chromosome ends from being recognized as DNA double-strand breaks, and provide 
protection from chromosomal deterioration during DNA replication. Telomeres also regulate 
telomerase activity.39 This enzyme is a reverse transcriptase that adds TTAGGG repeats to 
the ends of chromosomes and thus plays a vital role in telomere length homeostasis.40 To 
ensure optimal telomerase activity, telomeric G-rich single strands must unfold. On the other 
hand, folding of the unfolded structures into a G-quadruplex structure is expected to hinder 
telomere elongation by telomerase.41, 42  
Since telomerase is overexpressed in human cancer cells, it has emerged as a potential target 
in the development of anti-cancer drugs. One of the several different approaches to 
telomerase inhibition, the stabilization of G-quadruplexes by small molecules, has received 
much attention.43 
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A promoter is a region of DNA that initiates transcription of a gene. Promoters are located on 
the same strand and upstream on the DNA, i.e. towards the 5' region of the sense strand. 
Promoters can be about 100–1000 base pairs long.44 It has been shown that promoter regions 
are significantly enriched in quadruplex motifs relative to the rest of the genome, with more 
than 40% of human gene promoters containing one or more quadruplex motif.44 Furthermore, 
these promoter quadruplexes strongly associate with nuclease hypersensitive sites identified 
throughout the genome via biochemical measurement. Regions of the human genome that are 
both nuclease hypersensitive and within promoters show a remarkable enrichment of 
quadruplex elements, compared to the rest of the genome. These quadruplex motifs identified 
in promoter regions also show an interesting structural bias towards more stable forms.44 
These observations support the proposal that promoter G-quadruplexes are directly involved 
in the regulation of gene expression. It is established that G-quadruplex DNA motifs are 
embedded within the promoters of human oncogenes as well in several genes that encode 
transcription factors but are under-represented in the promoters of housekeeping genes and 
tumor suppressor genes.45 
Two examples of the formation of G-tetrads in promoter regions include c-myc and EAD2 as 
a form of parallel conformation. Moreover, another form of G-quadruplexes formed in human 
telomeres is the mixed-hybrid conformation 22AG. The G-quadruplex structures 22AG, c-
myc and EAD2 are demonstrated in Figure 1.13.46 
(A) (B) (C) 
   
Figure 1.13 (A) G-quadruplex structures of DNA (PDB: ID 2HY9), (B) 22AG and (C) c-
myc (PDB: ID 2HY9). 
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1.6. The genetic code 
According to the central dogma of molecular biology (Figure 1.14), the genetic information 
present in DNA in the form of codons is transferred to messenger RNA (mRNA) by the 
process of transcription and then the information is “translated” into protein sequence by the 
process of translation.47,48 A codon is a triplet of nucleotides that codes for a specific amino 
acid. Translation occurs in such a way that these nucleotide triplets are read in a successive, 
nonoverlapping fashion. A specific first codon in the sequence establishes the reading frame, 
in which a new codon begins every three nucleotide residues. There is no punctuation 
between codons for successive amino acid residues. The amino acid sequence of a protein is 
defined by a linear sequence of contiguous triplets. 
 
Figure 1.14 The central dogma of molecular biology. 
Figure 1.14 shows the two-step process, transcription and translation, by which the 
information in genes flows into proteins: DNA           RNA          protein. Transcription is the 
synthesis of an RNA copy of a segment of DNA. 
The cracking of the genetic code is regarded as one of the most important scientific 
discoveries of the twentieth century.  A striking feature of the genetic code is that an amino 
acid may be specified by more than one codon, so the code is described as degenerate. This 
does not suggest that the code is flawed: although an amino acid may have two or more 
codons, each codon specifies only one amino acid. The genetic code is nearly universal. 
Human, tobacco plant, E. coli, cobra, and Human Immunodeficiency virus share the same 
genetic code. Thus, all life forms have a common evolutionary ancestor, whose genetic code 
has been preserved throughout biological evolution. 
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1.7. Interaction of small molecules with nucleic acids 
The investigation of molecules that target DNA is an interesting field and could prompt 
applications by which it will be much easier to control numerous hereditary illnesses. 
1.7.1.  Interaction of small molecules with duplex DNA  
Many molecules, including proteins interact with DNA via various modes of interaction. 
Furthermore, molecules can interact either reversible or irreversibly with DNA. Irreversible 
binding normally involves non-specific covalent bonding to the phosphate or sugar part of the 
DNA backbone. This typically means that the DNA breakage, for instance in the case of 
cisplatin, an anticancer drug, acts exactly in this manner when it binds to nitrogen atoms 
within DNA bases (Figure 1.15). 
 
Figure 1.15 Cisplatin interactions with DNA (NDB ID: 1A84). 
 
Molecules can bind to DNA reversibly via several binding modes. Reversible DNA binders 
interact with DNA via (a) electrostatic interactions (b) intercalation (c) groove binding (major 
and minor). Electrostatic interactions occur on the backbone of the DNA. Groove binding or 
intercalation between the base pairs are shown in Figure 1.16. 
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(A) (B)  (C) 
Figure 1.16 Examples of different reversible interactions between molecules and DNA, (A) 
minor groove binding (NDB ID: GDLB05), (B) intercalation (NDB ID: DD0070) and (C) 
electrostatic (NDB ID: 2MCJ).    
A brief description of the three modes of interaction is provided further.  
1.7.2.  Electrostatic interaction       
Electrostatic interactions are normally non-specific and occur along the outside surface of the 
double helix structure of DNA. Because the structural framework of nucleic acids is made by 
alternating phosphate and sugar groups, the DNA backbone is negative charged. This 
negative charge allows occurrence of electrostatic interactions between DNA and cationic 
molecules.49  This specific mode of interaction can be affected by the size of the ligand, the 
charge on the ligand and ligand hydrophobicity. Electrostatic interactions normally play an 
important role for stability of the DNA.  Nonetheless, non-specific interaction with, for 
instance, Na+ or Mg2+ leads to partial neutralization of the phosphate backbone’s charge.  For 
that reason, the binding of small molecules to DNA is dependant on the ionic strength of the 
medium. 
 
1.7.3.  Intercalation and intercalators 
The concept of intercalation was introduced by Lerman in 1961. In this mode of binding, 
planar (flat and rigid) molecules slide in between the base pairs. Typically, intercalators are 
not flexible and normally have an aromatic conjugated system. Intercalation occurs between 
base pairs of DNA.50 The driving force in this event is π-π stacking interactions and Van der 
Waals interactions between the planar aromatic molecule and base pairs of DNA. Such 
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compounds as methylene blue, ethidium bromide and coralyne are intercalators (Figure 1.17). 
All these compounds are flat and rigid molecules. Metal complexes have several features that 
make them particularly suitable as G4 DNA binders and therefore as potential drugs. 
As human telomeric single-stranded DNA can fold into several intramolecular G-quadruplex 
structures, the structural features that are considered during the development of ligands 
include the G-tetrad surface, discrete grooves resulting from combinations of syn- and anti-
deoxyguanosine conformations, a central channel with a negative charge and motifs within 
the flexible loop regions.32, 51 Several classes of small molecules that bind and stabilize 
telomeric G-quadruplex structures have been reported. Most of the reported ligands have a 
planar aromatic surface and interact with the external surface of the G-quartet by π-stacking 
interactions. Moreover, selectivity and affinity of a ligand can be enhanced by electrostatic as 
well as H-bonding interactions of the neutral/cationic side chain with the grooves/loops of the 
quadruplex structure.44, 52  
Several techniques can be used to assess whether a compound binds to DNA via 
intercalation. For example, there have been many studies in the literature to investigate 
the mode of binding of ethidium bromide to duplex DNA. 53, 54  These studies have involved 
CD spectroscopy, UV-vis spectroscopy.55  
Coralyne is another example of an intercalating molecule.56 57, 58 There are many studies on 
the interaction between coralyne and DNA.57 The main binding forces are provided by the 
planar surface,59 and the positive charge. In addition, many analytic techniques such as, UV-
vis, CD spectroscopy, viscometry and fluorescence spectral study have been used to 
investigate the intercalation mode of binding.  
Another noteworthy example is daunomycin, an anticancer drug.  X-ray studies have been 
used to investigate the intercalation mode of binding of daunomycin to d (CGTACG) which 
involves insertion of the aromatic system between base pairs (Figure 1.18). 
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Figure 1.17 Chemical formulae of intercalators, (a) methylene blue, (b) ethidium bromide 
and (c) coralyne. 
 
 
Figure 1.18 Xray structure of daunomycin bound to d (CGTACG) (NDB DDF018).  
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1.7.4 Major and Minor groove binding  
Groove binding involves molecules interacting with DNA in the major or the minor groove. 
Groove binding has the advantage of allowing certain molecules to interact selectid with 
DNA. Major groove binding by proteins plays important roles in transcription and replication 
because the major groove provides a binding region allowing DNA-binding proteins to 
interact in a sequence-selective manner.60  The major groove is wide, which allows large 
biomolecules such as proteins to bind to the major groove predominantly through recognition 
of hydrogen bond donating and accepting sites (Figure A1.19 & B1.20). On the other hand, 
small molecules are often minor groove binders. Minor groove binders have several 
characteristics, for instance they are typically long and flexible. Often, minor groove binders 
are positively charged, and interaction can therefore also occur between the DNA binder and 
the anionic phosphate backbone of the DNA. In addition, these molecules also interact with 
the hydrophobic interior in the minor groove as well as through hydrogen bonding with 
donors and acceptors at the bottomof the minor groove.61  
 
Figure A1.19 nucleic acid base adenine (A), thymidine (C) cytosine and (G) guanine linked 
by hydrogen bonds (dot lines). 
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Figure B 1.20 Major and minor grooves of DNA structure (NDB ID: BD0002). 
A well-known example of a minor groove binder is Hoechst 33258. Hoechst 33258 has a 
crescent shape similar to netropsin and distamycin. Hoechst 33258 also has a π-conjugated 
oligoheteroaromatic framework. Moreover, Hoechst 33258 has enough rotational flexibility 
around the bonds to fit into the minor groove (Figure 1.21).  
 
Figure 1.21 Structure of H33258 (left), binding of H33258 to the minor groove 
d(CGCAAATTTGCG)2 (NDB ID: GDL028) (right). 
 
Studies of the interactions of H33258 to the minor groove show that H33258 interacts 
specifically with A●T-rich sequences, and has a binding site size of 4-5 base pairs. 
Nevertheless, H33258 also binds to G●C-rich sequences in the minor groove but with low 
affinity. Its binding has been studied through a variety of techniques, including Förster 
resonance energy transfer (FRET), UV-visible spectroscopy, isothermal titration calorimetry 
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(ITC), circular dichroism (CD) spectroscopy, fluorescence spectroscopy and pulsed gradient 
spin echo NMR.62  
Similar to H33258, studies have confirmed the interaction between DAPI and DNA by 
several biophysical methods such as UV-vis, fluorescence spectroscopy, viscosity and 
circular dichroism (Figure 1.22). 
 
Figure 1.22 Crystal structure of DAPI bound to DNA sequence D (CGTGAATTCACG) 
(NDB ID: 5T4W).  
 
Further examples of DNA minor groove binders include distamycin and netropsin (Figures 
1.23 and 1.24). Distamycin and netropsin are long, flexible and crescent-shaped. In 1974, 
Wartell et al showed minor groove binding for netropsin.63, 64 The driving force for binding to 
netropsin to A•T rich regions of B-DNA (Figure 1.23) is displacement of water molecules 
that hydrate the minor groove of DNA. The binding selectivity of netropsinto A•T rich 
sequences was attributed to the formation of hydrogen bonds between the NH groups on 
netropsin and the nitrogen in adenine and oxygen of thymine on each adjacent base pair by 
electrostatic and Van der Waals interactions. The binding of netropsin to DNA always occurs 
in a 1:1 ratio along four consecutive A•T base pairs. Distamycin binds to DNA in the minor 
groove by two different modes, viz. 1:1 and 2:1 ratio along five base pairs (Figure 1.23).  
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Figure 1.23 Structure of distamycin (A), the groove binding modes of distamycin with DNA 
duplexes, 1:1 binding of distamycin to DNA (NDB ID: GDL 003) (B); side-by-side binding 
of distamycin to DNA (NDB ID: GDH060) (C). 
 
 
 
Figure 1.24 Structure of netrospin (left), 1:1 binding of netropsin in the minor groove (based 
on NDB ID: GDL B05) (right). 
A partilarly well-known class of polyamide minor groove binders are known as Dervan’s 
hairpin polyamides (DHP). Dervan et al, whose research was inspired by sequence-selective 
natural compounds such asnetropsin and distamycin, provided insight into the molecular 
forces that govern the affinity and specificity of pyrrole-imidazole polyamides. Hairpin 
(A) (B) (C) 
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polyamides are synthetic ligands for sequence-specific recognition in the minor groove of 
double-helical DNA. DHPs are composed of amide-coupled heterocycles, which two 
polyamides binding to double-stranded DNA in the minor groove in a side-by-side manner 
forming 1:1 complexes with A•T base pairs. Furthermore, a 2:1 binding mode for this class of 
compounds was revealed for 1-methylimidazole-2-carboxamide netropsin (2-Im-N) which 
specifically binds to 5’-TGAT (Figure 1.25). 
 
 
 
 
 
 
 
Figure 1.25 X-Ray structure (left) and hydrogen bonds view of side-by-side dimer of 2-Im-N 
bound to d(TGACT) (NDB ID: BDD003).  
 
Recognition of double-stranded DNA by DHPS is limited to five base pairs. The reason for 
that is the curvature polyamide molecules no longer matches with the minor groove of 
DNA.65 Hence, Dervan and co-workers synthesized polyamides to bypass this, and “turn to 
turn” or “turn to tail” tandems recognise longer DNA sequences extending the selectivity to 
10 base pairs (Figure 1.26).66  
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           Turn-to-turn tandem             Turn-to-tail tandem              Candy cane 
 
Figure 1.26 cartoon representations of polyamide models for binding to extended DNA 
sequences. 45 
Additionally, minor groove binders can form hydrogen bonds with nucleotide bases. 
Examples of such groove binders are H33258, GB01, DAPI and DODC (Figure 1.27).                       
 
Figure 1.27 Chemical formulae of minor groove binders (a) H33258, (b) GB01 (c) DAPI and 
(d) DODC. 
On the other hand, some compounds combine two modes of interaction because the typically 
higher flexibility and also flat polycyclic aromatic ring molecules such as basic yellow 
(thioflavin T) and thiazole orange (Figure 1.28).67 
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Figure 1.28 Chemical formulae of minor groove binders and intercalators, (a) basic yellow 
(thioflavin T) and (b) thiazole orange. 
Basic yellow (thioflavin T) is a typical example of a fluorescent dye. The different binding 
modes of basic yellow have been investigated by spectrophotometric and spectrofluorometric 
methods. It has been reported that basic yellow (thioflavin T) displays several binding modes, 
including intercalating and minor groove binding.68 Key intercalated interactions are 
hydrophobic between benzothiazole and dimethylaniline groups and base pairs. Moreover, 
basic yellow is cationic by its nature, also allowing electrostatic interactions.  
1.8. Techniques for studying interactions between small molecules and nucleic acids 
The interaction of DNA binding-small molecules can be studied through a variety of 
techniques, viz. UV-visible, circular dichroism spectroscopy (CD), isothermal titration 
calorimetry (ITC), fuorescence resonance energy transfer (FRET) and competition dialysis.  
These techniques are briefly described below. 
1.8.1. UV-Visible Spectroscopy (UV-vis) 
UV-visible spectroscopy measures the amount of radiation absorbed by a sample at each 
wavelength in the ultraviolet and visible regions of the spectrum. The absorption of 
ultraviolet (200-400 nm) and visible (400-800 nm) light by molecules is associated with the 
excitation of valency electrons from the electronic ground state to higher energy states. The 
absorption of UV-visible radiation by a molecule typically results in the electronic transition 
of an electron from the highest occupied molecular orbital (HOMO) to the lowest unoccupied 
molecular orbital (LUMO). The wavelength of the absorbed radiation depends on the energy 
difference between the orbital originally occupied by the electron and the orbital to which it 
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is promoted. Absorbance (A) often, but not always, increases linearly with the concentration 
(c) of the chromophore as described by the Beer Lambert law (equation 1.1): 
A = ε×c×l     (1.1)                                   
where c is the concentration of the sample in moles per litre of the solution, ε the molar 
extinction coefficient in M-1 cm-1, and l the optical path length.69  
Absorption spectroscopy is an important technique for studying ligand-DNA interactions 
since spectroscopic information can be deconvoluted to yield concentrations of free and 
bound species. Because of interactions of molecules with DNA, modification in structural 
conformations of ligands and changes in the properties of the medium surrounding the binder 
occur, resulting in changes in spectroscopic response. Titration of a ligand with DNA can 
show changes in the position of the wavelength of maximum absorbance (λmax) and in 
extinction coefficient.  
These changes may be an increase (hyperchromicity) or decrease (hypochromicity) in molar 
absorptivity of ligands or conceivably a movement of the wavelength of highest absorption to 
higher wavelength (red shift) or to lower wavelengths (blue shift).70 Plotting these absorption 
spectra in one graph may reveal an isosbestic point which is the wavelength at which two 
species involved in the titration have the same molar absorptivity.71, 72 An example of an 
isosbestic point is demonstrated in Figure 1.29. 
 
Figure 1.29 Spectrum showing an isosbestic point73 
The observation of an isosbestic point suggests that an equilibrium is achieved between two 
species viz. free and bound ligand.74  
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When the spectra have been recorded, titration curves can be extracted from the UV-visible 
data by plotting the absorbance at one or more wavelengths against DNA 
concentration.75Absorbance data is then typically analysed in term of the multiple 
independent binding sites (MIS) model, which is used to determine the binding constant 
Kbinding and binding site size (n) or binding stoichimetries.  The MIS model is derived from 
the complexation equilibrium (equation 1.2). 
 Lf + bsf           Lb      (1.2) 
Lf and bsf, and complex are the concentrations of free ligand, free binding site and bound 
ligand (complex) which are related through Kbinding (equation 1.3). 
Kbinding = [L]b / [L]f . [bs]f      (1.3) 
Each binding site will cover a ligand-specific number of base pairs n for a single ligand 
molecule.  
[bs] = [DNA] / n   (1.4) 
The concentration of binding sites is the concentration of DNA base pairs divided by the 
binding site size n. The concentration of free ligand [L]f, free binding sites [bs]f and complex 
concentration [C] are related through the total ligand concentration [L]tot and total binding 
site concentration [bs]tot (1.5), (1.6). 
 [L]t = [L]f + [C]        [L]f =   [L]t  - [C]                                                    (1.5) 
 [bs]t = [bs]f + [C]     [bs]f =   [L]t  - [C]                                                   (1.6) 
Consequently, it is possible to establish an overall equation describing the equilibrium (1.7) 
[C] = Kbind [bs]t.[L]t – Kbind. [C]. [bs]t – Kbind. [C].[L]t – Kbind.[C]2                      (1.7) 
which is rearranged to give quadratic equation (1.8).    
Kbind [C]2 – (1 + Kbind. [bs]t + Kbind. [L]t). [C] + Kbind. [bs]t.[L]t = 0          (1.8) 
The quadratic equation (1.8) is solved using the classic Equation 1.9 to provide an expression 
for the concentration of complex [C] as a function of total ligand and binding site 
concentrations (1.10). 
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                                                                                            (1.9) 
  (1.10) 
 
By inserting the concentrations into the Beer-Lambert Law (Equation 1.1), modified for 
background absorbance, the observed absorbance is given by Equation 1.11. This equation 
can be fit to a plot of absorption against total DNA concentration to find the best 
approximation for binding constant and binding site size.  
signalobsd = background + signalfree, m.[L]t + ∆binding signalm    
Equation 1.11 
The terms in equation 1.11 are defined as follows.76 The term signalobsd is the observed 
absorbance at the selected wavelength; signalbackground is the background signal (baseline or 
buffer absorbance); signalfree,m is the molar signal of the free ligand (the molar extinction 
coefficient when UV-visible spectroscopy is used); [L]tot is the total ligand concentration; 
∆binding signalm is the change in the molar extinction coefficient signal upon binding;  K is the 
binding constant or equilibrium constant; [DNA]tot is the total DNA concentration in base 
pairs: n is the binding site size in base pairs.  
1.8.2. Circular Dichroism Spectroscopy (CDS) 
Circular dichroism (CD) spectroscopy is a technique that is widely used77 to study chiral 
molecules and for non-chiral molecules interacting with chiral compounds such as 
biomacromolecules.78, 79 Circular dichroism spectroscopy uses the difference in the 
absorption of left–handed circularly polarised light (L-CPL) and right–handed circularly 
polarised light (R-CPL) by chiral chromophores.78, 80, 81 If the molecules contains chiral 
chromophores, or if an achiral chromophore is placed in a chiral environment, then the 
chromophore will absorb one form of circularly polarised light to a higher extent than the 
other. For instance, if right-circularly polarised light (R-CPL) is absorbed to a smaller amount 
extent than left-circularly polarised light (L-CPL), a CD signal will appear at the 
corresponding wavelength.82, 83 Thus, CD spectroscopy has been used to study a wide range 
of biological molecules and processes such as DNA–ligand binding, and protein-ligand 
binding.83 CD spectroscopy can show how the DNA binds with the ligand by varying the 
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environment that a binder experiences.82 The effect where a chiral environment (such as 
DNA) causes a non-chiral molecule to display a circular dichroism signal is called induced 
circular dichroism (ICD). Previous studies have reported that large ICD signals and small 
ICD signals are indicative of groove binding and intercalation, respectively.  For 
intercalation, small ICD signals are common (< 10 M-1 cm-1) and the ICD signals 
(ellipticities) are usually negative. However, for groove binders, the ICD signal is typically 
strong and positive.84 Examples of no change in CD spectrum (sulforhodamine in the 
presence of DNA) and negative ICD (basic fuchsin (4) in the presence of DNA) are shown in 
Figure 1.30.  
 
 
 
 
 
 
 
Figure 1.30 Circular dichroism spectra for (A) no change for sulforhodamine, and (B) 
negative ICD for basic fuchsin.  
1.8.3. Isothermal Titration Calorimetry (ITC)      
Isothermal titration calorimetry (ITC) is a technique that can be used to study biomolecular 
interactions.85 ITC measures the heat generated or absorbed as a result of molecular 
interactions.86 A microcalorimeter contains two identical cells (Figure 1.31), one reference 
cell (filled with water or buffer), and one sample cell which contains the macromolecule. 
These two cells are kept at the same temperature by the microcalorimeter. When a ligand is 
titrated into the sample cell, there are two possible heat effects. If the reaction or interaction is 
exothermic, the temperature in the sample cell will increase relative to the reference cell. 
When this occurs the feedback power to the sample cell decreases. If the reaction is 
endothermic, the temperature in the sample cell decreases and the feedback power to the 
sample cell is increased.87 
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Figure 1.31 Schematic representation of a power compensation ITC88 
1.8.4. Isothermal Titration Calorimetry data analysis through IC-ITC 
In the case of isothermal titration calorimetry experiments, self-aggregation can happen 
because of the high concentration of ligand in the injection syringe.89 This is why the self-
aggregation of the ligand needs to be taken into account during the data analysis in 
conjunction with the consideration of DNA-binding parameters. The group has previously 
developed software called IC-ITC to analyse numerically calorimetric data for combined self-
aggregation and DNA binding.89 Using IC-ITC we can determine thermodynamic parameters 
for the various equilibria involved (Figure 1.32).  
 
                                                    Figure 1.32 90 
The software first calculates the concentrations of ligand and biomolecule after each addition 
of the ligand into the sample cell.62  
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The mass balance equation is expressed in terms of Equation 2.  
-[L]total +  = 0                                                              Equation 2 
The terms in equation 2 are as follows,  
The term [L]total is the total ligand concentration; [L]x is the concentration of ligand in all 
various forms X, for instance free, ligand, DNA-bound ligand, aggregated ligand, etc.  
Equation 3 shows the formal link between the ligand concentrations taken up in the 
complexes and in the aggregates, [L]x, and the free ligand concentration [L]f, which also 
depends on the total macromolecule concentrations [M]t and the interaction parameters ax for 
the complexation events for instance, equilibrium constants and the stoichiometry.  
[L]x = f([L]t, [M]t, ax)                                                           Equation 3 
Using a set of interaction parameters ax, the equilibrium concentrations are determined 
numerically by solving the mass balance equation using the Newton-Raphson algorithm.91 
IC-ITC provides the optimised values for the binding parameters ax, as identified by the 
lowest sum over square deviations. Furthermore, IC-ITC allows the determination of the error 
margins and covariance for various variables. 
1.8.5. Fluorescence resonance energy transfer (FRET) 
Fluorescence resonance energy transfer (FRET) is a physical mechanism of radiationless 
transfer of energy between two dye molecules called chromophores. FRET depends on the 
distance between donor and acceptor molecules. It is most suitable when the donor-acceptor 
distance is within 10 nm range.92  The donor molecule initially absorbs the energy which is 
subsequently transferred to the acceptor molecule.93 The donor fluorophore in a FRET 
experiment can be excited by using light.81 An excited electron can either return to the ground 
state by emitting light (fluorescence) or go through a non-radiative process, which requires an 
acceptor molecule in proximity. This interaction occurs over greater than interatomic 
distances without any molecular collision or any conversion to thermal energy. The energy 
transfer depletes the donor’s fluorescence intensity and its excited state lifetime and increases 
the emission intensity of the acceptor.  
A pair of molecules that interacts in such a manner that FRET occurs is often referred to as a 
donor/acceptor pair. FRET involves the energy transfer between excited states in donor 
molecules to acceptor molecules as a result of non-radiative dipole–dipole coupling.94  
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The process can be described with the following scheme [D-Donor, A-Acceptor]:95 
D + hv→ D* 
D* + A→D +A*  
A*→A + hv’ 
While there are many factors that influence FRET, the primary conditions that need to be met 
for FRET to occur are relatively few.  These include the following: 
• proximity between donor and acceptor molecules,  
• overlap of absorption and excitation spectra of donor and acceptor, respectively. 
• dipole orientations must be approximately parallel to each other,  
• sufficient lifetime of the fluorescence of the fluorophores. 96 
The required spectral overlap integral between the excited states in the donor molecules and 
the absorbance of the acceptor molecules is illustrated in Figure 1.33. 
FRET is actively used in biomedical research and drug discovery.97 For example, FRET is 
used to study structure and conformation of proteins and nucleic acids, spatial distribution 
and assembly of proteins, distribution and transport of lipids, interactions between 
receptor/ligand 
interactions, nucleic acid hybridization, membrane potential sensing, also to detect SNPs, to 
perform imunoassays and real-time PCR etc.98  
 
 
Figure 1.33 The FRET spectral overlap integral. 
Induced Fluorescence Resonance Energy transfer (iFRET) is used for the detection of DNA 
hybridization. This method is perfectly suited for melting curve analysis and entails using a 
double-strand DNA-specific intercalating dye (e.g., SYBR Green I) as the FRET donor, with 
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a conventional FRET acceptor affixed to one of the DNA molecules. Three strategies for 
detecting DNA hybridization with fluorescence are illustrated in Figure 1.34.99 
 
 
Figure 1.34 Three strategies for detecting DNA hybridization with fluorescence. Fluorescent 
outputs are indicated by radiating lines. (i) Intercalating dye, (D) donor moiety, 
and (A) acceptor moiety. 
 
iFRET provides fluorescence signals of enhanced magnitude, implying many advantages. For 
example, smaller volume or weaker PCR reactions will be possible to assay, and less 
sophisticated imaging equipment is used for signal detection. iFRET also reduces cost by 
removing the necessity for a physically attached donor on one of the interacting DNA 
molecules, yet it preserves the spectral-multiplexing potential afforded by FRET. Essentially 
all forms of florenscence background allow for very clean assays with all the benefits that 
naturally follow from this, such as allowing throughputs to increase and automation to 
replace human intervention.  
1.9. Application of small molecule DNA binders. 
1.9.1. Biosensors 
The enormous amount of genetic information brought by extensive genome sequencing 
allowed understanding how life is sustained, how diseases develop or how we can cure 
them.100, 101 Biosensor also has raised the need for simple, cheap and high-throughput 
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analytical devices to attend the growing market of molecular diagnostics for decentralized 
DNA testing.  
Such analytical devices, known as biosensors, convert a biochemical reaction or interaction 
into an analytical signal that can be further amplified, processed and recorded. Among them, 
DNA biosensors consist of an immobilized DNA strand to detect the complementary 
sequence by DNA–DNA hybridization. Biosensors have become extremely popular over last 
20 years.102  
Today biosensors are vitally important and are being used in many applications including 
industrial, clinical, chemical and environmental.103, 104 Some of the significant benefits for 
using biosensors include the high sensitivity and fast response. The most important reasons 
for using a biosensor in medicine are to establish the presence of pathogens or to estimate the 
chances of diseases to occur in the future. 
A typical biosensor includes a bioelement and a transducer. The bioelement is a biological 
molecule, which recognizes the target analyte while the transducer has capacity to convert 
that recognition event into a measurable signal. Transduction could be generated through 
several different mechanisms, or even through a combination of any of these mechanisms 
(Figure 1.35).  
 
Figure 1.35 Classification of biosensors based on type of biotransducer. 
Nucleic acid-based biosensors, also called genosensors, are considered one of the best 
biosensors in medicine due to the high sensitivity of detection.105 The recognition process in 
genosensors is based on the principle of complementary base pairing in DNA. If the target 
sequence is known, complementary sequences can be synthesized, labelled, and then 
immobilized on the sensor. The hybridization probes can then base pair with the target 
sequences, generating an optical signal.106 The favoured transduction principle employed in 
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this type of sensor has been optical detection (Figure 1.36). Genosensors are widely used not 
only in medicine but also in food industry and environmental monitoring.107  
 
Figure 1.36 description of the electrochemical detection of DNA targets, (a) without and (b) 
with non-complementary ss-DNA.108 
The initial efforts that have been carried out to detect the hybridization of DNA through 
electrochemical means were put forth by Garnier and his team, who covalently connected the 
probe of ssDNA to the backbone of polypyrrole.109 The most frequently used approach for 
detection of nucleic acids uses a single-stranded capture strand (ssDNA or ssPNA) which is 
typically immobilised on a transducing element such as an electrode. The capture strand is 
exposed to the sample solution where it finds its complementary target strand if it is 
present.110 The intrinsic sequence selectivity of DNA base pair formation assures the 
sequence specificity. Figure 1.37 illustrates a genosensor design where (a) denotes a surface-
immobilised capture strand and (b) denotes the duplex formed as a result of hybridisation 
with the target strand. The design then uses the fluorescence or redox property of the π-
conjugated DNA binders as a sensitizer. The detection procedure can be either labelled or 
label-free. In labelled detection, the target strands are covalently labelled with the 
sensitiser.111 In case of label-free detection, the nucleic acids are not required to be labelled 
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covalently, rather the sensitizer non-covalently binds to the target strand, as seen in Figure 
1.37 (c).  
 
Figure 1.37 schematic design of a genosensor for the sequence selectivity of the DNA 
detection including a duplex- DNA binding sensitizer.  
A transformation to a more positive potential of oxidation can be seen for the construct of the 
polypyrrole-oligonucleotide in a cyclic voltammogram. Such alterations in the electronic 
characteristics of polypyrrole were linked to the modifications in the conformation of 
polymer that takes place during the formation of duplex resulting from the attachment of a 
strand to the conjugate of polymer-oligonucleotide. Subsequently, several modified 
polythiophenes were used to detect the hybridization of DNA electrochemically. For 
instance, it has been reported by Lee et al.108 that terthiophene can be electropolymerised on 
the glassy carbon electrode surface due to the presence of the electroactive carboxylic acid 
groups (Figure 1. 38).  The incorporation of functional groups like carboxylic group onto the 
polymer backbone in covalently bound by an oligonucleotide may serve as a biosensor for 
DNA recognition involved the studying of genetic disease.112   
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Figure 1.38 Hybridization of terthiophene. 
Another example is provided by peptide nucleic acids (PNA), synthesized synthetic polymer 
similar to nucleic acid but replacing phosphate ester linkages with peptide linkages. Peptide 
nucleic acids are DNA mimics in which the sugar-phosphate backbone is replaced by 2-
aminoethyl-glycine linkages and the nucleotide bases are attached to the peptide nucleic 
acid’s backbone by a methylene bridge and also by a carbonyl group.113 The advantages of 
using PNAs as an example of capture probes in biosensing include elimination of repulsion 
forces between two hybridized strands because of the neutral backbone of PNAs.114 As a 
result, PNA can bind to complementary strands with a higher affinity and selectivity than 
DNA.115-117   
The thermodynamic stability of peptide nucleic acids (PNA) is greater than DNA. This is 
because the lack of electrostatic repulsion forces between the uncharged PNA backbone and 
negatively charged DNA or RNA backbone.118 
Leclerc and his colleagues have developed a ferrocene-functionalised cationic polythiophene 
that was used as a biosensor for free DNA detection paving the way to a new family of 
biosensors potentially useful for monitoring drinking water distribution systems.119, 120 The 
design of a genosensor for the sequence selectivity of the DNA detection is shown in Figure 
1.37. 
1.9.2. DNA in directed assembly  
DNA applications are also useful outside biology and medicine. The development of DNA 
origami and DNA nanotechnology uses the uniquely selective interactions between DNA 
strands for the directed assembly of functional nanostructures.121  
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The challenge in DNA-based self-assembly is the integration of different molecular 
constituents like fluorophores into the groups. DNA-based photonic wire systems have been 
designed, however, they have substantial energy losses during the energy transfer.122 
Inefficient communication between the components during the self-assembling of the 
structure suggests that tools which would help to control the location and spatial 
arrangements of the fluorophores are required. It has been shown, that DHPs can act as a 
controller ligand binding to the DNA duplex with high precision. The resulting DHP-
appended fluorophores are able to exhibit high-energy transfer over distancesof over 27 nm. 
In addition, when tested through FRET, DHP-appended fluorophores were shown to be 
efficient in controlling energy loss during energy transfers (Figure 1.39).  
 
Figure 1.39 schematic of the exemplar DNA-based photonic.122 
Three fluorophores used in a recent study are pacific blue (PB), oxazole yellow (YO) and 
cyanine 3 (Cy3). Pacific blue (PB) is the initial donor chromophore and oxazole yellow (YO) 
the terminal energy acceptor.122 The stepping-stones are the oxazole yellow dyes which are 
central to the design through the processes of homo-FRET. A significant amount of 
remaining energy exist in the YO dyes rather than being transported to the final acceptor dye. 
This results in the dropping off of the efficiencies of ET sharply by increasing the numbers of 
steps of YO-YO ET, as the ET process among the YO dyes is considered to be bi-directional. 
The length of the photonic wires is increased due to the modularity of perfect fluorophore, 
which helps to optimize the interfluorophores distances and increase the photonic lengths. 
Most importantly, the DHPs can target virtually all DNA sequences and thus can be used 
within high throughput multi-dimensional arrays and circuits.  
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For nanophotonic applications, DNA is programmed to compose special scaffolds in order to 
organize and manipulate fluorescence resonance energy transfer (FRET). Moreover, the 
ability to self-assemble into different arrays over small surface areas and with high precision 
makes DNA unique. DNA self-assembly leads to formation of programmable nanostructures 
with wide applications. DNA nanostructures are assembled with different materials through 
different methods. Solid phase chemical synthesis is the most common method, which is used 
to produce modified oligodeoxyribonucleotides (ODNs), where DNA nanostructure is 
assembled with non-natural functionality.123 Furthermore, DHPs are also used to organize the 
non-natural functionality together with DNA nanostructures. The DHPs have high selectivity 
and affinity for the DNA structures and are thus able to construct a DNA-based photonic 
wire. It is clear that “PA-programming” is able to programme a uni-directional FRET 
process. In addition, in order to complete the photonic wire in to the surface, single-molecule 
fluorescence spectroscopy (SMFS) is used and this ensures that 100% FRET is observed. 
DHPs are thus effective in the construction of fluorophore sequences templated by duplex 
DNA so that the FRET process is effectively controlled by the DNA duplex.  
 
1.9.3. Competition dialysis 
This study focuses on the development of a custom competition dialysis device to determine 
affinity and selectivity of ligands for nucleic acids structures. According to Muller and 
Crothers, who first  described competition  dialysis, it was  intended  to  revise  the first 
choice  of  ligand  for the base  pairs of the  G•C  or  A•T.124 The competition dialysis 
experiment is illustrated through a typical device in Figure 1.40.  
 
 
 
 
Figure 1.40 the competition dialysis assay. 125 
The principle of competition dialysis is based on the laws of thermodynamics and is very 
straightforward to put into practice.  
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Ligands that bind to nucleic acids, having structural or sequence selectivity, can be identified 
using a powerful tool called competition dialysis.125 This process is used as a simple and 
common test for affinity and selectivity of ligands and comprises of the dialysis of a ligand 
against an array of nucleic acids with different structures or sequences.124 For example, 
duplex DNA, triplex DNA and quadruplex DNA in dialysis tubing can be placed in a beaker 
with a ligand solution, illustrated in Figure 1.41.  
 
 
 
 
 
 
Figure 1.41 Schematic illustration of the competition dialysis process involving three nucleic 
acid structures, viz. quadruplex (Q), duplex (D) and triplex (T), and a ligand. 
Allowing adequate time for the diffusion to take place allows the ligand to diffuse across the 
dialysis tubing. The uniformly sized pores of the dialysis tubing will allow the ligand 
molecules to diffuse in and out of the dialysis tubing to achieve the equilibrium 
concentrations while the large nucleic acids are retained within the dialysis tubing. The 
equilibrium concentrations are defined by the affinity between the duplex DNA, triplex DNA 
and quadruplex and the ligand.126 
If the ligand binds to duplex DNA, triplex DNA and/or quadruplex DNA,127 when 
equilibrium is reached the ligand molecules are retained within the dialysis tubing. For 
instance, if a molecule has high affinity for triplex DNA, it will accumulate in the dialysis 
tubing with triplex DNA. Analysis of the ligand concentration in the different dialysis tubing 
then gives the affinity of the ligand for the different nucleic acid structures. 
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1.10. Project Aims 
This work aims to establish and identify couples of compounds displaying orthogonal 
selectivity for nucleic acid structures such as duplex, triplex and quadruplex DNA. The 
mutually orthogonal interaction pairs are required for the construction of self-assembled 
functional nanostructures, directing fluorescent molecules into a pre-designed sequence so 
that energy transfer by FRET takes place (illustrated in Figure 1.42). To achieve this, we 
develop and validate the double competition dialysis assay for the identification of mutually 
orthogonal interaction pairs as required for this process. Double competition dialysis can be 
used as a test for affinity and selectivity of ligands and comprises of the dialysis of a two (or 
more) ligands against an array of nucleic acids with different structures or sequences.     
 
Figure 1.42. (A) quadruplex DNA has a high affinity to bind selectively with TF1; duplex 
DNA has a high affinity for H33258; (B) FRET measures the energy which is transferred 
from H33258 on the duplex DNA to TF1 on the quadruplex DNA and will show whether the 
functional nanostructure is formed or not.                                                                                                                      
 
(B)    (A) 
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Abstract 
This chapter provides an overview of our attempts to determine extinction coefficients for 
selected optoelectronically active π-conjugated molecules in our aqueous buffers. 
Compounds eosin b, ponceau s, sulforhodamine, basic fuchsin, basic yellow (thioflavin T), 
ethidium bromide, DAPI, H33258, GB01 and coralyne were found to have extinction 
coefficients of (57063 ± 457), (36355 ± 581), (84469 ± 563), (79644 ± 192), (24073 ± 135), 
(6645 ± 65.27), (23570 ± 786), 42000, 33000 and 14500 M-1 cm-1, respectively. These 
compounds were found to be stable and not sensitive to light. On the other hand, TF1, 
methylene blue, thiazole orange and DODC were found to fade upon exposure of light. 
Moreover, this chapter describes binding studies of a series of potential nucleic acid binders 
from a library of available (commercial and in-house synthesised) ligands. Binding of 
potential ligands to double-stranded FS-DNA and to different quadruplex-forming sequences 
(c-myc, 22AG and EAD2) is studied using UV-visible, circular dichroism spectroscopy (CD), 
and isothermal titration calorimetry (ITC). As anticipated, negatively charged compounds 
were found not to bind to DNA, whereas positively charged compounds all showed binding 
with varying affinities.                                       
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2.1 Introduction 
2.1.1 Solubility and stability 
Solubility is the property which describes the ability of a substance, the solute, to dissolve in 
a solvent. Solubility is defined as the amount of substance that passes into solution to achieve 
a saturated solution at constant temperature and pressure. Solubility is expressed in terms of 
maximum volume, mass or number of moles of the solute that dissolve in a given volume or 
mass of a solvent at equilibrium.128 
Absorbance is a measure of the capacity of a solution to absorb light of a specified 
wavelength. It is equal to the logarithm of the reciprocal of the transmittance and therefore is 
dimensionless. 
Absorbance is not an adequate measure for making comparisons between substances and 
solutions as both concentration and path length have an impact on the absorbance in a similar 
way. If the concentration of solution is increased, then there are more molecules for the light 
to hit when it passes through. As the concentration increases, there are more molecules in the 
solution, and more light is blocked. Both concentration and pathlength of light passing 
through a solution are allowed for in the Beer-Lambert law.  
The Beer–Lambert law relates the attenuation of light to the properties of the material 
through which the light is travelling. This relationship links concentration to absorbance in 
the following equation (Equation 1): 
A = ε×c×l (1) 
Where A is the measured absorbance, c the concentration of the sample in moles per liter of 
the solution, ε is the molar extinction coefficient in M-1 cm-1, and l is the path length.69 
Equation (1), leads to the equation to determine the extinction coefficient if absorbance and 
concentration are known and the compound is sufficiently stable and soluble (Equation 2): 
ε = A/ c×l (2) 
Therefore, the extinction coefficient is determined from the absorbance of the ligand divided 
by the concentration in moles per liter of the ligand and multiplied by the typical 1.0 cm path 
length of cuvette.  In practice, extinction coefficients are determined as the slope of a plot of 
absorbance as a function of concentration of the dye of interest. Any deviations from linearity 
of such plots indicate that solutions may not involve individually solvated and/or stable 
molecules.  
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The Beer-Lambert law maintains linearity under specific conditions only. The law will lead 
to inaccurate measurements at high concentrations because at very high concentrations the 
molecules of the analyte exhibit stronger intermolecular and electrostatics interactions which 
is due to the lesser amount of space between molecules. This can change the molar 
absorptivity of the analyte. Not only do high concentrations change molar absorptivity, but it 
also changes the refractive index of the solution causing departures from the Beer-Lambert 
law. 
Aggregation is the process where assemblages are formed in a solution or suspension leading 
to altered stability of colloidal systems. During aggregation, particles that are dispersed in the 
liquid phase agglomerate leading to a spontaneous formation of irregular particles called 
aggregates, flocs or clusters. Aggregation is usually an irreversible process if covalent 
(chemical) bond formation occurs between the aggregates. However, aggregation is typically 
reversible when weak (physical) bonds are formed between particles that can be broken by 
the change in temperature. The intrinsic rate of the process of bonding is dependent on the 
bond formation kinetics which is controlled by the chemical composition of the system, and 
cluster diffusion that controls the encounter rate of the clusters. These two factors are said to 
be vital limiters of the aggregation process leading to the aspects of chemically-controlled 
and physically-controlled limits.129-131  
Extinction coefficient values depend not only on the chemical structure of a compound, but 
also on its environment. It is well established that many dyes can be strongly solvatochromic. 
Solvatochromism is the ability of a chemical compound to change colour due to a change in 
solvent polarity. For example, Reichardt's dye (Betaine 30) changes colour in response to 
polarity and gives a scale of ET (30) values. The ET (30) value corresponds to the transition 
energy between the ground state and the lowest excited state, in kcal/mol, of Reichardt’s ET 
(30) dye (Betaine 30). Extinction coefficients should therefore be determined in the solvent 
and at the temperature of interest.  
 
2.1.2 The dye chemical structure  
Typical dyes display a pi-conjugated system. A conjugated system is a system of connected 
p-orbitals with delocalized electrons in compounds with alternating single and multiple 
bonds, which in general may lower the overall energy of the molecule and therefore increase 
stability. Lone pairs, radicals or carbonium ions may be part of the system. The compound 
may be cyclic, acyclic, linear or mixed. Conjugation is the overlap of one p-orbital with 
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another across an intervening sigma bond (in larger atoms d-orbitals can be involved). A 
conjugated system has a region of overlapping p-orbitals, bridging the interjacent single 
bonds. They allow a delocalization of pi electrons across all the adjacent aligned p-orbitals. 
The pi electrons do not belong to a single bond or atom, but rather to a group of atoms. 
 
The chemical structure of a dye molecule can be shown as the main skeleton and the 
substituent group. Each type of dyes has a specific skeleton. Generally, the skeleton 
determines lightfastness properties of a dye, and the substituent groups such as -OH and R-
SO₃− groups change the photostability of a dye within a class to a lesser degree.132 
There are over 25 essential classes of dyes, with natural dyes falling within the following 
eight groups: anthraquinones, hydroxyketones, carotenoids, naphthoquinones, indigoids, 
flavonones, flavonols and flavones.133 
One of the most important tools in modern biology are “fluorescent probes” which are often 
based on particles and small molecules that are organic in nature.134 Molecules that 
particularly react with biological molecular particles in order to produce an output in the 
concomitant change, in their photochemical nature are known as fluorescent probes, which 
are characterised by parameters such as fluorescent intensity, excitation and emission 
wavelength.  
Tsien and his colleagues did their research on the Ca2+ probes over 20 years ago. The Journal 
of Biological Chemistry reported on a new generation of calcium probes that Tsien designed 
to replace quin2.135 Since then phenomenal development and increase in the production of 
fluorescent probes across the world took place.135 Today, several strategies for designing 
fluorescent probes, such as photo induced electron transfer (PET) intramolecular charge 
transfer (ICT), spirocyclization as well as fluorescence resonance energy transfer (FRET) are 
used in the producing different kinds of probes.136 
Cyanine dyes are the most common examples used oligonucleotide labelling, which are 
fluorogenic and unsymmetrical in nature.137-140 Upon interaction with certain kinds of 
proteins and nucleic acids, cyanine dyes become fluorescent and result in the formation of 
photochromic compounds.141 Illumination also causes change in their optical properties. 
Fluorescent dyes are available in huge varieties also including the Acridine5 as well as 
Cyanine dye (Cy)4 families. Fluorescent dyes are used widely as oligonucleotide labels 
and/or probes. Cyanine dyes are even capable of non-covalent interactions with DNA either 
by base pair intercalation (acridines, cyanine dyes and monomethine) or through the 
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aggregation into the minor grooves within double stranded DNA (cyanine dyes of trimethine 
and pentamethine groups). Thiazole orange (TO) is a popular cyanine dye which is 
fluorogenic monomethine in nature that is also non-fluorescent when left free within the 
solution (caused by fast deactivation towards the ground state which is nonradiative in 
nature). Thiazole orange (TO) becomes extremely fluorescent where the polymethine chain 
motions are kept under control (e.g., when in viscous solvents or upon DNA intercalation).142 
Therefore, the different interactions between fluorescent dye thiazole orange and the DNA 
(see chapter 1).142, 143 many of fluorescent dyes have negligible fluorescence in solution, and 
on mixing with nucleic acids produce immense fluorescence. The increased fluorescence 
arises when the bond rotations between these aromatic systems is controlled, thereby 
preventing non-radiative decay.67, 144 Supramolecular chemical research of cyanine dyes 
shows that the working of the local environment on TO aggregation has restricted to nucleic 
acids.145  
          
2.1.3 Fading 
TF1, methylene blue, thiazole orange and 3,3′-diethylthiacyanine iodide (DODC) were found 
to fade upon exposure of light as discussed in Chapter 2. Most natural dyes have poor 
lightfastness, while synthetic dyes show the full range from poor to excellent lighfastness. 
These differences are due to their different chemical and physical characteristics. The change 
in colour of dyes due to light exposure is a complex reaction affected by both the chemical 
and physical state of the dye. This phenomenon is called photofading.146-149  
The main factors influencing the photostability of dyes are: 
• the wavelength of initial radiation  
• the dye aggregation 
• the presence of metal ions (bound in dyes or bound in impurities) 
Furthermore, the composition and the concentration of buffer, temperature and pH can also 
influence the rate of fading. 
It has been reported in the literature that the centralized methane hydrogen of TO can be 
substituted with an electron-withdrawing cyano group. This group is reported to decrease the 
sensitivity of the dye to singlet oxygen-mediated deviation.150  
The existence of a low singlet excited state of a long duration can result in a degradation 
reaction. At this point intersystem crossing of molecules takes place where molecules are 
Selection of optoelectronically active π-conjugated compounds 
 
48 
 
allowed to cross to their matching triplet state. Triplet states can exist for more duration 
which may further result to production of more photo-degradation.  
The Jablonski diagram shown in Scheme 2.1 is used to clearly demonstrate and analyse the 
effects of photochemistry on dyes, the diagram is used in demonstrating the fundamental 
alterations that exists on the electronic states. In the diagram, the lowest vibration energy 
levels on every electronic state are demonstrated by using thick lines, while other light lines 
shows higher vibrational energy levels that are related to every electronic state. The light that 
is absorbed by the molecule raises it from its ground electronic state (S0) to excited states (S1 
or S2 for next level). Due to the short lifetime of excited state, the molecule will return back 
to the original ground states. The process of transitioning back from the excited electronic 
state to ground electronic state is a result of loss of the energy that was absorbed, due to one 
of the following processes.   
• Intersystem crossing which results to lack of radiative transition  
• Release of the radiation energy  
• photochemical reactions 
• Energy transfer  
 
Scheme 2.1. Jablonski scheme 
 
Scheme 2.1. demonstrates that the singlet excited state has a higher energy level which 
means that it has higher content of energy as compared to triplet state; this makes it more 
reactive. In contrast there exist a long lifetime with the triplet state, which means that it has 
more time to react.151 The existence of reactive groups on dyes enables them to react even in 
the singlet excited state even though it may have a lifetime that is short.  Furthermore, the 
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chances of the dye reacting with oxygen molecule are high in the triplet state, because oxygen 
is able to undergo diffusion on the neighboring molecules of the dye. 
In the process of the dye being in the triplet state, chances are that in presence of oxygen it 
will experience a triplet – triplet annihilation, which results in the formation of singlet oxygen 
as shown in Scheme 2.2. The subsequent initiation of destruction of dye is shown in Scheme 
2.3.  
3HD* + 3O2 1O2 
Scheme 2.2 
1O2 + HD  
Scheme 2.3 
Analysis of photosensitization principles through photo-oxidation has been done by Griffiths 
and Hawkins who explained the pathway of the azo dyes photo – oxidation.152 The singlet 
oxygen sensitiser under the condition of the presence of the methylene blue in the solvent of 
alcohol. The pathway of the photochemical proceeded through the attack of the signet oxygen 
on the dye, by the intermediate unsaturated azo hydro-peroxide as shown in scheme 2.4. The 
signet oxygen attack on the hydrazine dye is presented as a process called type 2 photo – 
oxidation, because radicals are not involved in the primary reaction. The degradation will be 
observed to occur even in the absence of methylene blue.  
 
Scheme 2.4. Mechanism of oxidation of azo dyes by singlet oxygen 
The degradation of dyes is predominantly through singlet oxygen where singlet oxygen 
sensitisers are present in combination with oxygen. Examples of singlet oxygen generator are 
methylene blue, copper (II) and phthalocyanine Their efficiency will depend on the type of 
the solvent that is used because this affects the singlet oxygen lifetime.153, 154 The senstitiser 
are in a position to transfer their own energy from a lowest excited triplet state to an acceptor 
state. In doing so, the donorsmolecules return from their excited state to their ground state 
whereas the acceptor molecules are raised to the excited state.  
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2.1.4 Nucleic acid binding 
In order to compare affinities and selectivities, the interaction of some optoelectronically 
active π-conjugated molecules (described in Chapter 1), with a double-stranded fish sperm 
DNA (FS-DNA) and three well-known quadruplex-forming sequences, specifically, c-myc, 
22AG and EAD2 is studied.  
Depending on the orientation of the strands in a G-quadruplex, oligonucleotides can either 
form parallel conformations (e.g, c-myc and EAD2) and antiparallel conformation or 
mixed/hybrid conformation (22AG) (see chapter 1). 
Noncovalent binding of different compounds with DNA is an object of numerous studies, 
since these substances possess high biological activity and influence on many vitally 
important processes occurring in the cells. Some ligands are mutagens (ethidium bromide 
(EtBr)) and transcription inhibitors (EtBr, some antibiotics) which is determined by the 
ability of these compounds to form stable complexes and hence to obstruct DNA uncoiling. 
Binding can be studied through a range of techniques, including UV-visible and circular 
dichroism spectroscopy and isothermal titration calorimetry (ITC). A brief description these 
methods is provided in Chapter1. 
Photophysical data obtained for methylene blue in complexes with DNA indicate different 
binding modes of the dye depending on base sequences. In addition, electrostatic interactions 
play an important role during DNA binding.53 Previous studies have found a binding affinity 
of methylene blue to duplex DNA (Kbinding) of ~ 2.2 ×105 M-1.155  
Moreover, some ligands are multimodal in the nature of their binding to DNA. For example, 
EtBr (10) has three modes of binding to double-stranded DNA. EtBr also binds very well to 
triplex DNA and quadruplex DNA. Ethidium bromide (EtBr) is commonly used to detect 
nucleic acids from polymerase chain reaction experiments and restriction digests etc. in 
molecular biology laboratories. Previous studies have found a binding affinity (Kbinding) of 
(1.23 ± 0.07) ×105 M (bp)-1 and a (Kbinding) of 1.5 ×105 M-1 for binding site size (n) of (1.0 ± 
0.1) for the duplex and G-quadruplexes DNA, respectively.156, 157 
Coralyne (14) is slightly soluble in water. The structure of coralyne contains four fused 
aromatic rings. It can bind with DNA triplexes poly(dT)●poly(dA)●poly(dT) and poly 
[d(TC)] ●poly-[d(GA)] ●poly[d(C+T)]. Studies have found binding affinitys (Kbinding) of 3.5 
×106 M-1 and  1.5 ×106 M-1 for these two triplexes, respectively.158 
Bisbenzimide H33258 (6) is a water-soluble groove binder with selectivity for A●T-rich 
sequences.159, 160 GB01 (7) is related to the aforementioned minor groove binder H33258.5 
Selection of optoelectronically active π-conjugated compounds 
 
51 
 
Hoechst dyes are normally less toxic than DAPI, which ensures a higher viability of stained 
cells. 4′,6-Diamidino-2-phenylindole (DAPI) also is a water soluble fluorescent dye that 
binds strongly to adenine●thymine rich regions in DNA. This simple-to-use fluorescent stain 
visualizes nuclear DNA in both living and fixed cells. Cells stained with DAPI showed no 
ultrastructural changes compared to the appearance of cells not stained with DAPI. Previous 
studies have suggested that DAPI (11) binds by several modes to duplex DNA.29, 161 DAPI 
staining allows multiple use of cells eliminating the need for duplicate samples. The binding 
affinity of DAPI to oligonucleotides containing three A●T base pairs is about 7×106 M-1 
(bp).162 
Another ligand, TF1 (8), has poor aqueous solubility. It is a groove binder with duplex DNA 
perhaps because of its length. Previous studies have found a binding affinity (Kbinding) of 0.12 
×106 M-1 for a binding site size (n) of 2 base pairs. However, TF1 bind strongly to G-
quadruplexes such as 22AG and c-myc with affinity 0.47 and 0.55 ×106 M−1, respectively for 
a binding site size (n) of 2.163  
DODC (13) is water-soluble. Previous studies have found that DODC binds to a quadruplex 
groove, with affinity (Ka) of ∼1–2×105 M−1.164  
Some ligands combine two modes of interaction (e.g. Thioflavin T and thiazole orange).  
Thioflavin T (also known as  basic yellow (5)) is a cationic benzothiazole dye, which  is 
water-soluble.165 For over fifty years, Thioflavin T has been an extremely popular dye in 
biomedical research. This compound has a very high affinity for human telomeric G-
quadruplexes. In addition, it becomes fluorescent upon interaction with such structures as 
duplex DNA, and therefore is often utilized as a light-up probe. Previous studies have found a 
binding affinity (Kbinding) of ~104 M-1. 166 
Thiazole orange (12) is water-soluble and is an example of the oldest synthetic cyanine dyes 
and commonly used in reticulocyte analysis.167 TO binds strongly to triplex- and quadruplex 
DNA. Previous studies have found a binding affinity of TO for G4 structures of ∼ 1-2×106 
M-1. The fluorescence efficiency increases approximately 1000-fold due to the binding of TO 
to DNA. 168  
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2.1.5 Aims  
My aims for this chapter are to determine the extinction coefficients for optoelectronically 
active compounds in our buffer solutions. It is anticipated that these studies will also 
highlight any lack of stability of these dyes. In addition, this chapter also describes the 
binding studies to screen binding between available fluorescent ligands and nucleic acids. 
Binding affinities will be determined using UV-visible spectroscopy, circular dichroism 
spectroscopy and isothermal titration calorimetry (ITC). The resulting data will allow 
validation of the results from our dialysis experiments in Chapter 3.  
Chemical structures of the ligands chosen for this study are shown in Scheme 2.1. Ligands 4-
14 were chosen through the literature review based on their ability to interact with different 
selectivity and affinity with various DNA sequences. Compounds 1-3, namely eosin b (1), 
ponceau s (2), and sulforhodamine (3) are dyes that do not bind significantly with FS-DNA. 
Therefore, these compounds were chosen as reference controls for this study.  
Most small molecules that bind to DNA are largely planar aromatic compounds of 
considerable hydrophobicity. Almost perversely, it is precisely this set of properties that 
makes compounds good intercalators and/or minor groove binders, which also favors self-
aggregation in aqueous solution. The phosphodiester backbone of DNA is negatively charged 
at every nucleotide unit in aqueous conditions. The resulting water solubility is extended to 
many modified oligonucleotides, conferring solubility to hydrophobic molecules conjugated 
to DNA. 
Methylene blue (9) is a water-soluble compound with redox features. There is a large volume 
of published studies describing that methylene blue binds strongly to  DNA through several 
binding modes.159, 169 It binds to DNA and induces photosensitized reactions which can be 
used for sequence-specific cleavage of the DNA backbone. 
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Scheme 2.5 Chemical formulae, (1) eosin b, (2) ponceau s, (3) sulforhodamine (4) basic 
fuchsin, (5) basic yellow (thioflavin T), (6) H33258, (7) GB01, (8) TF1, (9) methylene blue, 
(10) ethidium bromide, (11) DAPI, (12) thiazole orange, (13) DODC and (14) coralyne.         
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2.2 Results and Discussion    
The results of the determination of the extinction coefficients for optoelectronically active 
compounds 1-14 are presented and discussed for each individual compound.                            
                                     
 2.2.1 Extinction coefficient, stability and DNA binding of Eosin B 
We wanted to determine the extinction coefficient of Eosin B (1). A stock solution of 1 (1.2 
mM) in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl) was prepared. A series of solutions of 
0.0025, 0.0076, 0.012 and 0.017 mM was prepared from the stock solution and UV-visible 
spectra were recorded for these solutions in a 1.0 cm path length cuvette at 25 °C. 
Absorbances at the λmax of 520 nm were plotted against ligand concentrations (Figure 2.1).    
 
Figure 2.1 Absorbance for 1 as a function of concentration in buffer (25 mM MOPS, pH 7.0, 
50 mM NaCl), at 25 °C. 
Figure 2.1 shows a linear correlation between absorbance and concentration. A linear fit to 
the dtata (red line) yields an extinction coefficient of (57063 ± 457) M-1 cm-1.  The error 
margin as a percentage of the extinction coefficient is 0.8 %, which is acceptable.  With the 
extinction coefficient established, we explored the stability of 1, and in particular the 
photochemical stability.  
To study the photochemical stability, we measured the absorbance of 1, exposed to ambient 
light, in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl and 1 mM EDTA), at 25 °C as a 
function of time (Figure 2.2).  
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Figure 2.2 (A) Spectra for the solution of 0.5 mM 1 exposed to light, in buffer (25 mM 
MOPS, pH 7.0, 50 mM NaCl and 1 mM EDTA), at 25 °C.  (B) The absorbance of 1 at 520 
nm plotted as a function of time.  
Figure 2.2 (A) shows a slight decrease in the spectra, which suggests that 1 has some 
sensitivity to light. Figure (B) confirms the decrease in the absorbance for 1, but the decrease 
appears to stop after approximately 30 minutes with an overall loss of absorbance of around 
10%. The loss of absorbance does not lead to a change in the shape of the spectrum, making 
it unlikely that the decrease corresponds to photochemical fading of 1. 
Binding of 1 to FS-DNA was studied using UV-visible spectroscopy. The changes in 
absorption of 1 upon addition of FS-DNA were recorded in buffer (25 mM MOPS, pH 7.0, 
50 mM NaCl, 1 mM EDTA), at 25 °C (Figure 2.3).   
 
Figure 2.3 UV-visible spectra for a 0.015 mM solution of 1 upon addition of 0 – 4.17 mM 
FS-DNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA), at 25 °C. 
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Figure 2.3 shows that the absorbance at λmax (520 nm) of 1 decreases slightly upon addition 
of FS-DNA. We further note that the shape of the spectrum does not change significantly. 
This decrease in UV-visible absorption may have occurred as a result of 1 interacting weakly 
with DNA, but it is likely as a result of dilution. 
To quantify the affinity of 1 for DNA, the absorbance at 520 nm was plotted as a function of 
concentration of FS-DNA (Figure 2.4, for numerical data, see Appendix Table A1). 
 
 
Figure 2.4 Absorbance at 520 nm for a 0.015 mM solution of 1 as a function of DNA 
concentration in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA), at 25 °C. The 
line represents the best fit of a multiple independent binding sites model to the data.  
Figure 2.4 shows that the multiple independent binding sites model generates a straight-line 
fit to the data, suggesting negligible interaction of 1 with the DNA and the decrease therefore 
merely represents the effect of dilution of the ligand that occurs when the DNA solution is 
added.  
The fit of the multiple independent binding sites model to the data gives a binding affinity 
confirms that  bindingKfor a binding site size restricted to 3 base pairs. This  1-) of ~0 MbindingK(
1 does not interact with FS-DNA, as expected considering 1 carries a negative charge. In 
addition, the spiro centre also leads to significant non-planarity of the molecule which likely 
hinders binding as well.                                                                                                                 
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2.2.2 Extinction coefficient, stability and DNA binding of the Ponceau S 
We set out to determine the extinction coefficient of Ponceau S (2). A stock solution of 2 
(0.99 mM) in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl) was prepared. A series of 
solutions of 0.0021, 0.0062, 0.010 and 0.014 mM was prepared from the stock solution. UV-
visible spectra were recorded for these solutions in a 1.0 cm pathlength cuvette at 25 °C. 
Absorbances at the λmax of 520 nm were plotted against ligand concentrations (Figure 2.5). 
 
Figure 2.5 Absorbance at 520 nm as a function of concentration of 2 in buffer (25 mM 
MOPS, pH 7.0, 50 mM NaCl and 1 mM EDTA), at 25 °C.   
The data follow a linear trend, suggesting no solubility problems over the range of 
concentrations studied. A linear fit (red line) was applied to the data in Figure 2.5 to obtain 
the extinction coefficient of (36355 ± 581) M-1 cm-1. The error margin as a percentage of the 
extinction coefficient is 1.5 %, which is an acceptable margin of error. The good fit also 
suggests that 2 is stable in the buffer, at least on the timescale of the experiment.  
Binding of 2 to FS-DNA was studied using UV-visible spectroscopy. The changes in 
absorption of 2 upon addition of FS-DNA were measured in buffer (25 mM MOPS, pH 7.0, 
50 mM NaCl, 1 mM EDTA), at 25 °C (Figure 2.6).  
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Figure 2.6 UV-visible spectra for a 0.016 mM solution of 2 upon addition of 0 – 4.26 mM 
FS-DNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA), at 25 °C. 
Figure 2.6 shows that the absorbance at λmax (520 nm) of 2 decreases upon addition of FS-
DNA. This change in UV-visible absorption might occur as a result of 2 interacting weakly 
with DNA, but it is more likely the result of simple dilution.   
To quantify any affinity of 2 for DNA, the absorbance at 520 nm was plotted as a function of 
concentration of FS-DNA (Figure 2.7, see Appendix Table A2 for data in tabular format). 
 
Figure 2.7 Absorbance at 520 nm for a 0.016 mM solution of 2 as a function of DNA 
concentration in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA), at 25 °C. The 
solid line represents the best fit of the multiple independent binding sites model to the data.  
Figure 2.7 shows that the fit to the data is mostly a straight-line with only a small apparent 
deviation from linearity at low DNA concentrations. The fit thus suggests that 2 interacts 
weakly with the DNA or not at all, in which case the decrease in absorbance is the result of 
dilution. 
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The fit of the multiple independent binding sites model to the data gives a binding affinity 
for a binding site size restricted to 3 base pairs. This  1-M 310) ×) of (2.14 ± 0.73bindingK(
equilibrium constant again confirms negligible binding of 2 to FS-DNA, as expected for a 
negatively charged compound.                                                                                                      
To confirm limited binding, we calculate the fraction bound ligand at the end of the titration 
Assuming 
total[ligand] free[ligand] 
  
×0.00426/3= 3.033 2.14×10= Therefore, fraction bound  
The calculation thus shows that 75% of the ligand is bound, even in the presence of a high 
DNA concentration of 4.26 mM. The low binding affinity is reasonable in light of the fact 
that 2 is negatively charged.  
2.2.3 Extinction coefficient, stability and DNA binding of Sulforhodamine  
We wanted to determine the extinction coefficient of Sulforhodamine (3). A stock solution of 
3 (0.5 mM) in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl) was prepared. A series of 
solutions of 0.001 mM, 0.003 mM, 0.005 mM and 0.008 mM was prepared by dilution of the 
stock solution. UV-visible spectra were recorded for these solutions in a 1.0 cm pathlength 
cuvette at 25 °C. The absorbance at the λmax of 563 nm was plotted against ligand 
concentration (Figure 2.8). 
 
Figure 2.8 Absorbance for 3 as a function of concentration of 3 in buffer (25 mM MOPS, pH 
7.0, 50 mM NaCl), at 25 °C.   
0.0 2.0x10-6 4.0x10-6 6.0x10-6 8.0x10-6
0.0
0.2
0.4
0.6
0.8
A 5
63
/ a
.u
.
[L]/ mol dm-3
Selection of optoelectronically active π-conjugated compounds 
 
60 
 
Figure 2.8 shows a linear increase in absorbance with concentration. A linear fit (red line) 
was applied to obtain the extinction coefficient of (84.5 ± 0.6) ×103 M-1 cm-1.  The error 
margin as a percentage of the extinction coefficient is 0.6 %, which is acceptable. The good 
fit also suggests that 3 is stable in the buffer, at least on the timescale of the experiment.  
Binding of 3 to FS-DNA was evaluated using UV-visible spectroscopy. Absorption spectra 
for 3 upon addition of FS-DNA were recorded in buffer (25 mM MOPS, pH 7.0, 50 mM 
NaCl, 1 mM EDTA), at 25 °C (Figure 2.9).  
 
 
Figure 2.9 UV-visible spectra for a 0.0097 mM solution of 3 upon addition of 0 – 3.70 mM 
FS-DNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA), at 25 °C. 
Figure 2.9 shows that the absorbance at 563 nm decreases slightly upon the addition of DNA 
with no increases between 300 and 700 nm. The shape of the peak remains the same. 
Although this change in absorbance might still occur because 3 interacts very weakly with 
DNA, the decrease in absorbance is likely the result of simple dilution. To distinguish 
between the two possibilities, the absorbance at 563 nm was plotted as a function of 
concentration of FS-DNA (Figure 2.10, see Appendix Table A3 for numerical data). 
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Figure 2.10 Absorbance at 563 nm for a solution of 0.0097 mM 3 as a function of DNA 
concentration in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA), at 25 °C. The 
line represents the best fit of a multiple independent binding sites model to the data.  
The MIS model fitted to the data in Figure 4.6 is once more a straight line, suggesting very 
weak or no binding between 3 and FS-DNA. In the absence of binding, the decrease merely 
represents the effect of dilution of the ligand. The fit of the multiple independent binding sites 
for the  1-M 2) of (0.66 ± 2.34) ×10bindingKnt (model to the data gives an equilibrium consta
binding site size restricted to 3 base pairs. The binding constant for 3 is small, suggesting no 
binding.                                                                                                                                          
To confirm limited binding, we calculate the fraction bound ligand at the end of the titration. 
This calculation uses the equation.  
  
talto[ligand] freeassume  [ligand]we  iftherefore  
×0.0037/3= 0.082 0.66×10= Therefore, fraction bound   
The calculation thus shows that less than 10% of the ligand is bound. 
In order to further assess the interaction of 3 with FS-DNA, binding was studied using 
circular dichroism spectroscopy. Circular dichroism spectra for 3 were recorded in the 
presence of different concentrations (0 mM to 2.45 mM) of FS-DNA in 25 mM MOPS, pH 
7.0, 50 mM NaCl, 1 mM EDTA, at 25 °C (Figure 2.11).   
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Figure 2.11 Circular dichroism spectra for 0.0097 mM 3 in the presence of different 
concentrations of FS-DNA (0 mM to 2.45 mM) in 25 mM MOPS, pH 7.0, 50 mM NaCl, 1 
mM EDTA at 25 °C.  
The circular dichroism spectra in Figure 2.11 show no change or appearance of an induced 
circular dichroism peak around the wavelength of interest (563 nm) where compound 3 
absorbs upon addition of DNA. This suggests that 3 does not interact with the DNA. (Note:  
the small peak around 563 nm is an artefact that already appears for the ligand only) 
Therefore, the result is in agreement with the result from the UV-visible titration which 
showed no binding.  
 2.2.4 Extinction coefficient, stability and DNA binding of basic fuchsin  
We set out to determine the extinction coefficient of basic fuchsin (4). A series of solutions of 
0.0006 mM, 0.002 mM, 0.003 and 0.004 mM was prepared by dilution of a stock solution. 
UV-visible spectra were recorded for these solutions in a 1.0 cm path length cuvette at 25 °C. 
Absorbance at the λmax of 539 nm was plotted against ligand concentration (Figure 2.12). 
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 Figure 2.12 Absorbance at 539 nm as a function of concentration of 4 in buffer (25 mM 
MOPS, pH 7.0, 50 mM NaCl), at 25 °C.   
Figure 2.12 shows that the absorbance at 539 nm increases linearly with concentration of 4. A 
linear fit (red line) was applied to obtain the extinction coefficient of (79644 ± 192) M-1 cm-1.  
The error margin as a percentage of the extinction coefficient is 0.2 %, which is a small 
margin of error. The extinction coefficient of (79644 ± 192) M-1 cm-1 is lower than the 
previous reported value of 116000 M-1 cm-1 at 544 nm in a different buffer  (20 mM Tris-
HCl, pH 7).170  
2.2.4a Light sensitivity of basic fuchsin 
There is a possibility that the difference in extinction coefficient for 4 is the result of 
exposure to light. To study whether 4 is sensitive to light, we plot the absorbance of 4 as a 
function of time exposed to ambient light, with 4 dissolved in buffer (25 mM MOPS, pH 7.0, 
50 mM NaCl and 1 mM EDTA), at 25 °C (Figure 2.13).  
(A) (B) 
 
 
Figure 2.13 (A) Spectra of solutions of 0.013 mM 4 exposed to light, in buffer (25 mM 
MOPS, pH 7.0, 50 mM NaCl and 1 mM EDTA), at 25 °C. (B) The absorbance at 539 nm for 
4 upon exposure to light plotted as a function of time. 
Figure 2.13 (A) shows a very slight increase, which suggests that 4 has limited or no 
sensitivity to light. Figure 2.13 (B) confirms the data. This experiment therefore suggests that 
4 is stable and not sensitive to light. It is therefore clear that the difference in extinction 
coefficients for 4 is not related to light sensitivity of the compound. In this instance, maybe 
the purity of 4 affected the extinction coefficient.  
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Binding of 4 to FS-DNA was studied using UV-visible spectroscopy. The changes in 
absorption of 4 upon addition of FS-DNA were measured in buffer (25 mM MOPS, pH 7.0, 
50 mM NaCl, 1 mM EDTA), at 25 °C (Figure 2.14).  
 
Figure 2.14 UV-visible spectra for a 0.0080 mM solution of 4 upon addition of 0 – 4.25 mM 
FS-DNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA), at 25 °C. 
Figure 2.14 shows a hypochromic and bathochromic shift upon addition of FS-DNA. This 
change in absorption maximum suggests that the conformation of 4 and/or it is surrounding 
medium changes upon the addition of DNA, suggesting that 4 binds to DNA.  
To quantify the affinity of 4 for FS-DNA, the absorbance at 539 nm was plotted as a function 
of concentration of FS-DNA (Figure 2.15, see Appendix Table A4 for data in tabular format). 
 
Figure 2.15 Absorbance at 539 nm of a solution of 0.0080 mM 4 as a function of DNA 
concentration in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA), at 25 °C. The 
line represents the best fit of a multiple independent binding sites model to the data.  
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The titration curve in Figure 2.15 shows a decrease in absorbance at 539 nm upon the 
addition of FS-DNA. These changes in the UV-visible spectra occurred because 4 interacts 
with DNA. The titration data obtained for 4 was reproduced satisfactorily by the multiple 
independent binding sites model. Because the original binding site size of 4 was big (10.38 ± 
4.94 basepairs) it was considered unreasonable. Therefore, we decided to restrict the binding 
site size to 3.0 base pairs. This fit of the multiple independent binding sites model to the data 
gives a binding affinity (Kbinding) of (4.93 ± 0.94) ×104 M-1 .  
To investigate the binding mode of 4 with FS-DNA, we used circular dichroism 
spectroscopy. Induced circular dichroism spectra for 4 were recorded at different 
concentrations of FS-DNA (0 mM – 3.392 mM) in buffer (25 mM MOPS, pH 7.0, 50 mM 
NaCl, 1 mM EDTA), at 25 °C (Figure 2.16). 
 
Figure 2.16 Circular dichroism spectra for 0.0120 mM 4 in the presence of different 
concentrations of FS-DNA (0 mM – 3.392 mM) in 25 mM MOPS, pH 7.0, 50 mM NaCl, 1 
mM EDTA at 25 °C.  
The circular dichroism spectra in Figure 2.16 show a negative induced circular dichroism 
signal at 550 nm, which increases upon addition of DNA. This weak negative ellipticity 
suggests an intercalative binding mode for 4 binding to FS-DNA. To quantify the affinity of 4 
for FS-DNA, the ellipticities at 550 nm were plotted as a function of concentration of FS-
DNA (Figure 2.17).  
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Figure 2.17 Ellipticity at 550 nm plotted against FS-DNA concentrations for 0.0120 mM of 
4, in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA), at 25 °C. The solid line 
represents the best fit of a multiple independent sites model to the data.  
The titration curve in Figure 2.17 was analysed by fitting a multiple independent binding sites 
model, which also takes ligand dilution into account, to the data. The fit gives an equilibrium 
constant (Kbinding) of (1.44 ± 0.30) ×104 M-1 for a binding site size of 3 base pairs. A negative 
ICD signal suggests that 4 intercalates between the base pairs. 
2.2.5 Extinction coefficient, stability and DNA binding of thioflavin T  
To determine the extinction coefficient for thioflavin T (5) in our buffer, three stock solutions 
of 5 were made up in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA). The 
first and second stock solutions were 0.06 mM (by weight) and a series of dilutions of the 
first stock solution was prepared (0.0099 mM, 0.010 mM, 0.011 mM and 0.012 mM). A 
second series of solution (0.0032 mM, 0.0061 mM, 0.0088 mM and 0.011 mM) was prepared 
from the second stock solution. The third stock solution was 0.47 mM (by weight). A series 
of solutions of 0.0092 mM, 0.018 mM, 0.026 mM and 0.034 mM was prepared from this 
stock solution. UV-visible spectra were recorded for all solutions in a 1.0 cm path length 
cuvette at 25 °C. Absorbance at the λmax of 412 nm for all three dilution series were plotted 
against ligand concentration (Figure 2.18). 
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Figure 2.18 Absorbance at 412 nm as a function of concentration of 5 in buffer (25 mM 
MOPS, pH 7.0, 50 mM NaCl), at 25 °C.   
Figure 2.18 shows that the absorbance at 412 nm increases linearly with concentration of 5. A 
linear fit (red line) was applied to obtain the extinction coefficient of (24073 ± 135) M-1 cm-1. 
The error margin as a percentage of the extinction coefficient is 0.5 % which is a sufficiently 
small error.  
2.2.5a Light sensitivity of thioflavin T 
To study whether 5 is sensitive to light, we plot the absorbance of 5 as a function of time 
exposed to ambient light, with 5 dissolved in buffer (25 mM MOPS, 50 mM NaCl. pH 7.0), 
at 25 °C (Figure 2.19).  
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Figure 2.19 (A) Spectra of a 0.029 mM solution of 5 as a sample exposed to light, in buffer 
(25 mM MOPS, 50 mM NaCl. pH 7.0), at 25 °C. (B) The absorbance at 412 nm for 5 upon 
exposure to light plotted as a function of time. 
Figure 2.19 (A) shows sufficient stability, which suggests that 5 has no sensitivity to light. 
Figure 2.19 (B) confirms the data. This experiment therefore suggests that 5 is stable and not 
sensitive to light.  
We desired to know the affinity of 5 for DNA in our buffers.171 UV-visible spectroscopy has 
been used. The changes in absorption of 5 upon addition of FS-DNA in buffer (25 mM 
MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 25 °C are reported in Figure 2.20.  
 
Figure 2.20 UV-visible spectra for a 0.011 mM solution of 5 upon addition of 0 – 0.74 mM 
FS-DNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 25 °C. 
Figure 2.20 shows hypochromic and bathochromic shifts for 5 upon addition of DNA. This 
change in UV-visible absorption indicates interaction of 5 with DNA and the change in 
spectrum may indicate a conformational change of 5 upon binding but it may also be a result 
of a local medium effect.   
To quantify the affinity of 5 for FS-DNA, the absorbance at 412 nm was plotted as a function 
of concentration of FS-DNA (Figure 2.21, see Appendix Table A5 for numerical data). 
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Figure 2.21 Absorbance at 412 nm of a solution of 0.011 mM 5 as a function of DNA 
concentration in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 25 °C. 
The solid line represents the best fit of a multiple independent binding sites model to the data.  
The titration data obtained for 5 were reproduced satisfactorily by the multiple independent 
binding sites model. This fit of the multiple independent binding sites model to the data gives 
an equilibrium constant (Kbinding) of (1.18 ± 0.21) ×104 M-1 for the binding site size restricted 
to 3 base pairs. This binding constant is in a good agreement with the reported equilibrium 
constant of (Kbinding) of ~104 M-1. 166 
 
2.2.6 Extinction coefficient, stability and DNA binding of H33258                                           
There have been relatively recent studies on the molar extinction coefficient for H33258 (6) 
in SSC buffer containing 20 mM sodium citrate at pH 6.8. The extinction coefficient was 
found to be 42000 M-1 cm-1 at 343 nm.172 In light of these studies, we opted not to determine 
the extinction coefficient for 6. Compound 6 is also known to be sensitive to precipitation, 
but normally solutions can be prepared that are sufficiently stable to allow UV-visible 
totrations.62  
 
We know from the literature that 6 binds to DNA, and most strongly with A●T sequences.159 
However, we desired to know if the presence of a co-solvent in our chosen buffers affects the 
affinity of 6 for FS-DNA. In order to study the affinity of 6 for DNA UV-visible 
spectroscopy was used as before. The changes in absorption of 6 upon addition of FS-DNA 
were measured in buffer (25 mM MOPS, pH 7.0, 100 mM KCl, 9 vol -% DMSO and 1 mM 
EDTA), at 25 °C and are shown in Figure 2.22. 
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Figure 2.22 UV-visible spectra for (A) 0.018 mM 6 upon addition of 0 – 0.17 mM FS-DNA 
and, (B) 0.017 mM 6 upon addition of 0 – 0.65 mM FS-DNA, both in buffer (25 mM MOPS, 
pH 7.0, 100 mM KCl, 9 vol-% DMSO and 1 mM EDTA), at 25 °C. 
Figure 2.22 shows that 6 displays a hypochromic and bathochromic shift in absorbance upon 
addition of DNA with a maximum change in absorbance at 338 nm. This decrease in UV-
visible absorption occurs as a result of 6 interacting with DNA. To quantify the affinity of 6 
for FS-DNA in our buffer, the absorbances at 338 nm for both titrations were plotted as a 
function of concentration of FS-DNA (Figure 2.23 and appendix Tables A6&A6.1). 
 
 Figure 2.23Absorbance at 338 nm (■) for a solution of 0.018 mM 6 and (●) for a solution of 
0.017 mM 6, both as a function of DNA concentration, in buffer (25 mM MOPS, pH 7.0, 100 
mM KCl, 9 vol % DMSO and 1 mM EDTA) at 25 °C. The solid line represents the global fit 
of a multiple independent binding sites model to the data.  
The titration curves in Figure 2.23 were analysed globally using the multiple independent 
binding sites model, which also takes ligand dilution into account. This fit produces an 
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apparent binding affinity (Kbinding) of (8.5 ± 4.5) ×105 M-1 and a binding site size of (0.9 ± 
0.09) base pairs is a reasonable value. Therefore, the binding site size was not restricted to 3.0 
base pairs.     
                                                                                                                                           
 2.2.7 Extinction coefficient of, stability and DNA binding of GB01 
The molar extinction coefficient of GB01 (7) has been reported to be 33000 M-1 cm-1 at 332 
nm, in water containing NaCl (0.1 M), KH2PO4 (10 mM), and EDTA (0.1 mM), (pH not 
reported). This extinction coefficient was used as reported.173  
Compound 7 (Scheme 2.1) is related to the well-known minor groove binder H33258 (6).5 
The binding of 7 to FS-DNA was studied using UV-visible spectroscopy; the changes in 
absorption of 7 upon addition of FS-DNA were measured in buffer (25 mM MOPS, pH 7.0, 
50 mM NaCl, 1 mM EDTA), at 25 °C (Figure 2.24).  
 
 
 
 
 
 
 
Figure 2.24 UV-visible spectra for a 0.028 mM solution of 7 upon addition of 0 – 2.90 mM 
FS-DNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA), at 25 °C. 
Figure 2.24 shows that the absorbance of 7 changed and the wavelength of maximum 
absorption has shifted upon addition of FS- DNA. This change in absorption spectrum 
suggests that the conformation of 7 and/or the surrounding medium of 7 has changed upon 
at 331 nm was plotted as a  7he absorbance of .  Tand thus suggests binding addition of DNA
function of the concentration of FS- DNA (Figure 2.25, see Appendix Table A7 for data 
intabular ormat).                                                                                                                            
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Figure 2.25 Absorbance at 331 nm for a solution of 0.028 mM 7 as a function of FS- DNA    
 concentration in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA), at 25 °C.          
Figure 2.25 shows two events. The first event is a rapid decrease in absorbance upon the 
addition of a small amount of DNA. We attribute this decrease in absorbance to strong 
with DNA in multiple types of binding sites, leading to precipitation of  7interactions of 
ligand-DNA complexes as a result of charge neutralization. When the DNA concentration is 
increased further, a second event occurs. The second event leads to a clear increase in the 
attribute this increase in absorbance to ligands binding to the actual We  .7absorbance of 
preferred binding sites of 7 on DNA. A fit of the multiple independent binding sites model to 
 1-M3 ) of (5.15 ± 0.43) ×10bindingKpparent binding affinity (the second part of data gives an a
for a binding site size restricted to 3 base pairs. This is an apparent affinity because of the 
competition between specific and non-specific binding sites.                                                      
We investigated the binding of 7 with FS-DNA further using isothermal titration calorimetry 
(ITC).                                                                                                                                             
First, the self-aggregation of 7 in buffer was studied using an ITC dilution experiment. The 
differential heat flow and derived integrated heat effects were measured for dilution of a 0.95 
mM solution of 7 into 25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA at 25 °C (Figure 
2.26, Appendix Tables A7.1& A7.2 for numerical data). 
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Figure 2.26 (A) Dilution of a 0.95 mM solution of 7 (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 
mM EDTA), at 25 °C (B) Integrated heat effects for dilution of a 0.95 mM solution of 4.7 
into 25 mM MOPS, 50 mM NaCl, 1 mM EDTA, pH 7.0, at 25 °C, experimental heat effect 
per injection (▀), calculated heat effect per injection (-). 
According to Figure 2.26, the dilution of 7 is endothermic with non-constant heat effects. 
Non-constant heat effects are indicative of self-aggregation of 7.  We analysed this data using 
our ITC data analysis software IC-ITC.62  The reason for using ICITC is that the complexity 
of the data, once dilution will be combined with DNA binding, will require a complex data 
analysis model.  
We analysed the data in terms of a stepwise self-aggregation model, illustrated by model 
eqn.1 (Table 2.1). 
 
 
Table 2.1: Thermodynamic parameters for aggregation of 7 in 25 mM MOPS, pH 
7.0, 50 mM NaCl, 1 mM EDTA at 25 °C 
ΔH dilution / kcal mol-1 Kaggregation / M-1 ΔHaggregation / kcal mol-1 
-0.9 
 
1.48×103 
(900-2200) 
-9.0 
(-12.8  -   -7.2) 
Note: values in brackets indicate confidence intervals. 
 
The affinity of 7 for duplex DNA was studied using ITC. The differential heat flow and 
derived integrated heat effects for titration of a 0.95 mM solution of 7 into a 0.2 mM FS- 
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DNA solution were measured in 25 mM MOPS, 50 mM NaCl, 1 mM EDTA, and pH 7.0, at 
25 °C (Figure 2.27). 
 
(A) (B) 
 
 
 
Figure 2.27 (A) Titration of a 0.95 mM solution of 7 into a 0.2 mM FS-DNA in 25 mM 
MOPS, 50 mM NaCl, 1 mM EDTA, and pH 7.0, at 25 °C. (B) Integrated calorimetric data for 
titration of a 0.95 mM solution of 7 into a 0.2 mM fish sperm DNA in 25 mM MOPS, 50 mM 
NaCl, 1 mM EDTA, pH 7.0, at 25 °C, experimental heat (▀), calculated heat (●). 
Figure 2.27A shows the enthalpogram for binding of 7 to FS-DNA. The enthalpogram for 
binding of 7 to DNA suggests at least one binding event which is followed by ligand dilution. 
There may be a second, high affinity and low stoichiometry, binding event as well but based 
on previous experience we did not attempt to fit this because it appears poorly defined by the 
data. 
The fit of the model (Figure 2.27B) indicates that a binding model involving one type of 
binding event in combination with stepwise aggregation reproduces the data reasonably well. 
The binding constant K and binding site size n for binding of 7 to DNA in 25 mM MOPS, 50 
mM NaCl, pH 7.0, at 25 °C are summarised in Table 2.2. 
Table 2.2 Binding constant K, binding site sizes n, and interaction enthalpy ΔH for 
binding of 7 to DNA in 25 mM MOPS, 50 mM NaCl, pH 7.0, at 25 °C. 
ΔHA1 / kcal mol-1 KA1 / M-1 n=1/nA1 
-6.9 
(-7.3 - 6.4) 
4.48×105 
(1.8 ×105 - 5.8×105) 
1.14 
(1.10-1.18) 
1-cal mol 3and 9.02×10 1-M 3ricted to 1.48×10a) Aggregation parameters rest 
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It is interesting to compare DNA binding of 6 and 7 because they are structurally related and 
both of them bind to DNA as groove binders (Table 2.3) and previous ITC studies for 6 
binding to DNA are available.62 The enthalpogram for binding of 7 to DNA suggests at least 
one binding event. Enthalpograms for binding of 6 to specific sequences of DNA suggests 
two binding modes of which the non-selective electrostatic binding mode has a similar 
binding site size of 1 base pair. 
Table 2.3 Thermodynamic parameter for interaction of 6 to specific sequences of DNA in 0 
mM MOPS, 100 mM NaCl, pH 7.0, at 25 °C, and 7 to FS-DNA in 25 mM MOPS, 50 mM NaCl,  
pH 7.0, at 25 °C. 
Ligand             Kaggregation/ x103 M-1      ΔHaggregation/ kcal mol-1         KA1 / M-1                      ΔHA1 / kcal mol-1 
6                            2.70                  -10.79          8.2×106                                  -3.17 
7                            1.48                  -9.02               4.48×105                               -6.9 
 
Table 2.3 demonstrates that Kaggregation and ΔHaggregation, for 6 and 7 are similar. This 
observation suggests that both compounds aggregate in a similar manner. The binding 
affinity of the compound 6 is ten-fold higher than that of the compound 7. However, the 
value of enthalpy change for the compound 7 is almost twice of the value of the compound 6. 
 
2.2.8 Extinction coefficient, stability and DNA binding of TF1 
We wanted to determine the extinction coefficient of TF1 (8) in aqueous solutions. We 
attempted to dissolve 8 in buffer without added co-solvents but we found limited solubility in 
buffer. Therefore, we added 9 vol-% of DMSO to the buffer (25 mM MOPS pH 7.0, 100 mM 
KCl and 1 mM EDTA).   
A stock mixture of 8 (0.048 mM) in buffer (25 mM MOPS pH 7.0, 100 mM KCl, 1 mM 
EDTA and 9 vol-% DMSO) was prepared. In this mixture, 8 was not fully dissolved. Three 
dilution series were made (0.005 mM, 0.006 mM, 0.008 mM and 0.009 mM; 0.006 mM, 
0.007 mM, 0.008 mM and 0.009 mM; 0.0069 mM, 0.0076 mM and 0.009 mM). UV-visible 
spectra were recorded for those dilution series in a 1.0 cm pathlength cuvette at 25 °C. 
Absorbance at the λmax of 476 nm was plotted against ligand concentration (Figure 2.28).  
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Figure 2.28 Absorbance as a function of concentration of 8 in buffer (25 mM MOPS pH 7.0, 
100 mM KCl, 1 mM EDTA and 9 vol-% DMSO), at 25 °C (■). 
Figure 2.28 shows an increase in absorbance at 476 nm with increasing concentration. This 
increase does not appear to be linear with concentration. A linear fit (red line) was applied to 
obtain the extinction coefficient of (20059 ± 1902) M-1 cm-1.  The error margin as a 
percentage of the extinction coefficient is 9 %.  That is a very large margin of error. This 
large error may be because of limited solubility, and resulting precipitation, of 8 in 25 mM 
MOPS pH 7.0, 100 mM KCl, 1 mM EDTA and 9 vol-% DMSO. 
The error on the extinction coefficient in this work suggests that 9 vol-% of DMSO as a co-
solvent is not enough to keep 8 in solution. Alternatively, the poor correlation may result 
from fading of the colour of 8 during experiments (see below). 
To avoid the challenge of limited solubility, we determined the extinction coefficient of 8 in 
pure DMSO and pure acetonitrile.  
A stock solution of 8 (0.046 mM) (by weight) in DMSO was prepared and a dilution series 
was made (0.006 mM, 0.007 mM, 0.008 mM and 0.0086 mM). A second stock solution of 
the same concentration as the first stock solution was similarly used to prepare a second 
dilution series (0.002 mM, 0.004 mM, 0.006 mM, 0.007 mM and 0.009 mM). UV-visible 
spectra were recorded for the combined dilution series in a 1.0 cm pathlength cuvette at 25 
°C. The UV-visible spectra show that the λmax has shifted from 476 nm in aqueous buffer to 
500 nm in DMSO. Absorbance at the λmax of 500 nm was plotted against ligand concentration 
(Figure 2.29).  
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Figure 2.29 Absorbance at 500 nm as a function of concentration of 8 in DMSO at 25 °C 
Figure 2.29 shows an increase in absorbance at 500 nm with increasing concentration. A 
linear fit (red line) was applied to obtain the extinction coefficient. The extinction coefficient 
is (79579 ± 967) M-1 cm-1. The error margin as a percentage of the extinction coefficient is 
1.2 %, which is acceptable. 
We similarly examined the extinction coefficient for 8 in pure acetonitrile to explore potential 
solvent effects on the extinction coefficient of 8.   
A stock solution of 8 (0.050 mM) (by weight) in acetonitrile was prepared and a dilution 
series was made (0.0072 mM, 0.0079 mM, 0.008 mM and 0.009 mM). A second stock 
solution of the same concentration as the first stock solution led to a second dilution series 
(0.002 mM, 0.004 mM, 0.006 mM, 0.008 mM and 0.01 mM). UV-visible spectra were 
recorded for the combined dilution series in a 1.0 cm pathlength cuvette at 25 °C. Absorbance 
at the λmax of 500 nm was plotted against ligand concentration (Figure 2.30).  
 
Figure 2.30 Absorbance as a function of concentration of 8 in acetonitrile at 25 °C.  
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Figure 2.30 shows an increase in absorbance at 500 nm with increasing concentration. A 
linear fit (red line) was applied to obtain the extinction coefficient. The extinction coefficient 
in acetonitrile is (65962 ± 531) M-1 cm-1. The error margin as a percentage of the extinction 
coefficient is 0.7 %, which is a small margin of error. 
The extinction coefficient in DMSO is bigger than that in acetonitrile; we do not currently 
have an interpretation for this observation.  
We want to know how much co-solvent we need to create a stable solution. we therefore 
determined absorbances of 8 in 10 and 20 vol-% DMSO / buffer (25 mM MOPS pH 7.0, 50 
mM NaCl and 1 mM EDTA), at 25 °C. A stock solution of 8 in DMSO was diluted in buffer 
(25 mM MOPS pH 7.0, 50 mM NaCl and 1 mM EDTA) and DMSO added as required to 
keep the fraction of DMSO constant. 
 The absorbances for 8 in both the buffer containing 10 vol-% DMSO and 20 vol-% DMSO 
were plotted together as a function of concentration of 8 (Figure 2.31).  
 
Figure 2.31 Absorbance as a function of concentration in 10 and 20 vol-% DMSO/ buffer (25 
mM MOPS pH 7.0, 50 mM NaCl and 1 mM EDTA), at 25 °C.  
Figure 2.31 shows that the absorbance increases linearly with concentration of 8 and there is 
no significant difference between the systems involving 10 and 20 vol-% DMSO. A linear fit 
(red line) was applied to obtain the extinction coefficient. The extinction coefficient is (53580 
± 1690) M-1 cm-1. The error margin as a percentage of the extinction coefficient is 3.1 %, 
which is an acceptable margin of error. Compound 8 has sufficient solubility in both 10 and 
20 vol-% DMSO/ buffer (25 mM MOPS pH 7.0, 50 mM NaCl and 1 mM EDTA), at 25 °C. 
The results of this investigation show that aqueous solutions containing 10 and 20 vol-% 
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DMSO work well as a solvent for 8. These experiments also suggest that the scatter in Figure 
2.31 is the result of in solubility of 8 at the concentration of the stock solution.  
We next examine the effect of acetonitrile on the extinction coefficient in aqueous solution 
and compare the extinction coefficient with DMSO-containing aqueous solutions.  
A stock solution of 8 in acetonitrile was diluted in buffer (25 mM MOPS pH 7.0, 50 mM 
NaCl and 1 mM EDTA) and acetonitrile added as required to keep the fraction of acetonitrile 
constant. The absorbance of 8 in 10 and 20 vol-% acetonitrile / buffer (25 mM MOPS pH 7.0, 
50 mM NaCl and 1 mM EDTA) was measured at 25 °C. (Figure 2.32).   
 
Figure 2.32 Absorbance as a function of concentration of 8 in 10 and 20 vol-% acetonitrile / 
buffer (25 mM MOPS pH 7.0, 50 mM NaCl and 1 mM EDTA), at 25 °C.  
Figure 2.32 shows that the absorbance increases linearly with concentration of 8 and that 
there is no significant difference between the systems involving 10 and 20 vol-% acetonitrile. 
A linear fit (red line) was applied to obtain the extinction coefficient. The resulting extinction 
coefficient is (50539 ± 1984) M-1 cm-1. The error margin as a percentage of the extinction 
coefficient is 3.9 %, which is an acceptable margin of error. This work suggests that the 
extinction coefficients for 8 in aqueous acetonitrile and aqueous DMSO are similar. 
Therefore, co-solvent174 does not affect the extinction coefficient much. 
Another factor that can affect the extinction coefficient is the sensitivity of a compound to 
light. We suspected that 8 is light sensitive. In order to study whether 8 is sensitive to light 
we recorded the absorbance spectra for 8 as a function of time exposed to ambient light and 
we compared this with data for a sample shielded from light. Compound 8 was dissolved in 
pure acetonitrile and diluted in buffer (25 mM MOPS pH 7.0, 50 mM NaCl and 1 mM 
0.0 2.0x10-6 4.0x10-6 6.0x10-6 8.0x10-6
0.00
0.07
0.14
0.21
0.28
0.35
0.42
A 5
00
/ a
.u
.
[L]/ mol dm-3
Selection of optoelectronically active π-conjugated compounds 
 
80 
 
EDTA) and we recorded spectra with one sample exposed to light and the second sample 
shielded from light (Figure 2.33).  
(A) (B) 
  
Figure 2.33 UV-visible spectra for 8 dissolved in pure acetonitrile and diluted in buffer (25 
mM MOPS pH 7.0, 50 mM NaCl and 1 mM EDTA) to give the same concentration for A and 
B, (A) exposed to ambient light for 216 hours and (B) stored in a dark place for 260 hours 
(initial spectra are not shown). 
Figure 2.33 (A) shows a clear decrease in the absorbance of 0.046 mM 8 at the λmax of 476 
nm for the sample exposed to light and shows that a new peak appears around 350 nm. Figure 
(B) shows that a solution of 8 which was stored in a dark place does not fade.  
Moreover, it is clear that light affects 8 from visual observation as well because the solution 
becomes colourless with time, while the solution of 8 that was stored in a dark place does not 
show any visual change.  
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 We repeated the experiment but this time we dissolved 8 in pure DMSO and diluted in buffer 
(25 mM MOPS pH 7.0, 100 mM KCl, 9 vol-% of DMSO and 1 mM EDTA). We plot the 
absorbance spectrum of 8 as a function of wavelength after storing the sample exposed to 
light or protected from light (Figure 2.34). 
 
Figure 2.34 UV-visible spectra for 8 dissolved in DMSO and diluted in DMSO-containing 
buffer (25 mM MOPS pH 7.0, 100 mM KCl, 9 vol-% of DMSO and 1 mM EDTA); final 
concentration for A and B is identical. (A) exposed to light for 216 hours and (B) stored in a 
dark place for 260 hours. Note: initial spectra are not shown. 
Figure 2.34 (A) shows the appearance of a new peak around 350 nm when the sample is 
exposed to light. Figure (B) shows a solution of 0.046 mM 8 which was stored in a dark 
place. No significant changes in the absorbance spectrum are apparent. We conclude that 8 is 
sensitive to the light. To avoid fading it should be stored in a dark place.   
Based on our results, 8 is sparingly soluble in water but it is soluble in some organic solvents 
such as acetonitrile and DMSO. On the basis of it is structure, we suppose that 8 is a groove 
binder with duplex DNA because of it is length.163 In order to study the binding of 8 with 
duplex DNA in the presence of acetonitrile and DMSO, we prepared aqueous solutions 
starting from stock solutions of 8 in acetonitrile and DMSO. We then did two types titrations. 
In the first titration, a stock solution of 0.28 mM 8 in acetonitrile was prepared. A volume of 
this stock solution was added to 2375 µl buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM 
EDTA), in a 1.00 cm pathlength cuvette. In the second and third titrations, stock solutions of 
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0.006 mM 8 and 0.0031 mM 8 were prepared directly in DMSO-containing buffer (25 mM 
MOPS, pH 7.0, 100 mM KCl, 9 vol-% DMSO and 1 mM EDTA). 
In the first titration, binding of 8 to FS-DNA in 25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM 
EDTA in presence of 1.04 % of acetonitrile was studied using UV-visible spectroscopy. The 
changes in absorption of 8 upon addition of FS-DNA in buffer (25 mM MOPS, pH 7.0, 50 
mM NaCl, 1 mM EDTA), at 25 °C are as shown in Figure 2.35.  
 
Figure 2.35 UV-visible spectra for a 0.0029 mM solution of 8 upon addition of   0 – 1.04 
mM FS-DNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA), at 25 °C. 
Figure 2.35 shows that the absorbance of 8 changed and shifted upon addition of DNA. This 
change in absorption suggests that the conformation of 8 and/or the surrounding medium of 8 
has changed upon addition of DNA. 
The absorbance of 8 at 476 nm as well as the average absorbance in the range 670-700 nm 
was plotted as a function of the concentration of DNA (Figure 2.36 A, see Appendix Table 
A8 for numerical data). 
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Figure 2.36 (A) Absorbance at 476 nm of a 0.0029 mM solution of 8 in the presence of 1.04 
% of acetonitrile as a function of FS-DNA concentration in buffer (25 mM MOPS, pH 7.0, 50 
mM NaCl, 1 mM EDTA), at 25 °C. (B) The average absorbance in the range 670-700 nm as a 
function of FS-DNA concentration in the same experiment.  
Figure 2.36 (A) shows two events. The first event is accompanied by a rapid decrease in the 
absorbance upon addition of DNA. We attribute this decrease in absorbance to strong 
interactions of 8 with DNA in the regime where the ligand is present in large excess over the 
DNA. In this regime, the ligand binds to all available binding sites, leading to precipitation of 
ligand-DNA complexes as a result of charge neutralization.  
Figure 2.36 (B) shows the average absorbance in the range 670-700 nm and there are 
indications of scattering effects as a results of poor solubility and precipitation of the complex 
formed when DNA is saturated with bound 8. When the DNA concentration is increased, a 
second event occurs (figure 2.36A), leading to an increase in the absorbance of 8. This event 
corresponds to binding of the ligand bound in secondary binding sites (together with any 
remaining free ligand) to the principal binding sites on the DNA. A fit of the multiple 
independent binding sites model to the second part of the data gives an apparent binding 
affinity (Kbinding) of (9.7 ± 1.44) ×103 M-1 for a binding site size restricted to 3 base pairs. The 
first and second binding events as described above are illustrated in Figure 2.36. 
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           (A) (B) 
 
 
 
Figure 2.37 Cartoon representation of the DNA (blue rod) interacting with the ligands (pink 
oblong). 
Figure 2.37 (A) shows that the first event happens when many ligand molecules bind strongly 
to the backbone and the base pairs of the DNA at low concentration of DNA. Figure 4.17 (B) 
shows the second event, which happens when the concentration of DNA increases.   
In the second titration, the binding of 8 to FS-DNA in 25 mM MOPS, pH 7.0, 100 mM KCl, 
9 vol-% DMSO and 1 mM EDTA was studied using UV-visible spectroscopy. The changes 
in absorption of 8 upon addition of FS-DNA at 25 °C are shown in Figure 2.38.  
 
Figure 2.38 UV-visible spectra for (A) a 0.0008 mM solution of 8 upon addition of   0 – 0.44 
mM, FS-DNA and (B) 0.0015 mM solution of 8 upon addition of   0 – 0.45 mM FS-DNA, 
both in buffer (25 mM MOPS, pH 7.0, 100 mM KCl, 9 vol-% DMSO and 1 mM EDTA), at 
25 °C.  
Figure 2.38 shows a hypochromic and a bathochromic shift in absorbance of 8 upon addition 
of DNA. This change in UV-visible absorption may occur as a result of distortion upon 
interaction between 8 and DNA. It also may be a local medium effect. The absorbances of 8 
(A) (B) 
  
400 500 600 700
0.00
0.02
0.04
0.06
0.08
0.10
0.12
A/
 a
.u
.
Wavelength(nm)
400 500 600 700
0.00
0.02
0.04
0.06
0.08
0.10
0.12
A/
 a
.u
.
Wavelength(nm)
Selection of optoelectronically active π-conjugated compounds 
 
85 
 
at 476 nm for both titrations were plotted as a function of the concentration of DNA (Figure 
2.39, see Appendix Tables A8.1& A8.2 for numerical data). 
 
Figure 2.39 Absorbance at 476 nm (■) for a solution of 0.0015 mM of 8 and (●) for a 
solution of 0.0008 mM 8, as a function of DNA concentration in buffer (25 mM MOPS, pH 
7.0, 100 mM KCl, 9 vol-% DMSO and 1 mM EDTA), at 25 °C. The solid lines represent a 
global fit of a multiple independent sites model to the data.  
In this titration experiment, we did not observe the initial drop in absorbance. This 
observation suggests the absence of the initial precipitation observed in the absence of 
DMSO.  The titration curves in Figure 2.39 were therefore analysed by fitting a multiple 
independent binding sites model to the data. The obtained binding stoichiometry was small 
hence the data were reanalysed at fixed binding site size of 3.0 base pairs, giving an 
equilibrium constant (Kbinding) for 8 binding to FS-DNA of (1.04 ± 0.84) ×105 M-1. Previous 
studies reported a binding affinity (Kbinding) of 0.12 ×106 M-1 for a binding site size (n) of 2, in 
excellent agreement with our data.163  
2.2.9 Extinction coefficient, stability and DNA binding of methylene blue 
Most previous studies have determined the extinction coefficient of 9 in different buffers 
such as phosphate buffer in which the extinction coefficient at 665 nm was found to be 81600 
M-I cm-1. 175 In distilled deionized water containing 5 mM sodium sulfate, 1 mM phosphate 
buffer at pH 7 the extinction coefficient was found to be 82600 M-1 cm-1 at 665 nm.169  
We wanted to know if a co-solvent affects the extinction coefficient of methylene blue (9). 
We therefore determined the extinction coefficient of 9 in the presence of DMSO as a co-
solvent.176 
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A stock solution of 9 (0.15 mM) in buffer (25 mM MOPS, pH 7.0, 100 mM KCl, 9 vol-% 
DMSO and 1 mM EDTA) was prepared. A series of solutions (0.0011 mM, 0.0018 mM, 
0.0025 mM and 0.0033 mM) was prepared from the stock solution. UV-visible spectra were 
recorded for these solutions in a 1.0 cm pathlength cuvette at 25 °C. Absorbance at the λmax of 
663 nm was plotted against ligand concentration (Figure 2.40). 
 
Figure 2.40 Absorbance at 663 nm as a function of concentration of 9 in buffer (25 mM 
MOPS, pH 7.0, 100 mM KCl, 9 % DMSO and 1 mM EDTA), at 25 °C. 
Figure 2.40 shows an increase in absorbance at 663 nm with increasing concentration. A 
linear fit (red line) was applied to obtain the extinction coefficient of (79533 ± 2018) M-1 cm-
1. The error margin as a percentage of the extinction coefficient is 2.5 % which is an 
acceptable margin of error.  
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We also examine the extinction coefficient of 9 in the buffer without co-solvent. A stock 
solution of 9 (0.081 mM) in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA) 
was prepared. A series of solutions of 0.0015, 0.0023 0.0031 and 0.0038 mM was prepared 
by dilution. A second stock solution of 0.13 mM 9 in buffer (25 mM MOPS, pH 7.0, 50 mM 
NaCl, and 1 mM EDTA) was prepared. A second series of solutions (0.0015, 0.0040 0.0064 
and 0.0087 mM) was prepared from the second stock solution. UV-visible spectra were 
recorded for all diluted solutions in a 1.0 cm pathlength cuvette at 25 °C. Absorbance at the 
λmax of 663 nm for both dilution series were plotted against ligand concentrations (Figure 
2.41).  
 
Figure 2.41 Absorbance at 663 nm as a function of concentration of 9 in buffer (25 mM 
MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 25 °C. 
Figure 2.41 shows an increase in absorbance at 663 nm with increasing concentration. A 
linear fit (red line) was applied to obtain the extinction coefficient of (78618 ± 1922) M-1 
cm-1. The error margin as a percentage of the extinction coefficient is 2.4 %. That is an 
acceptable margin of error.  The extinction coefficient for 9 in the presence and absence of 
co-solvent is the same, which suggests again that co-solvent does not affect the extinction 
coefficient. 
These extinction coefficients are both roughly within the error margin of our extinction 
coefficient and are therefore in good agreement. 
Based on previous reports we assumed that 9 is light sensitive.177, 178 To study this light 
sensitivity, we plotted the absorbance of 9 as a function of time under exposure to light in 
buffer (25 mM MOPS pH 7.0, 50 mM 50 mM NaCl and 1 mM EDTA) (Figure 2.42).  
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(A) (B) 
  
Figure 2.42 (A) UV-visible spectra for 9 dissolved in buffer (25 mM MOPS pH 7.0, 50 mM 
NaCl and 1 mM EDTA) and exposed to light at 25 °C (B) The absorbance of 9 at 663 nm as a 
function of time. 
Figure 2.42 (A) shows that the spectra for a solution of 9 show a decrease upon exposure to 
light. This decrease suggests that 9 is sensitive to light. Figure 2.42 (B) shows the decrease of 
absorbance of 9 as a function of time.  
We wanted to know whether different buffers affect the fading of 9. To study the effect of 
buffer choice, we prepared an analogous stock solution of 9 but instead of MOPS buffer we 
made the stock solution in phosphate buffer and left out EDTA. The reason for this is that 
MOPS and EDTA contain an amine functional group. This amine could act as an electron 
donor to the excited state of 9 similar to the action of sacrificial amines as electron donors as 
used in development of photovoltaic systems.  
To study whether MOPS caused the light-driven fading, we plotted the absorbance of 9 as a 
function of time exposed to light in phosphate buffer (25 mM Na2HPO4, pH 7.0, and 50 mM 
NaCl) (Figure 2.43). 
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Figure 2.43 (A) UV-visible spectra for 9 dissolved in phosphate buffer (25 mM Na2HPO4, 
pH 7.0, and 50 mM NaCl), at 25 °C and under exposure to ambient light. Figure (B) the 
absorbance of 9 at 663 nm plotted as a function of time of exposure to light. 
Figure 2.43 (A) again shows a decrease. The time trace in Figure 2.43 (B) shows the extent of 
the decrease in absorbance of 9 as a function of time. These results indicate that the buffer 
does not affect significantly the sensitivity of 9 to light, and this indicates that MOPS and 
EDTA do not act as sacrificial electron donors in this particular reaction.  
In order to evaluate the binding of 9 with DNA in our buffers, UV-visible titrations were 
carried out. Binding of 9 to FS-DNA was studied using UV-visible spectroscopy. The 
changes in absorption of 9 upon addition of FS-DNA were measured in buffer (25 mM 
MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 25 °C and are shown in Figure 2.44. 
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Figure 2.44 UV-visible spectra for a 0.0035 mM solution of 9 upon addition of 0 – 4.6 mM 
FS-DNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 25 °C. 
Figure 2.44 shows a hypochromic shift in absorbance (at the λmax of 664 nm) of 9 upon 
addition of DNA. This change in absorption suggest that the conformation of 9 or the 
surrounding medium of 9 has changed upon the addition of DNA. Either way, of these 
changes would be the result of binding of 9 to DNA. The absorbance of 9 at 664 nm was 
plotted as a function of concentration of FS-DNA (Figure 2.45, see Appendix, Table A9 for 
data in tabular format). 
 
Figure 2.45 Absorbance at 664 nm for a solution of 0.0035 mM 9 as a function of DNA 
concentration in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 25 °C. 
The line represents the best fit of a multiple independent binding sites model to the data.  
The titration curve in Figure 2.45 shows a decrease in absorbance of 9 upon the addition of 
FS-DNA. This change in absorbance indicates that 9 interacts with DNA. The titration data 
obtained for 9 was reproduced satisfactorily by the multiple independent binding sites model. 
This fit of the multiple independent binding sites model to the data gives a binding affinity 
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(Kbinding) of (3.8 ± 0.78) ×105 M-1 for the binding site size restricted to 3 base pairs. This 
binding constant is in agreement with the reported equilibrium constant of (Kbinding) of ~ 2.2 
×105 M-1.155 
We wanted to know if added co-solvent affects the affinity of 9 for FS-DNA, because co-
solvent may be required in the double competition dialysis assay. Therefore, we did the same 
titration as above but in the presence of DMSO.  
Binding of 9 to FS-DNA was studied using UV-visible spectroscopy. The changes in 
absorption of 9 upon addition of FS-DNA in buffer (25 mM MOPS, pH 7.0, 100 mM KCl, 9 
vol-% DMSO and 1 mM EDTA), at 25 °C are shown in Figure 2.46.                                         
 
Figure 2.46 UV-visible spectra for a 0.004 mM solution of 9 upon addition of 0 – 0.19 mM 
FS-DNA in buffer (25 mM MOPS, pH 7.0, 100 mM KCl, 9 vol-% DMSO and 1 mM EDTA), 
at 25 °C. 
Figure 2.46 shows a hypochromic shift and a bathochromic shift in absorbance (at the λmax of 
664 nm) of 9 upon addition of DNA. This change in UV-visible absorption suggests that the 
conformation or the surrounding medium of 9 changes upon the addition of DNA. To 
quantify the affinity of 9 for FS-DNA, the absorbance at 664 nm was plotted as a function of 
concentration of FS-DNA (Figure 2.47, Appendix, Table A9.1 for data in tabular format). 
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Figure 2.47 Absorbance at 664 nm of a solution of 0.004 mM 9 as a function of DNA 
concentration in buffer (25 mM MOPS, pH 7.0, 100 mM KCl, 9 vol-% DMSO and 1 mM 
EDTA), at 25 °C. The line represents the best fit of a multiple independent binding sites 
model to the data.  
The titration data obtained for 9 were reproduced satisfactorily by the multiple independent 
binding sites model. This fit of the multiple independent binding sites model to the data gives 
a binding affinity (Kbinding) of (8.5 ± 1.35) ×104 M-1 for the binding site size restricted to 3 
base pairs. 
Based on the results from Figures 2.45 and 2.46, DMSO affects the interaction between 9 and 
DNA. The affinity is roughly five-fold weaker in the presence of DMSO then in the absence 
of DMSO.179 
 
Compound 9 is known to have affinity for a range of quadruplex sequences as well. Binding 
of 9 to c-myc180 was studied using UV-visible spectroscopy. The changes in absorption of 9 
upon addition of c-myc were measured in a buffer solution (25 mM MOPS, pH 7.0, 50 mM 
NaCl, and 1 mM EDTA), at 25 °C (Figure 2.48).  
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Figure 2.48 UV-visible spectra for a 0.007 mM solution of 9 upon addition of 0 – 0.006 mM 
c-myc in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 25 °C. 
Figure 2.48 shows a hypochromic shift in absorbance (at the λmax of 663 nm) which is 
accompanied by a bathochromic shift of 9 upon addition of c-myc. This change in UV-visible 
absorption may occur as a result of conformational changes when 9 interacts with c-myc, but 
it may also be a result of a local medium effect.  To quantify the affinity of 9 for c-myc, the 
absorbance at 663 nm was plotted as a function of concentration of c-myc (Figure 2.49, 
Appendix Table A9.2 for data in tabular format). 
 
Figure 2.49 Absorbance at 663 nm for a solution of 0.0073 mM of 9 as a function of c-myc 
concentration in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 25 °C. 
The line represents the best fit of a multiple independent binding sites model to the data.  
The titration data obtained for 9 were analysed satisfactorily by fitting the multiple 
independent binding sites model to the data. This fit of the multiple independent binding sites 
model to the data gives a binding affinity (Kbinding) of (5.25 ± 7.79) ×106 M-1 for a binding site 
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size (n) of (0.17 ± 0.02), i.e 0.17 quadruplexes per ligand. This suggests that 6 ligands bind 
per quadruplex. 
Binding of 9 to 22AG was studied using UV-visible spectroscopy. The changes in absorption 
of 9 upon addition of 22AG were measured in a buffer solution (25 mM MOPS, pH 7.0, 50 
mM NaCl, and 1 mM EDTA), at 25 °C (Figure 2.50).    
 
Figure 2.50 UV-visible spectra for a 0.0038 mM of a solution of 9 upon addition of 0 – 0.035 
mM 22AG concentration in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), 
at 25 °C. 
Figure 2.50 shows a hypochromic and bathochromic shift of 9 upon addition of 22AG. This 
change in absorption suggests that the conformation of 9 or the surrounding medium of 9 has 
changed upon the addition of DNA. The change in absorption therefore indicates an 
interaction between 9 and 22AG. To quantify the affinity of 9 for 22AG, the absorbance at 
663 nm was plotted as a function of concentration of 22AG (Figure 2.51, Appendix Table 
A9.3 for numerical data). 
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Figure 2.51 Absorbance at 663 nm for a solution of 0.0038 mM 9 as a function of 22AG 
concentration in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 25 °C. 
The line represents the best fit of a multiple independent binding sites model to the data.  
The titration data obtained for 9 were analysed by fitting the multiple independent binding 
sites model to the data. This fit of the multiple independent binding sites model to the data 
gives an equilibrium constant (Kbinding) of (5.95 ± 7.64) ×104 M-1 for a binding site size (n) of 
(0.13 ± 0.15). This suggests that 7 ligands bind per quadruplex.  
EAD2 was recently identified as a good target for 9.181 Binding of 9 to EAD2 was studied 
using UV-visible spectroscopy. The changes in absorption of 9 upon addition of EAD2 were 
measured in a buffer solution (25 mM MOPS, pH 7.0, 100 mM KCl, and 1 mM EDTA), at 
25°C (Figure 2.52).  
 
Figure 2.52 UV-visible spectra for a 0.0051 mM solution of 9 upon addition of 0 – 0.0069 
mM EAD2 in buffer (25 mM MOPS, pH 7.0, 100 mM KCl, and 1 mM EDTA), at 25 °C. 
Figure 2.52 shows a hypochromic and bathochromic shift of 9 upon addition of EAD2. This 
change in absorption suggests that the conformation of 9 or the surrounding medium of MB 
has changed upon the addition of DNA. To quantify the affinity of 9 for EAD2, the 
absorbance at 663 nm was plotted as a function of concentration of EAD2 (Figure, 2.53 
Appendix Table A9.4 for data in tabular format). 
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Figure 2.53 Absorbance at 663 nm for a solution of 0.0051 mM 9 as a function of EAD2 
concentration in buffer (25 mM MOPS, pH 7.0, 100 mM KCl, and 1 mM EDTA), at 25 °C. 
The line represents the best fit of a multiple independent binding sites model to the data.  
The titration data obtained for 9 were reproduced satisfactorily by the multiple independent 
binding sites model. This fit of the multiple independent binding sites model to the data gives 
a binding affinity (Kbinding) of (5.86 ± 0.61) ×105 M-1 for a binding site size (n) of (0.3 ± 0.01) 
which means 3 ligands bind per quadruplex. Previous studies have found a binding affinity 
(Kbinding) of ~ 1.3 ×106 M-1 for a binding site size (n) of 1.0, in reasonable agreement with our 
data.155 
The binding parameters for compound 9 interacting with FS-DNA and quadruplex structures 
are summarised in Table 2.4. 
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Table 2.4 Binding parameters from UV-visible spectroscopy of 9 interacting with FS-
DNA, c-myc 22AG and EAD2, in buffer. 
 FS-DNA c-myc 22AG EAD2 
Compound 
Binding    
constant 
K / M-1 
Binding 
site size 
N 
Binding 
constant 
106 K / 
M-1 
Binding 
site size 
n 
Binding 
constant 
K / M-1 
Binding 
site size 
n 
Binding    
constant 
106 K / 
M-1 
Binding 
site size 
n 
9 (a) 
(3.83 ± 0.78) 
×105 3
* / / / / / / 
9 (b) 
 
(8.5 ± 1.35) 
×104 3
* / / / / / / 
9 (c) 
 
/ / 
(5.25  ± 
7.79) 
(0.17 ± 
0.02) 
(5.95 ± 
7.64) 
×104 
(0.13 ± 
0.15) 
 
/ / 
9 (d) 
 
/ / / / / / 
(0.586 ± 
0.061) 
(0. 3 ± 
0.01) 
(25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA) in the presence of 1.04 % of 
acetonitrile (a), in buffer (25 mM MOPS, pH 7.0, 100 mM KCl, 9 vol-% DMSO and 1 
mM EDTA) (b) , in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA) (c) and 
in buffer (25 mM MOPS, pH 7.0, 100 mM KCl, and 1 mM EDTA), at 25 °C.  
 
Table 2.4 shows that compound 9 has a higher affinity for c-myc than for 22AG and EAD2. 
The binding stoichiometry for 9 interacting with c-myc was found to be 6 ligands per 
quadruplex. We attribute this high affinity of 9 for quadruplex structures to the presence of more 
aromatic rings, which leads to an increase in hydrophobic interactions between 9 and DNA. 
The weakest binding for 9 is to duplex FS-DNA with a binding constant ~ 104. The affinity is 
roughly five-fold weaker in the presence of DMSO than in the absence of DMSO. DMSO 
thus affects the interaction between 9 and DNA. The binding site size for 9 to duplex FS-
DNA is restricted to 3.0 base pairs in order to obtain a good fit to the titration curve.    
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2.2.10 Extinction coefficient and DNA binding of ethidium bromide 
Two stock solutions of ethidium bromide (10), both of 0.12 mM, were made up in buffer (25 
mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA) and two dilution series (0.014 mM, 
0.018 mM, 0.022 mM and 0.025 mM and 0.004 mM, 0.016 mM, and 0.026 mM) were 
prepared. UV-visible spectra were recorded for these solutions in a 1.0 cm pathlength cuvette 
at 25 °C. Absorbances at the λmax of 481 nm were plotted against ligand concentrations 
(Figure 2.54).  
 
Figure 2.54 Absorbance at 481 nm as a function of concentration of 10 in buffer (25 mM 
MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 25 °C.  
Figure 2.54 shows an increase in absorbance at 481 nm with increasing concentration of 10. 
A linear fit (red line) was applied to obtain the extinction coefficient of (6645 ± 65.27) M-1 
cm-1. The error margin as a percentage of the extinction coefficient is 0.9 %, which is a small 
margin of error.  
There have been several studies of the extinction coefficient for 10 in BPES buffer (6 mM 
Na2HPO4, 4 mM NaH2PO4, 1 mM Na2EDTA, and 100 mM NaCl), at pH 7.00,  and this was 
found to be 5680 M-1 cm-1 at 478 nm, and 5860 M-1 cm-1 at 480 nm in aqueous solution.156 
Our extinction coefficient is therefore remarkably higher for currently unknown reasons.  
 
Compound 10 is well known to bind to duplex DNA.182 We set out to determine whether 10 
binds to quadruplex DNA such as c-myc in our buffer. Binding of 10 to c-myc was studied 
using UV-visible spectroscopy. The changes in absorption of 10 upon addition of c-myc were 
measured in a buffer (25 mM MOPS, pH 7.0, 100 mM KCl, and 1 mM EDTA), at 25 °C 
(Figure 2.55).  
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Figure 2.55 UV-visible spectra for a 0.027 mM solution of 10 upon addition of 0 – 0.023 
mM c-myc concentration in buffer (25 mM MOPS, pH 7.0, 100 mM KCl, and 1 mM EDTA), 
at 25 °C. 
Figure 2.55 shows a decrease in absorbance (at λmax of 481 nm) and a bathochromic shift with 
an isosbestic point at 510 nm upon addition of c-myc.  
To quantify the affinity of 10 for c-myc, the absorbance at 481 nm was plotted as a function 
of concentration of c-myc (Figure 2.56, Appendix Table A10 for numerical data). 
 
Figure 2.56 Absorbance at 481 nm of a solution of 0.027 mM 10 as a function of c-myc 
concentration in buffer (25 mM MOPS, pH 7.0, 100 mM KCl, and 1 mM EDTA), at 25 °C. 
The line represents the best fit of a multiple independent binding sites model to the data.  
The data in Figure 2.56 were analysed in terms of a multiple independent binding sites 
model, given an equilibrium constant (Kbinding) of (4.01 ± 2.60) ×105 M-1 for a binding site 
size (n) of (0.37 ± 0.03) quadruplexes per ligand. This suggests that 3 ligands bind per 
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quadruplex. This binding constant is in agreement with the previously reported equilibrium 
constant of (Kbinding) of 1.5 ×105 M-1 for a binding site size (n) of (1.0 ± 0.1).157  
 
2.2.11 Extinction coefficient and DNA binding of DAPI 
We made two stock solutions of DAPI (11) (3.5 mM) and used these to prepare two dilution 
series (0.012 mM, 0.025 mM, 0.037 mM, 0.05 mM and 0.006 mM, 0.012 mM, 0.019 mM, 
0.025 mM).  A third stock solution of 11 (1.3 mM) was used to prepare a third dilution series 
(0.007 mM, 0.014 mM, 0.02 mM, 0.028 mM). Finally, a fourth stock solution of 11 (2.3 mM) 
was used to create one further dilution series (0.016 mM, 0.024 mM, 0.03 mM, 0.041 mM).  
All solutions were prepared in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl). UV-visible 
spectra were recorded for these solutions in a 1.0 cm path length cuvette at 25 °C. 
Absorbance at λmax of 342 nm for all dilution series were plotted together against ligand 
concentrations (Figure 2.57).  
 
Figure 2.57 Absorbance as a function of concentration of 11 in buffer (25 mM MOPS, pH 
7.0, 50 mM NaCl), at 25 °C.  
Figure 2.57 shows an increase in absorbance at 342 nm with increasing concentration. A 
linear fit (red line) was applied to obtain the extinction coefficient of (23570 ± 786) M-1 cm-1. 
The error margin as a percentage of the extinction coefficient is 3.3 %, which is acceptable. 
Previous studies have reported that the extinction coefficient of 11 in water is slightly higher 
at 27000 M-1 cm-1, more or less in agreement with our extinction coefficient.161  
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DAPI is known to bind to duplex DNA.183 The binding of 11 to 22AG was studied using UV-
visible spectroscopy; the changes in absorption of 11 upon addition of 22AG were measured 
in a buffer solution (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 25 °C 
(Figure 3.58).  
 
Figure 2.58 UV-visible spectra for a 0.019 mM solution of 11 upon addition of 0 – 0.007 
mM 22AG in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 25 °C. 
Figure 2.58 shows a decrease in absorbance (at the λmax of 342 nm) and a bathochromic shift 
with isosbestic point at 367 nm upon addition of 22AG to 11. This change in UV-visible 
absorption suggests that 11 interacts with 22AG, and it may represent a local medium effect 
exerted by 22AG or a conformational change of 11 caused by the binding event. The affinity 
of 11 for 22AG was quantified by plotting the absorbance at 342 nm as a function of 
concentration of (22AG) (Figure 2.59, Appendix Table A11 for data in tabular format). 
 
Figure 2.59 Absorbance at 342 nm for a solution of 0.019 mM 11 as a function of 22AG 
concentration in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 25 °C. 
The line represents the best fit of a multiple independent binding sites model to the data.  
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The titration data obtained for 11 were reproduced satisfactorily by the multiple independent 
binding sites model. This fit of the multiple independent binding sites model to the data gives 
an equilibrium constant (Kbinding) of (9.62 ± 2.88) ×104 M-1 for a binding site size (n) of (0.09 
± 0.01). This suggests that 11 molecules of DAPI ligand bind per 22AG quadruplex. This 
corresponds to one molecule of DAPI for every two bases in the quadruplex structure. This 
ratio is remarkably like the ratio required for full charge cancellation, so the interaction may 
be purely electrostatic. 
 
Binding of 11 to c-myc was also studied using UV-visible spectroscopy. The changes in 
absorption of 11 upon addition of c-myc were measured in a buffer (25 mM MOPS, pH 7.0, 
100 mM KCl, and 1 mM EDTA), at 25 °C (Figure 2.60).  
 
Figure 2.60 UV-visible spectra for a 0.019 mM solution of 11 upon addition of 0 – 0.025 
mM c-myc concentration in buffer (25 mM MOPS, pH 7.0, 100 mM KCl, and 1 mM EDTA), 
at 25 °C. 
Figure 2.60 shows hypochromic and bathochromic shifts in absorbance at the λmax of 342 nm, 
leading to an isosbestic point at 370 nm, upon addition c-myc. This change in UV-visible 
absorption shows that 11 interacts with c-myc.  
The affinity of 11 for c-myc was quantified by plotting the absorbance at 342 nm as a 
function of concentration of c-myc (Figure 2.61, Appendix Table A11.1 for numerical data). 
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Figure 2.61 Absorbance at 342 nm of a solution of 0.019 mM 11 as a function of the 
concentration of c-myc in buffer (25 mM MOPS, pH 7.0, 100 mM KCl, and 1 mM EDTA), at 
25 °C. The line represents the best fit of a multiple independent binding sites model to the 
data.  
The titration data obtained for 11 were analysed in terms of the multiple independent binding 
sites model. This fit of the multiple independent binding sites model to the data gives a 
binding affinity (Kbinding) of (7.4 ± 1.9) ×105 M-1 for a binding site size (n) of (0.27 ± 0.012). 
This suggests that 4 ligands bind per quadruplex. 
 
2.2.12 Extinction coefficient, stability and DNA binding of thiazole orange 
Four stock solutions of thiazole orange (12) were made up in buffer (25 mM MOPS, pH 7.0, 
50 mM NaCl, and 1 mM EDTA). The first stock solution of 12 was 0.62 mM and a dilution 
series of the first stock solution was prepared (0.0036 mM, 0.0073 mM, 0.010 mM and 0.014 
mM). The second stock solution of 12 (0.67 mM) was used to prepare a second series of 
solutions (0.0053 mM, 0.0092 mM, 0.01 mM and 0.016 mM). The third stock solution of 12 
(0.83 mM) was used to generate a third series (0.0098 mM, 0.013 mM, 0.016 mM and 0.019 
mM). The final stock solution of 12 (0.69 mM) was used for a final series of solutions 
(0.0054 mM, 0.0095 mM, 0.013mM and 0.017 mM). UV-visible spectra were recorded for 
all solutions in a 1.0 cm path length cuvette at 25 °C. Absorbances at the λmax of 500 nm for 
all solutions were plotted against ligand concentrations (Figure 2.62). 
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Figure 2.62 Absorbance at 500 nm as a function of concentration of 12 in buffer (25 mM 
MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 25 °C. 
A linear fit (red line) was applied to the data in Figure 2.62 to obtain the extinction 
coefficient of (44309 ± 2642) M-1 cm-1. This extinction coefficient is different from values 
reported in the literature. For example, in 20 mM Tris-HCl (pH 7.4), 140 mM NaCl, 5 mM 
KCl and 5 mM MgCl2 the extinction coefficient for 12 has been reported to be 63000 M-1 cm-
1 at 501 nm.184  The extinction coefficient for 12 in methanol was found to be > 70000 M-1 
cm-1. 185  
Beased on the scatter in Figure 2.61 and the differences with reported extinction coefficients, 
we assumed that 12 is light sensitive.184 To study the light sensitivity, we recorded the 
absorbance of 12 as a function of time exposed to ambient light in buffer (25 mM MOPS pH 
7.0, 50 mM 50 mM NaCl and 1 mM EDTA) (Figure 2.63). 
 
Figure 2.63 UV-visible spectra for 12 dissolved in buffer (25 mM MOPS pH 7.0, 50 mM 
NaCl and 1 mM EDTA) and exposed to ambient light. 
Figure 2.63 shows a decrease in absorbance without an increase between 600 and 700 nm, 
which suggests that 12 does not precipitate but is sensitive to light.  
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To study the sensitivity to light further we repeated the experiment with 12 dissolved in two 
different buffers because we wanted to check whether the buffers affect fading or not.141 We 
plot the absorbance of 12 as a function of time exposed to light in MOPS-based buffer (25 
mM MOPS pH 7.0, 50 mM 50 mM NaCl and 1 mM EDTA) ( Figure 2.62) and in phosphate-
based buffer with no EDTA (see below, Figure 2.64).  
 
 
 
 
 
 
 
 
Figure 2.64 (A) UV-visible spectra for 12 dissolved in buffer (25 mM MOPS pH 7.0, 50 mM 
NaCl and 1 mM EDTA) exposed to light. (B) Absorbance for 12 as a function of time upon 
exposure to light. 
The spectra in Figure 2.64 show a rapid decrease, in agreement with figure 2.62 12 is 
sensitive to light.  
A solution of 12 of the same concentration as above, but in phosphate buffer, was prepared. 
The absorbance of 12 as a function of time exposed to light in phosphate buffer (25 mM 
Na2HPO4, pH 7.0, and 50 mM NaCl) was recorded (Figure 2.65). 
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Figure 2.65 (A) UV-visible spectra for 12 dissolved in phosphate buffer (25 mM Na2HPO4, 
pH 7.0, and 50 mM NaCl), at 25 °C upon exposure to light (B) The absorbance of 12 at 500 
nm plotted as a function of time. 
Figure 2.65 (A) shows that the spectra display a rapid decrease upon exposure to light. This 
decrease suggests that 12 is sensitive to light in the absence of MOPS and EDTA as well. 
We combined the two time traces to confirm that the buffer does not affect the fading of 12. 
In other words, we checked whether phosphate buffer and MOPS and EDTA buffer influence 
the sensitivity of 12 (Figure 2.66). 
 
Figure 2.66 The absorbance of 12 at 500 nm in buffer (25 mM MOPS pH 7.0, 50 mM NaCl 
and 1 mM EDTA) (black squares) and in phosphate buffer (25 mM Na2HPO4, pH 7.0, and 50 
mM 50), at 25 °C (red dots) as a function of time. 
Figure 2.66 (A) shows that the decrease in absorbance in MOPS-based buffer and in 
phosphate-based buffer are very similar. This shows that the buffer does not affect the fading. 
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Visual inspection also clearly shows the effect of light on the colour of solutions of 12 as 
shown in Figure 2.67.  
 
Figure 2.67 Solutions of 12, as afunction of time exposed to ambient light.  
From Figure 2.67 it is clear the colour of the solution fades in 55 min. 
It has been reported in the literature that thiazole orange (12) has a higher affinity for 
quadruplex and triplex DNA compared with double-stranded DNA.168  This study set out to 
confirm the affinity of 12 for different sequences of quadruplex DNA, namely c-myc and 
22AG, in our buffer.  
Binding of 12 to c-myc was studied using UV-visible spectroscopy. The changes in 
absorption of 12 upon addition of c-myc were measured in buffer (25 mM MOPS, pH 7.0, 50 
mM NaCl, and 1 mM EDTA), at 25 °C (Figure 2.68).  
                                (A) 
 
(B) 
 
 
Figure 2.68 UV-visible spectra for (A) a 0.0061 mM solution of 12 upon addition of 0 – 
0.0027 mM c-myc and (B) a 0.0083 mM solution of 12 upon addition of 0 – 0.0066 mM c-
myc, in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 25 °C.  
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Figure 2.68 shows a decrease in absorbance (at the λmax of 500 nm) and a bathochromic shift 
upon addition c-myc. This change in UV-visible absorption shows that 12 interacts with c-
myc.  
To establish the affinity of 12 for c-myc, the absorbance at 500 nm was plotted as a function 
of concentration of c-myc (Figure 2.69, Appendix Tables A12& A12.1 for data in tabular 
format). 
 
Figure 2.69 Absorbance at 500 nm for (●) a solution of 0.0061 mM of 12 and (■) a solution 
of 0.00083 mM, as a function of c-myc concentration in buffer (25 mM MOPS, pH 7.0, 50 
mM NaCl, and 1 mM EDTA), at 25 °C.  Solid lines represent a global fit of a multiple 
independent sites model to the titration data.  
The titration data obtained for 12 were analysed by globally fitting the multiple independent 
binding sites model to the two titrations. The binding constant (K binding) was found to be 
(1.19 ± 2.38) ×107 M-1 for a binding site size (n) of (0.081 ± 0.008). This suggests that 12 
molecules of ligand bind per quadruplex. However, considering the shape of the titration 
curves in Figure 2.66, these parameters are interpreted as apparent parameters. The reason for 
this is the dip in absorbance followed by a small gradual increase, suggesting multiple 
binding events.  
 
Binding of 12 to 22AG was similarly studied using UV-visible spectroscopy. The absorption 
spectra for 12 upon addition of 22AG were recorded in buffer (25 mM MOPS, pH 7.0, 50 
mM NaCl, and 1 mM EDTA) at 25 °C (Figure 2.70).  
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Figure 2.70 UV-visible spectra for a 0.0048 mM solution of 12 upon addition of 0 – 0.003 
mM 22AG in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 25 °C. 
Figure 2.70 shows a decrease in absorbance at the λmax of 500 nm of 12 upon addition of 
22AG. This change in UV-visible absorption is likely a result of 12 interacting with 22AG.  
The affinity of 12 for 22AG was quantified by plotting the absorbance at 500 nm as a 
function of concentration of 22AG (Figure 2.71, Appendix Table A12.2 for numerical data). 
 
Figure 2.71 Absorbance at 500 nm (■) for a solution of 0.0048 mM 12 as a function of 22AG 
concentration, in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 25 °C. 
The line represents the best fit of a multiple independent binding sites model to the data.  
The titration data obtained for 12 were analysed by fitting the multiple independent binding 
sites mode to the data. The binding constant (K binding) was found to be 2.29 × 1018 ± 3.63 ×10 
29 M-1. The value of the affinity constant should not be taken literally but indicates that the 
affinity is too high to accurately quantify from these data. The binding site size (n) was found 
to be (0.10 ± 0.009). This indicates that 10 ligands bind per quadruplex. 
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2.2.13 Extinction coefficient, stability and DNA binding of DODC 
A stock solution of 0.16 mM 13 in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl and 1 mM 
EDTA) was prepared. A series of solutions (0.0018 mM, 0.0025 mM, 0.0031 mM and 0.0037 
mM) was prepared from the stock solution and UV-visible spectra were recorded for these 
solutions in a 1.0 cm path length cuvette at 25 °C. Absorbance at the λmax of 576 nm were 
plotted against ligand concentrations (Figure 2.72).    
 
Figure 2.72 Absorbance as a function of concentration of 13 in buffer (25 mM MOPS, pH 
7.0, 50 mM NaCl and 1 mM EDTA), at 25 °C. 
Figure 2.72 shows an increase in absorbance at 576 nm with increasing concentration. A 
linear fit (red line) was applied to obtain the extinction coefficient of (212590 ± 3306) M-1 
cm-1. The error margin as a percentage of the extinction coefficient is 1.5 % which is an 
acceptable margin of error.  
We set out to establish whether 13 is light sensitive. To study the light sensitivity of 13 we 
recorded the absorbance of 13 as a function of time exposed to light 186 in buffer (25 mM 
MOPS pH 7. 0, 50 mM 50 mM NaCl and 1 mM EDTA) (Figure 2.73). 
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Figure 2.73 (A) UV-visible spectra for 13 dissolved in buffer (25 mM MOPS pH 7.0, 50 mM 
50 mM NaCl and 1 mM EDTA) upon exposure to light. (B) The absorbance of 13 at 576 nm 
plotted as a function of time. 
Figure 2.73 shows that when 13 is exposed to light, the UV-visible spectra show a decrease. 
This observation suggests that 13 is indeed sensitive to light.  
In order to find out whether the fading of 13 is dependent on the buffer 187 we repeated the 
experiment using a phosphate buffer. We measured again the absorbance of 13 as a function 
of time exposed to light in phosphate buffer (25 mM Na2HPO4, pH 7.0, and 50 mM NaCl) 
(Figure 2.74). 
 
 
 
 
 
 
Figure 2.74 (A) UV-visible spectra for 13 in phosphate buffer (25 mM Na2HPO4, pH 7.0, 
and 50 mM NaCl) upon exposure to light. (B) The absorbance of 13 at 576 nm plotted as a 
function of time. 
The spectra in Figure 2.74 show a decrease, which suggests that 13 is sensitive to light in a 
phosphate buffer as well. As before, this indicates that the amine functional group in MOPS 
and EDTA is not acting as an electron donor in the fading process.  
The sensitivity of compounds to light may be affected by the presence of oxygen. To study 
the potential effect of oxygen on the fading, we carried out four experiments. The first 
experiment involves exposure of 13 to light and oxygen, the second experiment involves 
exposing 13 to light in the absence of oxygen, while the third experiment involves keeping 13 
in the dark in the absence of oxygen. The fourth experiment involves 13 exposed to oxygen, 
but not to light. 
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For the first experiment, we recorded the absorbance of 13 as a function of time exposed to 
light and oxygen, in buffer (25 mM MOPS pH 7.0, 50 mM 50 mM NaCl and 1 mM EDTA) 
(Figure 2.75, see Appendix Table A13). 
 
 
 
 
 
 
Figure 2.75 (A) UV-visible spectra for 13 in buffer (25 mM MOPS pH 7.0, 50 mM 50 mM 
NaCl and 1 mM EDTA) (B) The absorbance of 13 at 576 nm as a function of time. 
Figure 2.75 shows that the absorbance decreases over time.   
In the second experiment, the solution of 13 was degassed by using the freeze-pump-thaw 
method and placed under a nitrogen atmosphere. Therefore, we can see if the significant 
reduction in oxygen concentration causes any change to the fading.  
We recorded the absorbance of 13 as a function of time exposed to light in the absence of 
oxygen in buffer (25 mM MOPS pH 7.0, 50 mM 50 mM NaCl and 1 mM EDTA) (Figure 
2.76). 
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Figure 2.76 (A) UV-visible spectra for 13 in buffer (25 mM MOPS pH 7.0, 50 mM 50 mM 
NaCl and 1 mM EDTA) exposed to light in the absence of oxygen. (B) The absorbance of 13 
at 576 nm plotted as a function of time. 
Similar to Figure 2.75, Figure 2.76 shows a decrease in absorbance but now in the absence of 
oxygen. This observation suggests that the absence and presence of oxygen do not affect the 
fading kinetics of 13.  
The third experiment examined 13 in the absence of both light and oxygen. The absorbance 
spectra for 13 were again recorded as a function of time in buffer (25 mM MOPS pH 7.0, 50 
mM 50 mM NaCl and 1 mM EDTA) (Figure 2.77). 
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Figure 2.77 (A) UV-visible spectra for 13 in the absence of light and oxygen in buffer (25 
mM MOPS pH 7.0, 50 mM 50 mM NaCl and 1 mM EDTA). (B) The absorbance of 13 at 576 
nm plotted as a function of time. 
The spectra in Figure 2.77 show no significant change in the absorbance of 13 in the absence 
of light and oxygen.  
In the final experiment 13 was exposed to oxygen in the absence of light. As before, we 
recorded the absorbance of 13 as a function of time (Figure 2.78). 
(A) (B) 
  
Figure 2.78 (A) UV-visible spectra for 13 in the absence of light and presence of oxygen in 
buffer (25 mM MOPS pH 7.0, 50 mM 50 mM NaCl and 1 mM EDTA). (B) The absorbance 
of 13 at 576 nm plotted as a function of time. 
The spectra in Figure 2.78 show no significant change in the absorbance of 13 in the absence 
of light but in the presence of oxygen. Overall, these experiments suggest that fading of 13 is 
caused by light, but does not involve oxygen, at least not in the rate-determining step.  
Visual inspection also clearly shows the effect of light on the colour of solutions of 13 as 
shown in Figure 2.79.   
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0 min 2 min 15 min 10 min 5 min 20 min 60 min 
Figure 2.79 Solutions of 13, as afunction of time rxposed to ambient light.  
From Figure 2.79 it is clear the colour of the solution fades in 60 min. 
 
2.2.14 Extinction coefficient of coralyne 
Recent studies on the molar extinction coefficient for 14 in aqueous buffers (128 mM sodium 
cacodylate buffer pH 7) reported it to be 14500 M-1 cm-1 at 420 nm.58, 59 Other research has 
shown the molar extinction coefficient for 14 in 30% ethanolic medium to be 17500 M-1 cm-1 
at 424 nm.188 
Because of the poor solubility of coralyne (14) in buffer (25 mM MOPS, pH 7.0, 100 mM 
KCl, and 1 mM EDTA). We filtered the coralyne solution to remove any particulate matter. 
However, the absorption was low (0.1a.u). This is why we was unable to record the UV-
visible titration.58, 59, 188 
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2.2.15 Summary 
The UV-visible titrations have shown that ligands 1-3 do not bind significantly with FS-
DNA. However, ligands 4-9 show affinity for FS-DNA. The affinities of these compounds 
for FS-DNA are summarised in Table 2.5.   
* restricted. 
Table 2.5 Binding affinities and binding site sizes for binding of 1-9 to FS-DNA in 
buffer 
Ligand 
 
Binding constant 
K / M-1 
Binding site size 
n / bp 
1 negligible n.a. 
2 negligible n.a. 
3 negligible n.a. 
4 (4.93 ± 0.94) ×104 3* 
5 (1.18 ± 0.21) ×104 3* 
6 (a) (8.5 ± 4.5) ×105 0.9 ± 0.09 
7 (5.15 ± 0.43) ×103 3* 
8 (a) (9.79 ± 1.44) ×103 3* 
8 (b) (1.0 ± 0.84) ×105 3* 
9 (a) (3.83 ± 0.78) ×105 3* 
9 (b) (8.5 ± 1.35) ×104 3* 
(25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA) In the presence of 1.04 % of 
acetonitrile (a) and in DMSO-containing buffer (25 mM MOPS, pH 7.0, 100 mM KCl, 9 
vol-% DMSO and 1 mM EDTA), (b) at 25 °C. 
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Ligands 1 - 3 are negatively charged and the lack of binding is because the negative charge 
leads to electrostatic repulsion between ligand and DNA. The interaction of 3 with FS-DNA 
does not result in an important induced circular dichroism signal, which suggests that 3 does 
not interact strongly with DNA.  
At the same time, 4 and 5 have a high affinity (~ 104 M-1) for DNA. When we explored the 
binding mode for 4 with FS-DNA, ICD suggests that 4 binds with FS-DNA through 
intercalation. 84 On the other hand, the high affinity of 9 for DNA is clear from it is binding 
constant of ~ 105 M-1. We attribute the strong binding to the presence of a positive charge on 
9. Moreover, 9 is a planar aromatic compound. The planarity leads to increase in hydrophobic 
interactions between ligand and DNA, stabilising the interaction between 9 and DNA.159  
Table 2.5 shows that organic co-solvents play an important role during the interaction process 
decreasing the affinity between the ligands and DNA. However, DMSO is a useful co-solvent 
to help avoid precipitation of ligands and of ligand-DNA complexes.176   
It is obvious that 6 has a higher affinity for DNA with a binding constant of ~ 105 M-1 in 
DMSO-containing buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA) than in the 
presence of 1.04 % of acetonitrile at 25 °C. 
The data in Tables 2.5 shows that binding is weaker in the presence of acetonitrile. DMSO 
can affect DNA structure and may also improve ligand solubility, thus decreasing binding 
affinity.179  Interestingly, 8 in the presence of DMSO has a higher affinity (~ 105 M-1) 
compared to the apparent affinity of 8 for DNA in presence of acetonitrile (~ 103 M-1). This is 
because the poor solubility and precipitation of the complex formed between 8 and DMSO in 
the presence of acetonitrile.  
All the binding site sizes for 1-9 were restricted to 3.0 base pairs in order to obtain a good fit 
to the titration curve with reasonable binding parameters. However, the binding site size for 6 
was reanalysed at 1.0 base pair per binding site, in order to obtain reasonable binding 
parameters.  
The interactions of 9-12 with specific quadruplex-forming sequences such as c-myc, 22AG and 
EAD2, were quantified using UV-visible spectroscopy titrations. The binding parameters for 
9-12 compounds interacting with quadruplex structures are summarised in Table 2.6. 
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Table 2.6 Binding parameters from UV-visible spectroscopy of 9-12 to c-myc, 22AG, 
and EAD2. 
 c-myc 22AG EAD2 
Compound 
Binding 
constant 
106 K / M-1 
Binding site 
size 
n 
Binding 
constant 
K / M-1 
Binding site 
size 
n 
Binding 
constant 
106 K / M-1 
Binding site 
size 
N 
9 (a) (5.25 ± 7.79) (0.17 ± 0.02) (5.95 ± 7.64) 
×104 
(0.13 ± 
0.15) 
/ / 
9 (b) / / / / 
(0.586 ± 
0.061) 
(0. 3 ± 0.01) 
10(b) 
(0.401 ± 
0.260) 
(0.37 ± 0.03) / / / / 
11(a) / / 
(9.62 ± 2.88) 
×104 
(0.09 ± 
0.01) / / 
11(b) (0.74 ± 0.19) 
(0.27 ± 
0.012) / / / / 
       
12 (11.9 ± 23.8) (0.081 ± 
0.008) 
2.29 × 1018 ± 
3.63 ×10 29 
(0.10 ± 
0.009) 
/ 
/ 
 
in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA) (a) and in buffer (25 
mM MOPS, pH 7.0, 100 mM KCl, and 1 mM EDTA) (b), at 25 °C. 
 
In general, 9 has a high affinity for c-myc with a binding constant of ~ 106 M-1 which is 
stronger than Kbinding for EAD2 and 22AG. The binding stoichiometry for 9 with c-myc was 
found to be 6 ligands per quadruplex. 
Several studies have revealed that 10 binds very strongly to duplex DNA.125 The interaction 
between 10 and c-myc has a binding constant of ~ 105 M-1 and a stoichiometry of 3 ligands 
per quadruplex.  
Compound 11 also binds more strongly to c-myc than to 22AG with a binding constant of ~ 
105 M-1 and a stoichiometry which suggests that 4 ligands bind per quadruplex of c-myc. The 
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binding stoichiometry for 22AG was found to be 11 ligands per quadruplex. Interestingly, 12 
has a very strong affinity for 22AG comparing to c-myc with a binding constant that is too 
high to quantify from the current data.   
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2.3 Conclusion 
Compounds 1-7 and 9-13 are highly soluble in our aqueous buffers. Compound 8 is sparingly 
soluble in water, but it is soluble in some organic solvents such as acetonitrile and DMSO. To 
avoid the challenge of limited solubility, we determined the extinction coefficient of 8 in pure 
DMSO and pure acetonitrile but also in aqueous solutions containing DMSO and acetonitrile. 
The results show that the extinction coefficients for 8 in aqueous acetonitrile and aqueous 
DMSO are similar. Therefore, co-solvent does not affect the extinction coefficient of 8 much. 
Furthermore, all our compounds are stable except 8, 9 12 and 13; these compounds are found 
to fade upon exposure to light.  
Compounds 4-9 bind to duplex FS-DNA, with a high affinity of 9 for FS-DNA as quantified 
by a binding constant of ~ 105 M-1. However, anionic compounds 1-3 show no significant 
binding to duplex FS-DNA.  Moreover, compounds 6, 8 and 9 bind to duplex FS-DNA in the 
presence of co-solvents such as DMSO and acetonitrile. All DNA binding site sizes for 1-9 
are restricted to 3.0 base pairs in order to obtain a good fit to the titration curve corresponding 
to reasonable binding parameters. The binding site size for 6 was reanalysed at 1.0 base pair 
per binding site, in order to obtain reasonable binding parameters. Moreover, compounds 9-
12 bind to specific quadruplex-forming sequences such as c-myc, 22AG and EAD2. 
Compound 9 has a higher affinity for c-myc than for 22AG and EAD2. The binding 
stoichiometry for 9 with c-myc was found to be 6 ligands per quadruplex. Compound 11 also 
binds more strongly to c-myc than to 22AG. The binding stoichiometry for 11 with c-myc 
was found to be 4 ligands bind per quadruplex. Compound 12 has a strong affinity for 22AG 
than for c-myc. Therefore, its binding to 22AG was not possible to determine. 
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2.4 Materials and Methods 
2.4.1 Buffer preparation  
All experiments were carried out in one of 4 buffers. Buffer A contained 25 mM MOPS, 50 
mM NaCl and 1 mM EDTA, pH 7.0; buffer B contained 25 mM MOPS, 50 mM NaCl, 1 mM 
EDTA and 9 vol-% DMSO, pH 7.0; buffer C contained 25 mM MOPS, 100 mM KCl and 1 
mM EDTA, pH 7.0; phosphate buffer D contained 25 mM Na2HPO4, pH 7.0, and 50 mM 
NaCl. The buffer components were purchased from Melford (CAS 1132-61-2), NaCl was 
purchased from Fisher Scientific (CAS 7647-14-5), KCl was purchased from Sigma Aldrich 
(CAS 7447-40-7), Na2HPO4 was purchased from Melford (CAS 7558-79-4), EDTA was 
purchased from VWR (CAS 60-00-4) and DMSO from Fisher Scientific (CAS 67-68-5). 
Buffers were titrated with aqueous NaOH or KOH to the required pH. The pH of aqueous 
solutions was determined using a Hanna microprocessor pH 113 pH-meter equipped with a 
VWR 662-1382 glass electrode. Materials were weighed out on a Fisherbrand 4-decimal 
balance. De-ionised water was produced using an ELGA water purifier for all solutions. 
Buffer A, containing 25 mM MOPS (3-(N-morpholino) propanesulfonic acid), 50 mM 
sodium chloride (NaCl) and 1 mM EDTA was prepared by dissolving MOPS, sodium 
chloride (NaCl) and EDTA in distilled water and stirring at room temperature until the solid 
dissolved. A solution of sodium hydroxide (NaOH) was used for adjusting the pH to 7.0 and 
the buffer was made up to 2 liters in a volumetric flask. 
Buffer B, containing 25 mM MOPS (3-(N-morpholino) propanesulfonic acid), 50 mM 
sodium chloride (NaCl) and 1 mM EDTA was prepared by dissolving MOPS, sodium 
chloride (NaCl) and EDTA in distilled water and stirring at room temperature until the solid 
dissolved. 9 vol-% of DMSO was add to the buffer solution. Sodium hydroxide (NaOH) was 
used for adjusting the pH to 7.0 and the buffer was made up to 2 liters in a volumetric flask.  
Buffer C, containing 25 mM MOPS (3-(N-morpholino) propanesulfonic acid), 100 mM 
potassium chloride (KCl) and 1 mM EDTA was prepared by dissolving MOPS, potassium 
chloride (KCl) and EDTA in distilled water and stirring at room temperature until the solid 
dissolved. Potassium hydroxide (KOH) was used for adjusting the pH to 7.0 and the buffer 
was made up to 2 liters in a volumetric flask. 
Phosphate buffer D contained 25 mM Na2HPO4 (sodium phosphate) and 50 mM NaCl, and 
was prepared by dissolving Na2HPO4 and NaCl in distilled water and stirring at room 
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temperature until the solid dissolved. Sodium hydroxide (NaOH) solution was used for 
adjusting the pH to 7.0 and the buffer was made up to 2 liters. 
2.4.2 DNA preparation 
Fish sperm DNA was purchased from Acros Organics (CAS 68938-01-2). The stock solution 
of fish sperm DNA was prepared by dissolving approximately 0.1217grams DNA in 10 ml of 
buffer and sonicating the solution of FS-DNA for about 10 minutes. All DNA solutions were 
dialysed against buffer. The dialysis process for the DNA solution was carried out by taking 
the DNA solution and placing it into the dialysis tube of sufficient pore size (3.5 kDa 
MWCO).189 The dialysis tube was suspended for 24 hours inside a beaker that contains the 
MOPS buffer to allow impurities to diffuse out. The DNA concentrations were determined 
using the extinction coefficient for FS-DNA of 12800 M-1 cm-1 (bp) at 260 nm.190 
The concentration of c-myc (dTdGdA dGdGdG dTdGdG dGdTdT dGdGdG dTdGdG 
dGdTdAdA) was determined using UV-visible spectroscopy using the extinction coefficient 
of 228700 M-1 cm-1 at 260 nm.76 The concentration of  22AG (dAdGdG dGdTdT dAdGdG 
dGdTdT dAdGdG dGdTdT dAdGdGdG) was determined using UV-visible spectroscopy 
using the extinction coefficient of 228500 M-1 cm-1 at 260 nm.76 
For double-stranded synthetic DNA, i.e poly (dAdT) and poly (dGdC), we dissolve each 
sequence in 1 ml of buffer. Then, the dialysis process for the DNA solution was carried out 
by taking the DNA solution and placing it into the dialysis tube of sufficient pore size (3.5 
kDa MWCO). The dialysis tube was suspended for 24 hours inside a beaker that contains the 
MOPS buffer until the impurities were completely diffused out. The DNA concentration was 
determined using UV-visible spectroscopy using the extension coefficient of 14800 M-1 cm-1 
at 254 nm for poly (dGdC) and of 12000 M-1 cm-1 at 260 nm for poly (dAdT).127 Then, the 
DNA solutions were annealed by placing each DNA solution into an Eppendorf and placing 
the Eppendorf in a beaker that contains a water at 95 °C, allowing to cool down and finally 
determine the concentration of each solution.  
For single-stranded DNA such as poly (dA) and poly (dT), we dissolve each sequence in 1 ml 
of buffer in (25 mM MOPS, 50 mM NaCl and 1 mM EDTA, pH 7.0, at 25 °C). The dialysis 
process for the DNA solution was carried out by taking the DNA solution and placing it into 
the dialysis tube of sufficient pore size (3.5 kDa MWCO). The dialysis tube was suspended 
for 24 hours inside a beaker that contains the MOPS buffer until the impurities were 
completely diffused out. The DNA concentration was determined using UV-visible 
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spectroscopy and the extinction coefficient of 8600 M-1 cm-1 at 257 nm for single-strand 
purine poly (dA) and 8520 M-1 cm-1 at 264 nm for single-stranded primidine poly (dT). We 
then mixed both sequences to have a 1:1 mixture of strands in an Eppendorf. The duplex was 
annealed by placing the Eppendorf in a beaker that contains water at 95 °C and allowing to 
cool to room temperature.124 Finally, the concentration of each solution was determined using 
UV-visible spectroscopy using the extinction coefficient of 12000 M-1 cm-1 at 260 nm for 
poly (dA)-poly (dT). 127 
2.4.3 Dialysis units 
The dialysis tubing was purchased from (Medicell Membranes Ltd, MWCO 12-14000 and 
3500 Daltons).  
 
2.5 Equipment 
2.5.1 Spectroscopic studies 
UV-visible spectra were recorded using a Jasco V-630BIO spectrophotometer with a Peltier 
temperature controller at 25 °C. All UV-visible titrations were carried out in a 1.0 cm path 
length cuvette starting with the volume of the buffer (2000-2500 µl). After that an aliquot 
from the ligand solution was added and the absorbance was measured. UV-visible titrations 
were carried out by adding the stock solution of DNA into the 1.0 cm cuvette which contains 
the ligand solution. UV-visible spectra in the range 200 - 600 nm were recorded after each 
addition of DNA. The absorption of the ligand was kept in the range of 0.1-0.8 a.u. The 
absorptions at selected wavelength were plotted against DNA concentrations. The multiple 
independent binding sites model was used to analyse the data of UV-visible spectra using 
Origin 9. Circular dichroism spectra CD were recorded using a Chirascan CD spectrometer. 
84  
 
2.5.2 Isothermal titration calorimetry 
ITC experiments were conducted using a Microcal VP-ITC microcalorimeter at 25 °C. 
Concentrations for 7 were determined using UV-visible spectroscopy based on the extinction 
coefficient of 7 of 33000 M-1 cm-1 at 332 nm173 in 25 mM MOPS, 50 mM NaCl, 1 mM 
EDTA, and pH 7.0 at 25 °C. 
First of all we cleaned both cells and the syringe with ethanol and after that with distilled 
water.89 The sample cell was filled with a FS-DNA solution (approximately 1.9 ml) and the 
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syringe was filled with the ligand solution (approximately 300 µl). The concentration of the 
ligand solution is higher than the DNA solution (usually 12-fold higher than DNA solution).  
The ligand solution was added in 1 injection of 5 µl and 19 injections of 15 µl each to the 
sample cell and injecting every 300 second automatically with a stirring speed of 307 rpm. 
Origin (Microcal, Inc) was used to calculate the heat effects per injection (dh). We analysed 
integrated heat effects using our ITC data analysis software IC-ITC. 
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Abstract 
This chapter describes the development of a custom competition dialysis device. We test the 
use of this device to determine affinity and selectivity of ligands for nucleic acids structures. 
We studied the affinity and selectivity of single ligands for FS-DNA, specific duplex 
sequences (dA)24 • (dT)24 and (dG)24• (dC)24, and different quadruplex structures such as, c-
myc, 22AG and EAD2. We compare the results with the results from UV-vis titrations (as 
shown in Chapter 2) and conclude that both results are in agreement.  
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Part A   
3.1 Introduction 
3.1.1 Competition dialysis 
Ligands that bind to nucleic acids, having structural or sequence selectivity, can be identified 
using a powerful tool called “competition dialysis”.125 This process is used as a test for 
affinity and selectivity of ligands for nucleic acids and comprises of the dialysis of a ligand 
against an array of nucleic acids with different structures or sequences.124 In this method, 
separate nucleic acid structures are exposed to a solution of a potential nucleci acid binder 
through a dialysis membrane. As dialysis progresses, equilibration of the system is achieved 
with the binder accumulating where its highest affinity target is. Absorbance or fluorescence 
measurements are then used to determine the amount of ligand bound to each structure. The 
competition dialysis process is amenable to the study of soluble and stable ligands.  
In the traditional setup, dialysis tubing is filled with samples of different nucleic acids. The 
dialysis tubing is placed in a beaker with a ligand solution, allowing enough time for the 
diffusion of the ligand across the dialysis tubing to take place (Figure 3.2). 
 
Figure 3.2 Schematic illustration of the dialysis process involving three different 
concentrations of FS-DNA, and a ligand (orange dots). 
The uniformly sized pores of the dialysis tubing (e.g. 3.5 kDa MWCO) allow the ligand 
molecules to diffuse in and out of the multiple dialysis tubing to achieve the equilibrium 
concentration, while the large nucleic acids are retained within the dialysis tubing.124 The 
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equilibrium concentrations are defined by the affinity between the FS-DNA and the ligand 
(Equation 1). 
K = [ligand]bound / ([ligand]free × [binding sites]free)                                                 Equation 1 
It has been previously reported by Brad Chaires127 that the first generation of the competition 
dialysis enabled the determination of the selectivity and affinity for 13 different samples of 
the nucleic acid structure as shown in Scheme 3.1. In this study, MMQ1, a 
dibenzophenthroline, adriamycin, an anthracycline antibiotic and DODC, a cyanine dye were 
chosen and their selectivities studied (Scheme 3.1). 
 
 Scheme 3.1. First generation of the competition dialysis results for the amount of bound for 
each of the 13 different structure of DNA. A) MMQ1, a dibenzophenthroline. B) Adriamycin, 
an anthracycline antibiotic and c) DODC, a cyanine dye.  
The data show that MMQ1 has different selectivity for different structures of DNA.  
Adriamycin has a selectivity for triplex and quadruplex DNA structure, while DODC has a 
higher affinity toward triplex DNA rather than toward any other structures.  
The second generation of the competition dialysis method enabled evaluation of 14 to 19 
nucleic acid samples. Both methods of the competition dialysis utilized 200 ml of 1 uM ligand 
solution and 0.5 mL of 75 uM of the nucleic acid structures placed in the dialysis units.   
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A quantitative analysis was applied to the competition dialysis data (Scheme 3.2).    
 
Scheme 3.2. The second generation of the competition dialysis assay for different ligands 
such as A) Ethidium bromide has selectivity for the DNA:RNA hybrid polyrAdT and for the 
RNA sequence polyrArU. B) NMM has selectivity for quadruplex structures especially on 
(50G10T4G10) 4. C) DODC has a high selectivity for the triplex DNA polydAdT-dT. D) 
PIPER is selective for the human telomere. E) Methylene blue is also selective for the 
telomere. F) Berberine has a selectivity for the triplex DNA polydAdT-dT and also for 
quadruplex (50G10T4G10)4, Quadruplex 1, (50T2G20T2)4, Quadruplex 2, human telomere. 
The third generation of competition dialysis utilises a 96-well format in Sceme 3.3. The 
volume for each well is around 150-200 uL of 75 um samples of the nucleic acid structure, 
250 mL was the volume of the ligand solution. Examples of data analysis conducted in this 
experiment include competition dialysis assay involving extensive ranges of DNA sequences 
and structures (Scheme 3.4).  
    
 
  
Scheme 3.3. The competition dialysis assay.124 
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   Scheme 3.4. The third generation of competition dialysis result for NMM. NMM is found to 
be selective for the G-quadruplex (50G4T4)3, however NMM has similar affinities for the 
quadruplex (50G10T4G10) and i-motif quadruplex (50C4T4C4).124  
To improve the wetting property of the solution, surfactants were added. Surfactants lower the 
surface tension while improving the wetting and ultimately binding characteristics. The ligand 
solution was added at the end as a surfactant solution to the dialysate solution to introduce 
lower surface tension between the dialysate solutions and to act as an emulsifier in the nucleic 
acid. Hence, the presence of a surfactant results in free flow of the molecules across the 
dialysis unit.  
Scheme 3.5 shows all three generations of the competition dialysis assay for the ethidium 
bromide with 13, 19 and 46 nucleic acids structures. 
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 Scheme 3.5. Development of the competition dialysis results for ethidium bromide. A) The 
first and second generation assays for ethidium bromide with 13 and 19 nucleic acid 
structures. Ethidium bromide appears to be selective for duplex RNA and DNA–RNA hybrid, 
poly (rAdT), and binding strongly to duplex and triplex DNA. B) The third generation assay 
involves 46 structures and ethidium bromide prefers the quadruplex VEGF, also to DNA and 
RNA triplexes, DNA–RNA hybrid forms and finally to duplex DNA with alternating purine-
pyrimidine sequences.125 
A further quantitative analysis was performed for DAPI, this includes the first and third 
generations of the competition dialysis assay (Scheme 3.6).     
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Scheme 3.6. Development of the competition dialysis results for DAPI. A) The first 
generation assay which representing DAPI bound to ATrich duplex DNA, also DAPI has a 
moderate binding to the DNA–RNA hybrid poly(rA)–poly(dT) and the quadruplex 
(T2G20T2)4. B) The third generation assay confirmed that DAPI is still preference to AT-
rich duplex DNA.125  
Selectivity graphs were plotted using difference plots in order to obtain a set of bindings of 
test compounds that fits the structure of the DNA and to offer a selection of compounds that 
have the most preferred target (Scheme 3.7).  
 
Scheme 3.7. The competition dialysis results for the selectivity of BePI (left), coralyne 
(middle), and berberine (right) for different nucleic acid structures.126  
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Scheme 3.7 shows difference plots to discover the selectivity of three compounds for triplex 
DNA structures. The graph on the right is for berberine and shows weaker biding to triplex 
DNA compared with coralyne to triplex DNA. Utilizing difference plots is effective in 
selective compounds having a particular affinity and aimed at a specific target.   
Typically, (UV)-visible spectroscopy, circular dichroism spectroscopy and thermal 
denaturation studies are being used to control all the experiments to determine the 
concentrations and the extinction coefficient of the DNA/ ligand samples.  
3.1.2 An overview of selected nucleic acid binders with structural selectivity 
Table 3.1 shows the properties of ligands chosen for this study and their nucleic acid targets 
like optical emission, absorption, and structural selectivity. 
Table 3.1 lists the properties of selected combinations of ligands and nucleic acid structures 
like optical emission, absorption and selectivity. Basic yellow and methylene blue target G-
quadruplex DNA. Ethidium bromide has affinity toward triplex but also to polyA • polyT. 
Optical emission and absorption for the basic yellow, methylene blue and ethidium bromide 
are very important for selection of the second ligand for double competition dialysis. The 
importance of the optical emission spectrum of the donor and the absorption spectrum of the 
acceptor relative to each other is critical for FRET.  
 
Table 3.1:  Optical emission, absorption and nucleic acid targets for optoelectronically active 
nucleic acid binders.  
Ligand Solubility Nucleic acid target λex 
/nm 
λem 
/nm 
Ref. 
basic yellow (thioflavin) Soluble Quadruplex 22AG 330 450 191 
methylene blue Soluble Telomere G-quadruplex DNA 663 / 124 
ethidium bromide Soluble polyA • polyT  
Triplex  
481 616 125,126 
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3.1.3 Aims 
There are several aims to discuss in this chapter.  
Firstly, in part A, we will validate the traditional approach to competition dialysis for the 
quantification of affinities for FS-DNA using dialysis tubing. We will develop a device which 
allowed me to carry out competition dialysis in a simpler manner, which is compatible with 
UV-vis spectroscopy and which allows us to follow equilibration as a function of time. 
Finally, in part B, we will studiy the affinity of selected ligands for FS-DNA, (dA)24 (dT)24, 
and different quadruplex structures such as c-myc, 22AG and EAD2. For these studies, we 
pre-identified some compounds potentially displaying orthogonal selectivity for nucleic acid 
structures.  
We will compare the selectivity and affinity obtained using both the traditional assay and our 
approach to competition dialysis. We will studiy the affinity and selectivity of a single ligand 
for FS-DNA, specific duplex sequences (dAdT)12 and (dGdC)12, and different quadruplex 
structures, viz c-myc, 22AG and EAD2. Fish sperm DNA, deoxyribonucleic acid sodium salt 
were used to study DNA binding. 
Finally, this chapter will also present the results from our competition dialysis assay for the 
compounds, which were selected based on their previously reported properties such as optical 
emission, absorption and selectivity toward to nucleic acid. 
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3.2 Results and discussion  
Part A 
3.2.1 Development and optimisation of a device for competition dialysis 
3.2.1a Validation of the traditional approach to competition dialysis methods for the 
quantification of affinities of small molecules for FS-DNA. 
We wanted to test the validity of affinities determined using the traditional approach to 
competition dialysis to this end, 500 ml of a solution of known concentration (1.2×10-5 M) of 
methylene blue (9) in buffer (25 mM MOPS, 50 mM NaCl, 1 mM EDTA and pH 7) is placed 
in a beaker. We placed 10 ml of solutions of three different concentrations of FS-DNA (27 
µM, 63 µM, and 248 µM) in dialysis tubing (DT) and placed the dialysis tubing in the beaker. 
We assumed that equilibrium had been achieved after around 48 hours and analysed the 
contents of the dialysis tubing using UV-visible spectroscopy (Table 3.2).  
Table 3.2: Equilibrium constant K for 9 a intreacting with FS-DNAb 
 dialysis tubing DT1 DT2 DT3 
[DNA]total / M 2.7×10-5 6.3×10-5 2.48×10-4 
unit conc bp bp Bp 
bind. sites / unit conc.d 3.33×10-1 3.33×10-1 3.33×10-1 
[binding sites]total / M 9.00×10-6 2.10×10-5 8.27×10-5 
A663 nm 0.1382 0.1795 0.354 
A663 nm, bound c 0.0200 0.0613 0.2358 
C bound / M c 3.66×10-6 1.12×10-5 4.31×10-5 
[ligand]free / M 1.13×10-5 1.13×10-5 1.13×10-5 
[binding sites]free / M 5.34×10-6 9.78×10-6 3.95×10-5 
K / M-1 6.03×104 1.01×105 9.61×104 
a) Concentration of 9 in the beginning was 12 µM. 
b) In buffer (25 mM MOPS, 50 mM NaCl, 1 mM EDTA and pH=7), at 25 
°C.   
c) A663 bg = 0.0295, A663 free = 0.0887, ε free = 78000 M-1 cm -1 and ε bound = 
54618 M-1 cm -1. 
d) We assume the binding site size in base pairs is 3.0.  
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Table 3.2 shows a higher absorbance of 9 with a higher concentration of FS-DNA in the 
dialysis tubing. The average value for the equilibrium constant (Kbinding) is (8.5 ± 2.22) × 104 
M-1. The result is in reasonable agreement with the results from the UV-visible titrations as 
shown in Chapter 2 which gave Kbinding of (3.83 ± 0.78) ×105 M-1. The slightly lower apparent 
affinity may be the result of incomplete equilibration.  
We realised that it it is probably a better idea to repeat the same experiment but for a longer 
time in order to check whether we achieve equilibration. We therefore, carried out the same 
experiment of 9 (12 µM) in 25 mM MOPS, 50 mM NaCl, 1 mM EDTA and pH 7. The 
concentrations and apparent affinities of the ligand were determined after 72 hours, i.e. after 
more time than the previous experiment (Table 3.3). 
Table 3.3: Equilibrium constants K for 9 a interacting with DNAb  
 dialysis tubing DT1 DT2 DT3 
[DNA]total / M 2.7×10-5 7.4×10-5 2.4×10-4 
unit conc. bp bp Bp 
bind. sites / unit conc.d 3.33×10-1 3.33×10-1 3.33×10-1 
[binding sites]total / M 9.00×10-6 2.47×10-5 8.00×10-5 
A663 nm 0.1436 0.2255 0.5321 
A663, bound c 0.0517 0.1336 0.4402 
C bound / M c 9.46×10-7 2.44×10-6 8.05×10-6 
[ligand]free / M 8.84×10-7 8.84×10-7 8.84×10-7 
[binding sites]free / M 8.05×10-6 2.22×10-5 7.19×10-5 
K / M-1 1.33×105 1.24×105 1.27×105 
a) Concentration of 9 in the beginning was 12 µM.  
b) In buffer (25 mM MOPS, 50 mM NaCl, 1 mM EDTA and pH=7), at 25 °C.   
c) A663 bg= 0.0229,  A663 free = 0.069, ε free 78000 M-1 cm -1 = and ε bound = 54618 
M-1 cm -1. 
d) We assume the binding site size in base pairs is 3.0. 
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Table 3.3, shows the higher absorbance of 9 with the higher DNA concentration in DT3. The 
equilibrium constant for the three different FS-DNA concentrations are almost the same with 
an average equilibrium constant (Kbinding) of (12.8 ± 0.4) × 104 M-1. Comparison with the data 
in Table 3.2 shows that the equilibrium has been not achieved after around 48 hours. This 
means that we cannot be sure that the solutions are fully equilibrated by only looking at the 
end point of the experiments. The result is in agreement with the results from the UV-visible 
titrations as shown in Chapter 2 which gave Kbinding of (3.8 ± 0.78) ×105 M-1. 
We wanted to know whether the equilibrium constant was affected by the presence of 9 vol-
% DMSO because DMSO is a useful cosolvent to help avoid ligand precipitation.176 We 
carried out the same experiment, but with MOPS buffer containing 9 vol-% DMSO. The 
concentrations and apparent affinities of the ligand are reported in Table 3.4. 
Table 3.4: Equilibrium constants K for 9 a interacting with DNAb  
 dialysis tubing DT1 DT2 DT3 
[DNA]total / M 2.3×10-5 5.8×10-5 2.49×10-4 
unit conc. bp bp Bp 
bind. sites / unit conc.d 3.33×10-1 3.33×10-1 3.33×10-1 
[binding sites]total / M 7.67×10-6 1.93×10-5 8.30×10-5 
A663 nm  0.1533 0.1804 0.2835 
A663 nm, bound c 0.0160 0.0431 0.1462 
C bound / M c 2.92×10-6 7.89×10-6 2.67×10-5 
[ligand]free / M 1.34×10-5 1.34×10-5 1.34×10-5 
[binding sites]free / M 4.74×10-6 1.14×10-5 5.62×10-5 
K / M-1 4.60×104 5.13×104 3.54×104 
a) Concentration of 9 in the beginning was 14 µM.  
b) In buffer (25 mM MOPS, pH 7.0, 100 mM KCl, 9 vol-% DMSO and 1 
mM EDTA), at 25 °C.   
c) A663 bg = 0.0324, A663 free = 0.1049, ε free = 78000 M-1 cm -1 and ε bound = 
54618 M-1 cm -1. 
d) We assume the binding site size in base pairs is 3.0. 
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As Table 3.4 shows, there is no significant difference between the equilibrium constants 
(Kbinding) for the different concentrations of FS-DNA. The average equilibrium constant 
(Kbinding) is (4.42 ± 0.80) × 104 M-1. The result is in reasonable agreement with the results 
from the UV-visible titrations in the presence of DMSO as shown in Chapter 2 which gave 
Kbinding of (8.5 ± 1.35) ×104 M-1.  The data clearly confirm that binding is weaker compared 
with the result in the absence of DMSO.  
DMSO can affect DNA structure and may also improve ligand solubility, thus decreasing 
binding affinity. Just like in the absence of DMSO, the apparent affinity according to 
competition dialysis may be lower than the affinity according to UV-visible titrations because 
of incomplete equilibration.  
 
3.2.1b Some problems of the traditional approach to competition dialysis  
Competition dialysis relies on solubility and chemical stability of the ligand in the buffer over 
the duration of the experiment. One of the more significant findings to emerge from our first 
experiments is that precipitation occurred when using TF1 (8) (Figure 3.3). 
 
 
 
 
 
 
 
 
 
Figure 3.3 (A) Precipitation of ligand 8 on the dialysis tubing and (B) on the clip but (C) less 
precipitation of 8 in the presence of 9 vol-% DMSO. 
             (A)             (B)  (C) 
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Figure 3.3 Shows that the precipitation can occur during the competition dialysis study. To 
address this challenge, we have to study ligands that have very good solubility in the buffer, 
if necessary in the presence of added DMSO, to avoid precipitation of the ligand.  
In addition, the lack of access to the nucleic acid solutions during the experiment means that 
we cannot follow the equilibration process. This means that we cannot be sure that the 
solutions are fully equilibrated.  
3.2.1c A new competition dialysis device 
To facilitate our competition dialysis studies, we decided to design a new device, based on 
previously available commercial devices.  
The design criteria were as follows: 
• Holes containing nucleic acids compatible with typical volumes required for 1 cm 
pathlength cuvettes. 
• Reservoir containing initial ligand solution compatible with volumetric glassware, and 
the volume must correspond to a large excess over the volume of the initial nucleic 
acid solutions in the top of the device. 
• Easy access to solutions during competition dialysis so that equilibration can be 
followed. 
• Material easy to clean. 
The basic device we designed was made out of Teflon and encompasses three major 
components as shown in Figure 3.4 (B). The bottom of the device contains the ligand 
solution, and has a capacity of just below 100 mL.  
The middle part of the device provides support for the dialysis membrane. Dialysis 
membrane will allow the ligand molecules to diffuse in and out of the holes containing the 
nucleic acid structures to achieve the equilibrium concentration. 
The top of the device has five holes for different concentrations of DNA or for different 
sequences of DNA such as duplex DNA, triplex DNA and quadruplex.192 The maximum 
capacity of each hole is 10 mL. However, in practice, 3 ml was used which is enough volume 
to fill a quartz cuvette. The actual device is shown in Figure 3.4B. 
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Figure 3.4 (A) the design of a new competition dialysis device, (B) a photo of the new 
competition dialysis device. 
To check if there is any leak in any part of the dialysis device, we filled the complete device 
with water. Unfortunately, the device failed this test. Then, we tried to test it part by part and 
it leaked again. We noted that the leaking occurred from the second part of device. Therefore, 
to stop the leaking, we added a rubber O-ring between parts 1 and 2. This modification 
stopped the leaking.  
To test the middle part of the device, we checked the diffusion between the bottom part of the 
device and the top of the device by placing a dye solution of methylene blue (9) in the bottom 
of the device and recording the UV-visible absorbance of the solutions in the holes above as a 
function of time (Table 3.5). 
Table 3.5: Testing the diffusion of a solution of methylene blue (9) in our device a 
time / hours hole 1 hole 2 hole 3 hole 4 hole 5 Buffer 
5 0.0248 0.0233 0.0239 0.0249 0.0243 0.0213 
23 0.0403 0.0303 0.2229 0.074 0.1275 0.0268 
41 0.0359 0.0459 0.2282 0.0838 0.1264 0.032 
48 0.0416 0.0454 0.2217 0.0924 0.1288 0.0323 
72 0.0428 0.0484 0.2217 0.1008 0.124 0.0274 
96 0.0421 0.0462 0.2131 0.109 0.1268 0.0274 
a) In buffer (25 mM MOPS, 50 mM NaCl, 1 mM EDTA and pH=7), at 25 °C.   
b) Concentration of 9 in the beginning was 0.0088 µM. 
                
Table 3.5 shows that the absorbances for some of the holes in the top of the device are close 
to the absorbance for the buffer. Nevertheless, some other holes, in particular hole 3, show a 
A) (B) 
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higher absorbance at 663 nm. We explored several solutions to the failure of the dye to reach 
the top of the device, such as washing the dialysis membrane and the placement of the 
dialysis membrance.   
The success of our method is contingent on the solution in the bottom of the device being in 
contact with the solution in the top part through the dialysis membrane. This means that the 
solution in the device must show a convex surface when the middle part of the device is in 
place as clearly shown in Figure 5.5. If this is the case, no bubbles will form below the 
dialysis membrane. Bubbles break the contact between the liquids.  In addition, it is 
important to clean the dialysis membrane before use by placing it in a beaker of hot water for 
10 min, to remove any impurities. 
 
 
 
 
Figure 3.5 a convex meniscus on the solution on the top of the middle part of the device 
To investigate that the device works well if good contact between the solutions was created, 
we carried out the same experiment involving a solution of 9 in the bottom of the device and 
MOPS buffer in the top of the device. UV-visible spectroscopy was used to determine the 
concentration of 9 at 663 nm as a function of time (Table 3.5). 
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Table 3.6, shows that the absorbance of 9 at 663 nm is similar for all holes. This absorbance 
result suggests that diffusion is now satisfactory. In general, the top and middle part of device 
are working well.  
In order to test the device further, we determined the affinity of 9 for FS-DNA at different 
concentrations of FS-DNA (26 µM, 69 µM, and 230 µM) at a concentration of 9 of 1.4×10-6     
M. The concentrations and apparent affinities of the ligand for DNA in 25 mM MOPS, 50 
mM NaCl, 1 mM EDTA and pH 7 were determined (Table 3.7). 
Table 3.6: for testing the diffusion of solution of  methylene blue (9) a 
 time/ hours  hole 1 hole 2 hole 3 hole 4 hole 5 Buffer 
5 0.594 0.6371 0.8731 0.7035 0.7334 0.0231 
24 1.9726 1.9193 2.1191 2.0445 2.1411 0.0219 
72 2.4015 2.4012 2.4376 2.4296 2.4865 0.0208 
95 2.4148 2.4255 2.4473 2.4452 2.5181 0.022 
a) In buffer (25 mM MOPS, 50 mM NaCl, 1 mM EDTA and pH=7), at 25 °C.   
b) The concentration of 9  in the beginning of this experiment was 0.055 µM.  
c) The concentration of 9 in the end of this experiment was 1.9×10-3 µM. 
d)  A663 bg = 0.0274, A663 free = 0.1542, A reservoir = 0.1816. 
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Table 3.7 presents a higher absorbance of 9 with a higher concentration of FS-DNA. The two 
holes with 2.3×10-4 M-1 FS-DNA give the same absorbance. What is promising in this data is 
that the equilibrium constant K for the three different concentrations of DNA are almost the 
same. The average equilibrium constant (Kbinding) is (5.1 ± 1.2) × 104 M-1. Accordingly, the 
result is in agreement with the results from the UV-visible titrations as shown in Chapter 2. 
However, we also note that the absorbance of the buffer is much higher than the absorbance 
of the ligand solution in the bottom of the device. Unfortunately, our control therefore shows 
us that there is a problem with 9. This problem was later attributed to fading of 9. 
We set to determine if the position of the holes in the top of the device can affect the apparent 
affinity. For example, data from the hole in the middle of the device always suggested a 
higher affinity compared with other holes. To investigate this, the experiment is repeated. 
This experiment focused on the positions of the holes as shown in Figure 3.6. 
Table 3.7: Equilibrium constants K for 9 a interacting with FS-DNAb  
 DNA FS-DNA FS-DNA FS-DNA FS-DNA buffer 
[DNA]total / M 2.6×10-5 6.9×10-5 2.3×10-4 2.3×10-4 0 
unit conc. bp bp bp Bp / 
bind. sites / unit conc. d 3.33×10-1 3.33×10-1 3.33×10-1 3.33×10-1 / 
[binding sites]total 8.67×10-6 2.30×10-5 7.67×10-5 7.67×10-5 / 
A663 nm 0.0815 0.1001 0.1564 0.1566 0.0924 
A663 nm, bound c 0.0165 0.0351 0.0914 0.0916 0.0274 
C bound / M c 6.04×10-7 1.28×10-6 3.35×10-6 3.35×10-6 / 
[ligand]free / M 1.09×10-6 1.09×10-6 1.09×10-6 1.09×10-6 1.09×10-6 
[binding sites]free / M 8.06×10-6 2.17×10-5 7.33×10-5 7.33×10-5 / 
K / M-1 6.84×104 5.41×104 4.17×104 4.18×104 / 
a) Concentration of 9 was 1.4 µM. 
b) In buffer (25 mM MOPS, 50 mM NaCl, 1 mM EDTA and pH 7), at 25 °C.   
c) Abg, = 0.0223, Afree, =  0.0427, A663 reservoir = 0.0650, ε free = 78000 M-1 cm -1 and ε bound = 54618 M-1 
cm -1. 
d) We assume the binding site size in base pairs is 3.0. 
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Figure 3.6 the top of the device with five holes. 
A solution of 1.3×10-6 M 9 was exposed to different concentrations of FS-DNA (25 µM, 69 
µM, and 208 µM) in 25 mM MOPS, 50 mM NaCl, 1 mM EDTA and pH 7 in the top of the 
device. The fifth hole was filled with buffer as a control experiment. After equilibration for 
72h, the concentrations and apparent affinities of the ligand and DNA were determined 
(Table 3.8). 
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Table 3.8 demonstrates that the device is not working well and that the results are not 
independent of the hole used in the experiment. The problem appears from the results that 
show a different absorbance of 9 at 663 nm with the same concentration of DNA (2.08×10-4 
M). The cause is probably evaporation because the lid of the device has a small hole above 
the center hole of the top part of the device as shown that in table 3.13.   
 Furthermore, the data presented a similar equilibrium constant of (6.5 ± 1.17) × 104 M-1. 
However, we observe another problem that appears from the control for this experiment. The 
absorbance of free ligand in the reservoir was 0.0702 and in the control hole it was 0.1106. 
That is a big difference. Unfortunately, our control therefore again shows us there is a 
problem with 9. This problem was later attributed to the fading. 
Table 3.8: Equilibrium constants K for 9 interacting with FS-DNAa  
 DNA FS-DNA FS-DNA FS-DNA FS-DNA Buffer 
[DNA]total / M 2.5×10-5 6.9×10-5 2.08×10-4 2.08×10-4 0 
unit conc. bp bp bp Bp / 
bind. sites / unit conc. d 3.33×10-1 3.33×10-1 3.33×10-1 3.33×10-1 / 
[binding sites]total / M 8.33×10-6 2.30×10-5 6.93×10-5 6.93×10-5 / 
A663 nm 0.1203 0.1644 0.2502 0.3219 0.1106 
A663nm, bound c 0.0284 0.0725 0.1583 0.23 0.0187 
C bound / M c 5.199×10-7 1.32×10-6 2.89×10-6 4.21×10-6 / 
[ligand]free / M 9.00×10-7 9.00×10-7 9.00×10-7 9.00×10-7 9.00×10-7 
[binding sites]free / M 7.81×10-6 2.17×10-5 6.64×10-5 6.51×10-5 / 
K / M-1 7.39×104 6.81×104 4.85×104 7.18×104 / 
a) Concentration of 9 in the beginning was 1.3 µM. 
b) In buffer (25 mM MOPS, 50 mM NaCl, 1 mM EDTA and pH=7), at 25 °C.   
c) Abg, 0.0217, Afree, 0.0702, A663 reservoir was 0.0919, ε free = 78000 M-1 cm -1 and ε bound = 
54618 M-1 cm -1. 
d) We assume the binding site size in base pairs is 3.0. 
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3.2.1c DMSO affects the observed affinities in competition dialysis 
As we have shown in Chapter 2, DMSO affects the interaction between 8 and FS-DNA. Here, 
we want to test this effect again in our competition dialysis assay and compare the results to 
those from UV-visible spectroscopic titrations. The experiment involved different 
concentrations of FS-DNA (25 µM, 60 µM, and 227 µM) and a concentration of 8 of 
1.16×10-6 M in a DMSO-containing buffer (25 mM MOPS, pH 7.0, 100 mM KCl, 9 vol-% 
DMSO and 1 mM EDTA).  The concentrations and apparent affinities of the ligand after 
equilibration were determined and are shown in Table 3.9. 
Table 3.9: for testing the concentration of 8a exposed to different 
concentrations of  FS-DNA b 
 Time / hours buffer FS-DNA FS-DNA FS-DNA FS-DNA 
        24 0.0346 0.0354 0.0352 0.0337 0.0345 
        48 0.0444 0.0458 0.0435 0.0429 0.0456 
        72 0.048 0.0557 0.0469 0.0482 0.0494 
        96 0.0516 0.0595 0.0489 0.0503 0.0516 
       120 0.052 0.0607 0.0522 0.0516 0.0526 
       144 0.0494 0.0648 0.0513 0.0534 0.053 
       168 0.0529 0.0664 0.0523 0.0521 0.0516 
a) Concentration of 8 was 1.1 µM. 
b) In buffer (25 mM MOPS, pH 7.0, 100 mM KCl, 9 vol-% DMSO and 
1 mM EDTA), at 25 °C.   
c) The 8 concentration in the end of this experiment was 0.6 µM. 
d) Abg, 0.0207, Afree, 0.0324 and A476 reservoir was 0.0531. 
 
Table 3.9 shows all the absorbance data for 8 at 476 nm are close to absorbance of the buffer. 
This absorbance result suggests that diffusion is not satisfactory, which may be due to a low 
solubility of 8 and resulting precipitation which can affect our data.  To avoid that error, the 
experiment was repeated using both a magnetic stirrer in the bottom part of the device and 
placing the device inside a Heidolph incubator at 25 °C for all experiments from now on.  
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Table 3.10: Equilibrium constants K for 8 a interacting with FS-DNAb 
 DNA FS-DNA FS-DNA FS-DNA FS-DNA buffer 
[DNA]total / M 2.23×10-4 2.6×10-5 6.8×10-5 2.6×10-5 0 
unit conc. bp bp bp Bp / 
bind. sites / unit conc. d 3.33×10-1 3.33×10-1 3.33×10-1 3.33×10-1 / 
[binding sites]total / M 7.43×10-5 8.67×10-6 2.27×10-5 8.67×10-6 / 
A476 nm 0.5669 0.3969 0.3853 0.4581 0.3838 
A476, bound c 0.2037 0.0337 0.0221 0.0949 0.0206 
C bound / M c 5.53×10-6 9.15×10-7 6×10-7 2.58×10-6 / 
[ligand]free / M 6.57×10-6 6.57×10-6 6.57×10-6 6.57×10-6 6.57×10-6 
[binding sites]free / M 6.88×10-5 7.75×10-6 2.21×10-5 6.09×10-6 / 
K / M-1 1.22×104 1.80×104 4.14×103 6.44×104 / 
a) Concentration of 8 was 6.2 µM. 
b) In buffer (25 mM MOPS, pH 7.0, 100 mM KCl, 9 vol-% DMSO and 1 mM EDTA), 
at 25 °C.   
c) Abg, 0.0254, Afree, 0.3378, A476 reservoir was 0.3632, ε free = 51398 M-1 cm -1 and ε bound = 
36828 M-1 cm-1. 
d) We assume the binding site size in base pairs is 3.0. 
 
To check if we can solve the solubility problem shown above by adding DMSO, two 
experiments were carried out. The first experiment involved different concentrations of FS-
DNA (26 µM, 68 µM, and 223 µM) and 6.2×10-6 M 8, while the The second experiment 
involved FS-DNA (24 µM, 67 µM, and 176 µM) and 7.7×10-6 M 8.  
 Both experiments were in buffer (25 mM MOPS, pH 7.0, 100 mM KCl, 9 vol-% DMSO and 
1 mM EDTA) at 25 °C. The concentrations and apparent affinities of the ligand after 
equilibrium were determined in Tables 3.10 and 3.11. 
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Tables 3.10 and 3.11 present the affinities of 8 for FS-DNA as determined at different 
concentrations of FS-DNA. The data in Tables 3.10 and 3.11 give the same affinities of 8 for 
FS-DNA. These absorbance results suggest that the diffusion is satisfactory. The average 
equilibrium constants (Kbinding) are (2.4 ± 2.7) × 104 M-1 and (2.8 ± 1.8) × 104 M-1, 
respectively. These results are in agreement with the results from the UV-visible titrations as 
shown in Chapter 2 which gave (Kbindin)g of (1.04 ± 0.84) × 105 M-1. 
We further tested whether a magnetic stirrer can be added in the bottom reservoir of the 
device (Tables 3.10 and 3.11). The data show that a magnetic stirrer enhances the experiment. 
The reason to store the device at 25 °C is to keep all the conditions the same to compare this 
data with Chapter 2.  The device was stored at 25 °C during equilibration. Despite the 
precautions, however, the low solubility of 8 causes precipitation, which affects our data as 
shown in Figure 3.7.  
Table 3.11: Equilibrium constants K for 8 a interacting with FS-DNAb  
 DNA FS-DNA FS-DNA FS-DNA FS-DNA buffer 
[DNA]total / M 1.76×10-4 2.4×10-5 1.76×10-4 6.7×10-5 / 
unit conc. bp bp Bp bp / 
bind. sites / unit conc. d 3.33×10-1 3.33×10-1 3.33×10-1 3.33×10-1 / 
[binding sites]total / M 5.87×10-5 8.00×10-6 5.87×10-5 2.23×10-5 / 
A476 nm 0.4935 0.3966 0.4948 0.4547 0.4798 
A476, bound c 0.1672 0.0703 0.1685 0.1284 0.1535 
C bound / M c 4.53×10-6 1.91×10-6 4.58×10-6 3.48×10-6 / 
[ligand]free / M 5.84×10-6 5.84×10-6 5.84×10-6 5.84×10-6 5.84×10-6 
[binding sites]free / M 5.41×10-5 6.09×10-6 5.41×10-5 1.88×10-5 / 
K / M-1 1.44×104 5.36×104 1.45×104 3.17×104 / 
a) Concentration  of 8 was 7.7 µM. 
b) In buffer (25 mM MOPS, pH 7.0, 100 mM KCl, 9 vol-% DMSO and 1 mM EDTA), at 25 °C.   
c) Abg, 0.0259,  Afree, 0.3004, A476 reservoir was 0.3263, ε free = 51398 M-1 cm -1 and ε bound = 36828 
M-1 cm -1. 
d) We assume the binding site size in base pairs is 3.0. 
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Figure 3.7 Precipitate of 8 in the bottom reservoir of the device and on the magnetic stirrer in 
buffer containing 9 vol-% DMSO. 
It is obvious that 9 vol % DMSO was not enough to keep 8 in solution. We avoided using 
more than 10 vol % of any of organic solvents, such as DMSO and acetonitrile, as we have 
shown in Chapter 2 that this can affect the affinities and the literature indicates that higher 
fractions of DMSO may destabilise nucleic acid structures.  
To further explore the validity of affinities determined using dialysis, we employed ligand 6 
together with 23 µM, 64 µM, and 152 µM of FS-DNA at a concentration of 6 of 5.9×10-5 M, 
in 25 mM MOPS, pH 7.0, 100 mM KCl, 9 vol-% DMSO and 1 mM EDTA. The 
concentrations and apparent affinities of the ligand at equilibrium were determined in Table 
3.12. 
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Table 3.12: Equilibrium constants K for 6 a interacting with FS-DNAb  
 DNA FS-DNA FS-DNA FS-DNA FS-DNA buffer 
[DNA]total / M 2.3×10-5 6.4×10-5 1.52×10-4 6.4×10-5 / 
unit conc. bp bp bp Bp / 
bind. sites / unit conc.  3.33×10-1 3.33×10-1 3.33×10-1 3.33×10-1 / 
[binding sites]total / M 7.67×10-6 2.13×10-5 5.07×10-5 2.13×10-5 / 
A338 nm  1.1712 0.944 0.5059 0.8043 1.211 
A338 nm, bound -0.2093 -0.4365 -0.8746 -0.5762 -0.1695 
C bound / M / / / / / 
[ligand]free / M 3.19×10-5 3.19×10-5 3.19×10-5 3.19×10-5 3.19×10-5 
[binding sites]free / M 1.57×10-5 3.81×10-5 8.43×10-5 4.35×10-5 / 
K / M-1 / / / / / 
a) Concentration of 6 was 59 µM. 
b) In buffer (25 mM MOPS, pH 7.0, 100 mM KCl, 9 vol-% DMSO and 1 mM EDTA), at 25 
°C.   
c) Abg, 0.0405, Afree, 1.3406, A338 reservoir was 1.381, ε free = 42000 M-1 cm -1 and ε bound = 26030 
M-1 cm -1. 
d)  we assume the binding site size in base pairs is 3.0. 
 
The table 3.12 shows very strange data. For all DNA concentrations, the absorbance is lower 
than the absorbance of the solution in the hole containing only buffer and lower than the 
solution in the bottom reservoir of the device.  
In this experiment, a very high concentration of ligand 6 was used. Precipitation of ligand 
was observed and this can affect the diffusion. Furthermore, we found some bubbles in the 
middle part of the device that could also have affected our data as shown in Figure 3.8 (C).  
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Figure 3.8 (A) precipitate of 6 on the bottom of the device and on the magnetic stirrer with 9 
vol-% DMSO, (B) the dialysis membrane with clear precipitation of 6 and (C) bubbles in the 
middle part of the device. 
In the next experiment, a more dilute solution of 3.2×10-6 M 6 was used to avoid 
precipitation. In addition different concentrations of synthetic nucleic acids (dA)24 (dT)24  
were used (25 µM, 72 µM, and 176 µM) in 25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM 
EDTA. The absorbance of 6 at 338 nm was plotted as a function of time (Figure 3.9).                       
(A) (B) 
  
 
Figure 3.9 (A) Final UV-visible spectra for 6 with 25, 72 and 176 µM of (dA)24 (dT) (B) The 
absorbance of 6 at 338 nm as a function of time for (dA)24 (dT)24, 25 µM (▲), 176 µM (●), 72 
µM (♦), and buffer (■).            
Figure 3.9A shows the change in absorbance at λmax 338 nm of 6 in the presence of DNA. 
Figure 3.9B shows that the equilibrium has not been achieved. The absorbance at λmax 338 
nm of 6 is higher for the hole filled with 25 µM (dA)24 (dT)24 (▲). This problem was later 
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attributed to the middle hole in the device. The lid of the device had a hole in the middle as a 
result of the fabrication technique used. This hole allowed evaporating of the solution. 
The final test for our method and our device involves a compound that shows no binding to 
DNA, viz. anionic 3, with different concentrations of FS-DNA (24 µM, 68 µM, and 169 µM) 
in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA) at 25 °C. The absorbance of 3 
at 563 nm was plotted it as a function of time (Figure 3.10).                                                                                                                                                        
(A) (B) 
  
Figure 3.10 (A) Final UV-visible spectra for 3 with different concentrations of FS-DNA in 
buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA) at 25 °C. (B) The absorbance of 
3 at 563 nm as a function of time for FS-DNA at 24 µM (♦), 68  µM (▲), 169 µM (■) and 
buffer (●), in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA), at 25 °C.           
Figure 3.10A shows the final spectra of 3 at the λmax of 3 in the presence of DNA. Figure 
3.10B shows that the absorbance of 3 for all holes of the device is close to the absorbance for 
the buffer, except for the hole where the DNA concentration is (24 µM) (♦). This problem 
was later attributed to the middle hole in the device where the lid for the device had a hole. 
The Figure shows equilibrium has been achieved after around 269 hours. 
The concentrations and apparent affinities of the ligand for DNA were determined from the 
absorbance data at 563 nm (Table 3.13). 
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Table 3.13: Equilibrium constants K for 3 a interacting with FS-DNAb  
 DNA FS-DNA FS-DNA FS-DNA FS-DNA buffer 
[DNA]total / M 1.69×10-4 6.8×10-5 1.69×10-4 2.4×10-5 0 
unit conc. bp bp bp Bp / 
bind. sites / unit conc. / M d 3.33×10-1 3.33×10-1 3.33×10-1 3.33×10-1 / 
[binding sites]total / M 5.63×10-5 2.27×10-5 5.63×10-5 8.00×10-6 / 
A563 nm 0.6517 0.642 0.6501 0.7579 0.6401 
A563, bound c 0.0072 -0.0025 0.0056 0.1134 -0.0044 
C bound / Mc 7.45×10-8 / 5.79×10-8 1.17×10-6 / 
[ligand]free / M 7.34×10-6 / 7.34×10-6 7.34×10-6 7.34×10-6 
[binding sites]free / M 5.63×10-5 / 5.63×10-5 6.83×10-6 / 
K / M-1 1.80×102 / 1.40×102 2.34×104 / 
a) Concentration of 3 was 8.9 µM. 
b) In buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 25 °C.   
c) Abg, 0.0244, Afree, 0.6201, A563 reservoir was 0.6445, ε free = 8683 M-1 cm -1 and ε bound = 10285 
M-1 cm -1. 
d) We assume the binding site size in base pairs is 3.0. 
 
Table 3.13 shows that the absorbance of 3 at 563 nm with the concentration of DNA of 
2.40×10-5 M is higher than the absorbance for the other holes. Accordingly, our calculations 
result in relatively high apparent affinity of 3 for FS-DN. We know that 3 has no affinity for 
DNA. This means that something else increases the concentration of 3 in this hole. The cause 
is probably evaporation because the lid of the device has a small hole above the center hole of 
the top part of the device.  
One more alteration was therefore done to develop the top of this device, which is to close the 
hole in the lid of the device.  
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Part B 
3.3 validation of dialysis and quantification.  
The results of our validation of our dialysis methods for the quantification of affinities of 3, 9, 
5 and 6 for different DNA sequences, viz. FS-DNA, (dA)24 (dT)24, (dAdT)12●(dAdT)12 and 
(dGdC)12●(dGdC)12 are given below. 
3.3.1 Non-binding DNA 
We wanted to confirm that the device works properly with the hole closed and that we can 
get quantitative data from our device.  
We determined the affinity of anionic 3 in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 
1 mM EDTA) for FS-DNA at different concentrations of FS-DNA (23 µM, 69 µM, and 167 
µM). The spectra of 3 after equilibration with different concentrations of DNA are shown in 
Figure 3.11.    
(A) (B) 
 
 
 
 
Figure 3.11 (A) UV-visible spectra after the equilibration for 3 with different concentrations 
of FS-DNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA), at 25 °C. (B) The 
absorbance of 3 at 563 nm as a function of time for FS-DNA 23 µM (♦), 69 µM (▲), 167 µM 
(■) and buffer (●), in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA), at 25 °C.   
Figure 3.11A and Figure 3.11B show that the different concentrations of FS-DNA give 
spectra that are close to the buffer. Consequently, there is no affinity between 3 and FS-DNA 
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the result is in agreement with the results from the UV-visible titrations as shown in Chapter 
2. Equilibrium has been achieved after around 500 hours.                                                                                                         
The concentrations and apparent affinities of the ligand for FS-DNA after equilibration were 
determined (Table 3.14).     
           
It is apparent from the Table that the absorbance of 3 at 563 nm with the different 
concentrations of DNA are almost the same as the absorbance of buffer only. The low 
apparent equilibrium constant (Kbinding) of (8.3 ± 7.6) ×102 M-1 suggests that no binding is 
taking place. Accordingly, the result is in agreement with the results from the UV-visible 
titrations as shown in chapter 2, which yielded an affinity of (0.66 ± 2.34) ×102 M-1. These 
data also demonstrate what is expected from a non-binding ligand: absorbance as a function 
of time simply mirrors that of the buffer, reaching the same final absorbance.  Our control 
Table 3.14: Equilibrium constants K for 3 a interacting  with FS-DNAb  
 DNA FS-DNA FS-DNA FS-DNA FS-DNA buffer 
[DNA]total / M 1.67×10-4 6.9×10-5 1.67×10-4 2.3×10-5 / 
unit conc. bp bp bp bp / 
bind. sites / unit conc. d 3.33×10-1 3.33×10-1 3.33×10-1 3.33×10-1 / 
[binding sites]total / M 5.57×10-5 2.30×10-5 5.57×10-5 7.67×10-6 / 
A563 nm 0.3142 0.3148 0.3113 0.3127 0.3131 
A563, bound c 0.0060 0.0066 0.0031 0.0045 0.0049 
C bound / M c 5.83×10-7 6.42×10-7 3.01×10-7 4.37×10-7 
 
[ligand]free / M 3.27×10-5 3.28×10-5 3.28×10-5 3.27×10-5 3.28×10-5 
[binding sites]free / M 5.51×10-5 2.24×10-5 5.54×10-5 7.23×10-6 / 
K / M-1 3.23×102 8.76×102 1.66×102 1.85×103 / 
a) Concentration of 3 was 4.4 µM. 
b) In buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 25 °C. 
c) Abg, 0.0238, Afree, 0.2844, A563 reservoir was 0.3082, , ε free = 8683 M-1 cm -1 and ε bound = 10285 
M-1 cm -1. 
d) We assume the binding site size in base pairs is 3.0.  
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(Areservoir = 0.3082and Abuffer hole = 0.3131 i.e. 98 %) shows us that the device works well for 
this compound.  
3.3.2 DNA binding                           
We decided to further study the validity of affinities determined using our approach to 
dialysis. We used three different concentrations of FS-DNA (24 µM, 69 µM, and 227 µM) 
together with 1.4 × 10-6 M (methylene blue) 9 in buffer (25 mM MOPS, pH 7.0, 50 mM 
NaCl, and 1 mM EDTA), at 25 °C.  The spectra of 9 after equilibration for 168 hours are 
shown in Figure 3.12.           
  
Figure 3.12 (A) Final UV-visible spectra for 9 with different concentrations of FS-DNA in 
buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA), at 25 °C. (B) The absorbance of 
9 at 663 nm a function of time for the FS-DNA concentrations 24 µM (■), 69 µM (■) and (♦), 
for 227 µM (▲) and buffer (●).                                                                                                            
Figure 3.12A shows the spectra following equilibration of 9 in the presence of the different 
concentrations of DNA. Figure 3.12B shows the highest absorbance of 9 with the highest 
DNA concentration of 227 µM. The Figure also shows that equilibrium has been achieved 
after around 150 hours. 
The concentrations and apparent affinities of the ligand at equilibrium were determined 
(Table 3.15).   
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Table 3.15 presents a higher absorbance of 9 with a higher concentration of DNA. The 
equilibrium constant (Kbinding) is (9.8 ± 5.5) ×104 M-1, in reasonable agreement with the result 
of (3.83 ± 0.78) ×105 M-1 from UV-visible titrations (Chapter 2). Unfortunately, our control 
(Areservoir = 0.1072 and Abuffer hole = 0.1361 i.e. 78 %) shows us and that there is a problem with 
9. This problem was later attributed to fading of 9. 
 
 
 
 
Table 3.15: Equilibrium constants K for 9 a interacting with FS-DNAb                                                                                                 
 DNA FS-DNA FS-DNA FS-DNA FS-DNA Buffer 
[DNA]total / M 6.9×10-5 2.27×10-4 2.4×10-5 6.9×10-5 0 
unit conc. bp bp bp Bp / 
bind. sites / unit conc.d 3.33×10-1 3.33×10-1 3.33×10-1 3.33×10-1 / 
[binding sites]total / M 2.30×10-5 7.57×10-5 8.00×10-6 2.30×10-5 0 
A663 nm 0.171 0.2884 0.1624 0.1978 0.1361 
A663, bound c 0.0638 0.1812 0.0552 0.0906 0.0289 
C bound / M c 1.16×10-6 3.32×10-6 1.01×10-6 1.66×10-6 0 
[ligand]free / M 8.166×10-7 8.17×10-7 8.17×10-7 8.17×10-7 8.17×10-7 
[binding sites]free / M 2.18×10-5 7.23×10-5 6.99×10-6 2.13×10-5 / 
K / M-1 6.55×104 5.61×104 1.77×105 9.52×104 / 
K average / M-1 (9.85 ± 5.50)×104 
a) Concentration  of 9 was 1.4 µM. 
b) In buffer (25 mM MOPS, 50 mM NaCl, 1 mM EDTA and pH=7), at 25 °C.     
c) Abg, 0.0435,  Afree, 0.0637, A663 reservoir was 0.1072, ε free = 78000 M-1 cm -1and ε bound = 
54618 M-1 cm -1. 
d) Weassume the binding site size in base pairs is 3.0. 
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3.3.2.a Competition dialysis methods for the quantification of affinities and selectivities 
for FS-DNA and specific sequences.  
We wanted to study the selectivity of 5 for duplex DNA of different sequences. We therefore 
exposed 1.5×10-5 M of 5 to different DNA sequences, viz., FS-DNA (151 µM), 
(dGdC)12●(dGdC)12 (24 µM) and of (dAdT)12●(dAdT)12 (55 µM). The spectra of 5 after 
equilibration with different DNA sequences are shown in Figure 3.13.     
 
Figure 3.13 (A) post-equilibration UV-visible spectra for 5 with different DNA sequences in 
buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA), at 25 °C. (B) The absorbance of 
5 at 412 nm as a function of time, 151 µM FS-DNA (■), 24 µM (dGdC)12●(dGdC)12 (■), 55 
µM (dAdT)12●(dAdT)12 (●), and buffer (▲). 
Figure 3.13A shows a higher absorbance of 5 with FS-DNA. This suggests that 5 has the 
highest affinity for FS-DNA. There is negligible affinity between 5 and (dGdC)12●(dGdC)12 
and (dAdT)12●(dAdT)12. Figure 3.13 also shows that equilibrium has been achieved after 
around 150 hours.  
The concentrations and apparent affinities of the ligand after equilibration were determined 
(Table 3.16).           
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Table 3.16 shows that there is no significant difference between the absorbance of the buffer 
as control and the absorbance of ligand in the reservoir at λmax 412 nm (the ligand absorbance 
of reservoir is 0.2762). This means that our device is working well in this experiment. The 
affinity for FS-DNA 1.09×104 M is in agreement with the results of (1.18 ± 0.21) × 104 M 
from the UV-visible titrations as shown in chapter 2.  
 
 
 
 
  Table 3.16: Equilibrium constants K for 5 a interacting with FS-DNA, (dGdC)12●(dGdC)12 and 
(dAdT)12●(dAdT)12 b   
DNA FS-DNA 
(dGdC)12● 
(dGdC)12 
(dAdT)12● 
(dAdT)12 
(dGdC)12● 
(dGdC)12 Buffer 
[DNA]total / M 1.51×10-4 2.4×10-5 5.5×10-5 2.4×10-5 0 
unit conc. Bp bp bp Bp / 
bind. sites / unit conc. d 3.33×10-1 3.33×10-1 3.33×10-1 3.33×10-1 / 
[binding sites]total / M 5.03×10-5 8.00×10-6 1.83×10-5 8.00×10-6 / 
A412 nm 0.3667 0.2875 0.2992 0.2958 0.2842 
A412 nm,bound c 0.0905 0.0113 0.023 0.0196 0.008 
C bound / M c 5.00×10-6 6.25×10-7 1.27×10-6 1.08×10-6 / 
[ligand]free / M 1.01×10-5 1.01×10-5 1.01×10-5 1.01×10-5 1.01×10-5 
[binding sites]free / M 4.53×10-5 7.37×10-6 1.71×10-5 6.92×10-6 / 
K / M-1 1.09×104 8.40×103 7.39×103 1.55×104 / 
a) Concentartion of 5 was 15 µM. 
b) in buffer (25 mM MOPS, 50 mM  NaCl, 1 mM EDTA and pH=7), at 25 °C.     
c) Abg, 0.0333, Afree, 0.2429, A412 reservoir was 0.2762, ε free = 24073 M-1 cm -1and ε bound = 18073 M-
1 cm -1. 
d) We assume the binding site size in base pairs is 3.0. 
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3.3.2.b Competition dialysis methods for the quantification of affinities and selectivities 
for FS-DNA and (dA)24 ● (dT)24, (dAdT)12●(dAdT)12 and (dGdC)12●(dGdC)12. 
We repeat the previous experiment above, but this time using similar concentrations of the 
different DNA sequences in order to find out whether 5 has a high affinity for FS-DNA or for 
specific sequences such as (dA)24 (dT)24, (dAdT)12●(dAdT)12 and (dGdC)12●(dGdC)12.                                                              
A solution of 1.0×10-5 M of 5 was exposed to FS-DNA (70 µM), (dGdC)12●(dGdC)12 (74 
µM), (dA) 24 (dT)24 (79 µM) and (dAdT)12●(dAdT)12 (68 µM). The spectra of 5 after 
equilibration are shown in Figure 3.14.  
)B( )A( 
 
 
 
Figure 3.14 (A) UV-visible spectra for 5 exposed to different DNA sequences in buffer (25 
mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA), at 25 °C. (B) The absorbance of 5 at 412 
nm as a function of time, 70 µM FS-DNA (●), 74 µM (dGdC)12●(dGdC)12 (▲), 79 µM (dA)24 
(dT)24 (■), buffer (■) and 68 µM (dAdT)12●(dAdT)12 (♦).                                                                                                                                                                                                        
Figure 3.14A shows the absorbance at 412 nm after equilibration in the presence of the 
various DNA sequences. Figure 3.14B shows that equilibrium has been achieved after around 
150 hours. 
The concentrations and apparent affinities of the ligand for the different sequences were 
determined (Table 3.17).       
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Table 3.17: Equilibrium constants K for 5 interacting with FS-DNA, (dGdC)12●(dGdC)12,  (dA)24 
(dT)24 and (dAdT)12●(dAdT)12 a  
DNA FS-DNA 
(dGdC)12● 
(dGdC)12 (dA)24 (dT)24 
(dAdT)12● 
(dAdT)12 Buffer 
[DNA]total / M 7.0×10-5 7.4×10-5 7.9×10-5 6.8×10-5 0 
unit conc. bp bp bp Bp / 
bind. sites / unit conc. d 3.33×10-1 3.33×10-1 3.33×10-1 3.33×10-1 / 
[binding sites]total / M 2.33×10-5 2.47×10-5 2.63×10-5 2.27×10-5 / 
A412, end 0.2409 0.2409 0.2387 0.2322 0.2161 
error 0.0018 0.003 0.0039 0.0032 0.0028 
A412, bound / M c 0.0371 0.0371 0.0349 0.0284 0.0123 
C bound / M c 2.07×10-6 2.08×10-6 1.95×10-6 1.59×10-6 / 
[ligand]free / M 7.39×10-6 7.39×10-6 7.39×10-6 7.39×10-6 7.39×10-6 
[binding sites]free / M 2.13×10-5 2.26×10-5 2.44×10-5 2.11×10-5 / 
K / M-1 1.32×104 1.24×104 1.08×104 1.02×104 / 
a) Concentration of 5 was 10 µM. 
b) In buffer (25 mM MOPS, 50 mM  NaCl, 1 mM EDTA and pH=7), at 25 °C.         
c) Abg, 0.0258,  Afree, 0.178,  A412 reservoir was 0.2038, ε free = 24073 M-1 cm -1 and ε bound = 17852 
M-1 cm -1. 
d) We assume the binding site size in base pairs is 3.0. 
 
Table 3.17 presents the same affinity of 5 for the sequences FS-DNA, (dGdC)12●(dGdC)12, 
(dA)24 (dT) 24 and (dAdT)12●(dAdT)12. The equilibrium constants are almost the same. The 
affinity for FS-DNA 1.32×104 M, is in agreement with the results of (1.18 ± 0.21) × 104 M 
from the UV-visible titrations. Our control (Areservoir = 0.2038 and Abuffer hole = 0.2161, i.e. 94 
%) shows that the device works well.  
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We desired to know whether H33258 (6)  has affinity for FS-DNA and for specific sequences 
(dA)24 (dT)24, (dAdT)12●(dAdT)12 and (dGdC)12●(dGdC)12.172 193                        
A solution of 2.4×10-6 M of 6 was exposed to FS-DNA (70 µM), (dGdC)12●(dGdC)12 (74 
µM), (dA)24 (dT)24 (79 µM) and (dAdT)12●(dAdT)12 (68 µM). The spectra of 6 after 
equilibration are shown in Figure 3.15.        
 
Figure 3.15 (A) UV-visible spectra for 6 exposed to different DNA sequences in buffer (25 
mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA), at 25 °C. (B) The absorbance of 6 at 338 
nm as a function of time, 70 µM FS-DNA (■), 74 µM (dGdC)12●(dGdC)12 (●), 79 µM (dA)24 
(dT)24(▲), 68 µM (dAdT)12●(dAdT)12 (♦) and buffer (■).                                                                                                                                                                                        
Figure 3.15A and Figure 3.15B suggest that 6 has the highest affinity for (dA)24 (dT)24(▲). 
Furthermore, the equilibrium was reached after 300 hours. We cannot offer an explanation as 
to why (dA)24 (dT)24(▲) increases and subsequently decreases, but we noted that this 
behavior was typically only observed for (dA)24 (dT)24 sequences. We do not know why this 
is the case. 
The concentrations and apparent affinities of the ligand after equilibration were determined 
(Table 3.18).                                                                                                                                                                                                                                                                                                                                                                                                                             
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From Table 3.18, there is the same affinity of 6 for different DNA sequences. Unfortunately, 
our control (Areservoir = 0.0426 and Abuffer hole = 0.2738, i.e. 61 %) revealed that there was a 
problem with 6, which was later attributed to the fading of 6. 
 
 
 
 
 
Table 3.18: Equilibrium constants K for 6 a interacting with FS-DNA, (dGdC)12●(dGdC)12, 
(dA)24 (dT)24 and (dAdT)12●(dAdT)12 b  
DNA FS-DNA 
(dGdC)12● 
(dGdC)12 (dA)24 (dT)24 
(dAdT)12● 
(dAdT)12 buffer 
[DNA]total / M 7.0×10-5 7.4×10-5 7.9×10-5 6.8×10-5 0 
unit conc. bp bp bp bp / 
bind. sites / unit conc. d 3.33×10-1 3.33×10-1 3.33×10-1 3.33×10-1 / 
[binding sites]total / M 2.33×10-5 2.47×10-5 2.63×10-5 2.27×10-5 / 
A 338, end 0.2072 0.2345 0.2494 0.2378 0.2738 
Error 0.0261 0.0414 0.0211 0.0284 0.091 
A338 bound c 0.1646 0.1919 0.2068 0.1952 / 
C bound / M c 6.32×10-6 7.37×10-6 7.94×10-6 7.50×10-6 / 
[ligand]free / M 1.21×10-7 1.21×10-7 1.21×10-7 1.21×10-7 1.21×10-7 
[binding sites]free / M 1.70×10-5 1.73×10-5 1.84×10-5 1.52×10-5 / 
K / M-1 3.06×106 3.51×106 3.56×106 4.07×106 / 
a) Concentration of 6 was 2.4 µM. 
b) In buffer (25 mM MOPS, 50 mM  NaCl, 1 mM EDTA and pH=7), at 25 °C.            
c) Abg, 0.0375,  Afree, 0.0051,  A338 reservoir was 0.0426, ε free = 42000 M-1 cm -1and ε bound = 
26030 M-1 cm -1. 
d) We assume the binding site size in base pairs is 3.0 
e) Abg and Afree in the beginning were 0.0209 and 0.1013, respectively.   
                    
Development and validation of a custom device for competition dialysis assays     
 
164 
 
Part C 
3.4 Selection of promising ligands for double competition dialysis.  
3.4.1 Competition dialysis methods for the quantification of affinities for quadruplex 
DNA, c-myc and 22AG and specific sequences (dAdT)12●(dAdT)12 and 
(dGdC)12●(dGdC)12.                                                                                                                          
We wanted to select which ligands have the required selectivity for different DNA structures. 
We determine the affinity and selectivity of ethidium bromide (10) for different sequences of 
quadruplex and duplex DNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM 
EDTA), at 25 °C.  The spectra of 10 after equilibration with different DNA structures are 
reported in Figure 3.16.   
 
Figure 3.16 (A) UV-visible spectra for 10 after equilibration with 8.7 µM c-myc, 8.6 µM 
22AG, and specific duplex forming sequences 33 µM (dAdT)12●(dAdT)12 and 34 µM 
(dGdC)12●(dGdC)12. (B) The absorbance of 10 at 481nm as a function of time for DNA, 8.7 
µM c-myc (●), 8.6 µM 22AG (■), 33 µM (dAdT)12●(dAdT)12 (■), 34 µM of 
(dGdC)12●(dGdC)12 (▲) and buffer (♦).            
Figure 3.16A shows the absorbance of 10 in the presence of the different nucleic acid 
structures. Compound 10 has a slightly higher absorbance with c-myc. Similarly, Figure 
5.16B shows that the absorbance at λmax 481 nm of 10 is slightly higher with c-myc and no 
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increase in absorbance is seem with 22AG. Moreover, the equilibrium has been achieved 
after around 100 hours.  
The concentrations and apparent affinities of the ligand at equilibrium were determined 
(Table 3.19).        
                                               
Table 3.19 shows that 10 has the same affinities for duplex and quadruplex forming 
sequences. Our control (Areservoir = 0.2435 and Abuffer hole = 0.2634, i.e. 92 %) shows us that the 
device works well.  
Table 3.19: Equilibrium constant K for 10 a interacting with (dAdT)12●(dAdT)12 , c-myc, 
(dGdC)12●(dGdC)12, and 22AG b 
DNA 
(dAdT)12● 
(dAdT)12 c-myc 
(dGdC)12● 
(dGdC)12 22AG buffer 
[DNA]total / M 3.3×10-5 8.7×10-6 3.4×10-5 8.6×10-6 0 
unit conc. bp quadruplex bp quadruplex / 
bind. sites / unit conc. d,e 3.33×10-1 3 3.33×10-1 2 / 
[binding sites]total / M 1.10×10-5 2.61×10-5 1.13×10-5 1.72×10-5 / 
A481, end 0.27697 0.2963 0.27583 0.27107 0.26349 
Error 0.00161 0.00168 0.00169 0.00374 0.00308 
A481,bound 0.03347 0.0528 0.03233 0.02757 0.01999 
C bound / M 7.52×10-6 1.19×10-5 7.27×10-6 6.2×10-6 / 
[ligand]free / M 3.32×10-5 3.32×10-5 3.32×10-5 3.32×10-5 3.32×10-5 
[binding sites]free/ M 3.48×10-6 1.42×10-5 4.07×10-6 1.10×10-5 / 
K / M-1 6.52×104 2.51×104 5.38×104 1.70×104 / 
a) Concentration of 10 was 41 µM. 
b) In buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 25 °C.                
c) Abg, 0.0213,  Afree,  0.2222,  A481 reservoir was 0.2435, ε free = 6696 M-1 cm -1and ε bound = 4450 M-1 
cm -1. 
d) We assume the binding site size in base pairs is 3.0, which means 1 ligand binds to 3 base pairs. 
e) We have assumed the binding sites per quadruplex of 22AG is  two and we know that the binding 
sites per quadruplex of c-myc is  three. 
                    
Development and validation of a custom device for competition dialysis assays     
 
166 
 
 Next, we studied the affinity of 5 for c-myc and 22AG and specific duplex-forming 
sequences (dAdT)12●(dAdT)12 and (dGdC)12●(dGdC)12, in buffer (25 mM MOPS, pH 7.0, 50 
mM NaCl, and 1 mM EDTA) at 25 °C.  Figure 3.17 shows the spectra for 5 after 
equilibration. 
)B( )A( 
  
 
Figure 3.17 (A) UV-visible spectra for 5 with 8.9 µM c-myc, 8.7 µM 22AG, 34 µM 
(dAdT)12●(dAdT)12 and 34 µM (dGdC)12●(dGdC)12. (B) The absorbance of 5 at 412 nm as a 
function of time for 8.9 µM c-myc (●), 8.7 µM 22AG (♦), 34 µM (dAdT)12●(dAdT)12 (▲), 34 
µM (dGdC)12●(dGdC)12 (■) and buffer (■).        
Figure 3.17A shows the absorbance of 5 in the presence of the different DNA structures. It is 
evident from Figure 3.17B that 5 has a higher affinity for c-myc. The equilibrium has been 
achieved after around 100 hours.  
The concentrations and apparent affinities of the ligand were determined (Table 3.20).      
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Table 3.20 provides the affinities of 5 for quadruplex-forming c-myc and 22AG and for 
duplex-forming (dAdT)12●(dAdT)12 and (dGdC)12●(dGdC)12. There is a significant 
difference between the affinities. For example, 5 has a higher affinity for c-myc than for 
22AG. On the other hand, there is no affinity for (dAdT)12●(dAdT)12. The control hole 
suggests that the experiment did not work well; (Areservoir at the end of the experiment was 
0.7879 while Abuffer hole was 0.9353, (i.e. 84 %).  
 
 
Table 3.20: Equilibrium constants K for 5 a interacting with c-myc,  (dAdT)12●(dAdT)12 , 
(dGdC)12●(dGdC)12, and 22AG b 
DNA c-myc 
(dAdT)12● 
(dAdT)12 
(dGdC)12● 
(dGdC)12 22AG buffer 
[DNA]total / M 8.9×10-6 3.4×10-5 3.4×10-5 8.7×10-6 0 
unit conc. quadruplex bp bp quadruplex / 
bind. sites / unit conc. d,e 2 3.33×10-1 3.33×10-1 2 / 
[binding sites]total / M 1.78×10-5 1.13×10-5 1.13×10-5 1.74×10-5 / 
A412, end 1.0709 0.8643 0.8682 0.9598 0.9353 
Error 0.0132 0.01245 0.0169 0.0058 0.0113 
A412 bound 0.283 0.0764 0.0803 0.1719 / 
C bound / M 1.58×10-5 4.27×10-6 4.49×10-6 9.62×10-6 / 
[ligand]free / M 3.17×10-5 3.17×10-5 3.17×10-5 3.17×10-5 3.17×10-5 
[binding sites]free / M 1.95×10-6 7.05×10-6 6.84×10-6 7.77×10-6 / 
K / M-1 2.57×105 1.91×104 2.07×104 3.91×104 / 
a) Concentration of 5 was 40 µM. 
b) in buffer (25 mM MOPS, 50 mM  NaCl, 1 mM EDTA and pH=7), at 25 °C.     
c) Abg, 0.0241,  Afree, 0.7638,  A412 reservoir was 0.7879, ε free = 24073 M-1 cm -1and ε bound = 17852 M-1 
cm -1. 
d) We assume the binding site size in base pairs is 3.0, which means 1 ligand binds to 3 base pairs. 
e) We have assumed the binding sites per quadruplex of c-myc and 22AG are two. 
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3.4.1.a Competition dialysis methods for the quantification of affinities of 9 for different 
nucleic acid structures. 194 195 194 
The present experiment was designed to determine the affinity of methylene blue (9) for 
quadruplex sequences c-myc and 22AG, and duplex sequences (dAdT)12●(dAdT)12 and 
(dGdC)12●(dGdC)12 in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 25 
°C. The spectra of 9 after equilibration with different DNA structures are shown in Figure 
3.18.   
 
Figure 3.18 (A) UV-visible spectra for 9 with 4.5 µM c-myc, 4.9 µM 22AG, 24 µM 
(dAdT)12●(dAdT)12 and 39 µM (dGdC)12●(dGdC)12. (B) The absorbance of 9 at 663nm as a 
function of time for 4.5 µM c-myc (▲), 4.9 µM 22AG (■), 24 µM (dAdT)12●(dAdT)12 (■), 39 
µM (dGdC)12●(dGdC)12 (●) and buffer (♦).        
Figure 3.18A shows the spectra of 9 after equilibration, the highest absorbance, in the 
presence of c-myc. Figure 3.18B shows the absorbance at λmax 663 nm of 9 is highest with c-
myc. The equilibrium has been achieved after around 300 hours. Surprisingly, the absorbance 
goes through a maximum after 100 hours, before decreasing again. Again, we cannot explain 
this, but we noted that this behavior is typically observed only for quadruplex-forming 
sequences. 
The concentrations and apparent affinities of the ligand after equilibrium were determined 
(Table 3.21).                
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Table 3.21 shows that the affinity of 9 is for (dAdT)12●(dAdT)12 with a binding constant of 
2.96×105 M-1. The lowest affinity of 9 is for 22AG. Unfortunately, our control (Areservoir = 
0.4599 and Abuffer hole = 0.7418, i.e. 61 %) shows us that there is a problem with 9. This 
problem was later attributed to the fading of 9. 
We repeated the experiment and recorded the spectra of 9 after equilibration with different 
DNA sequences are shown in Figure 3.19.  
 
Table 3.21: Equilibrium constant K for 9 a interacting with (dGdC)12●(dGdC)12, (dAdT)12●(dAdT)12 , 
22AG and,  c-myc b 
 DNA 
(dGdC)12● 
(dGdC)12 
(dAdT)12● 
(dAdT)12 22AG c-myc buffer 
[DNA]total / M 3.9×10-5 2.4×10-5 4.9×10-6 4.5×10-6 0 
unit conc. bp bp quadruplex quadruplex / 
bind. sites / unit conc. d,e 3.33×10-1 3.33×10-1 7 6 / 
[binding sites]total / M 1.30×10-5 8.00×10-6 3.43×10-5 2.70×10-5 / 
A663, end 0.7409 0.732 0.8718 1.0693 0.7418 
Error 0.014 0.0131 0.0185 0.0417 0.0213 
A 663 bound 0.281 0.2721 0.4119 0.6094 0.2819 
C bound / M 5.14×10-6 4.98×10-6 7.54×10-6 1.11×10-5 / 
[ligand]free / M 5.56×10-6 5.56×10-6 5.56×10-6 5.56×10-6 5.5×10-6 
[binding sites]free / M 7.86×10-6 3.02×10-6 2.68×10-5 1.58×10-5 / 
K / M-1 1.18×105 2.96×105 5.06×104 1.26×105 / 
a) Concentration of 9 was 8.1 µM. 
b) In buffer (25 mM MOPS, 50 mM  NaCl, 1 mM EDTA and pH 7), at 25 °C.   
c) Abg, 0.0255, Afree, 0.4344, A663 reservoir was 0.4599, ε free = 78000 M-1 cm -1 and ε bound = 54618 M-1 cm 
-1. 
d) We assume the binding site size in base pairs is 3.0. 
e) We know the binding sites per quadruplex of 22AG is seven and six for c-myc. 
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Figure 3.19 (A) UV-visible spectra for 9 with c-myc 5.6 µM, 22AG 6 µM, and specific 
sequences such as, (dAdT)12●(dAdT)12 40 µM and 40 µM (dGdC)12●(dGdC)12. (B) The 
absorbance of 9 at 663 nm as a function of time for 5.6 µM (■) c-myc, 6 µM 22AG (■), 40 
µM (dAdT)12●(dAdT)12 (●), 40 µM (dGdC)12●(dGdC)12 (♦) and buffer (▲).        
Figure 3.19A shows the spectra of 9 at λmax 663 nm with the highest absorbance for the hole 
containing c-myc. It is apparent from B that the equilibrium has been achieved after around 
200 hours. We also note that the maximum in absorbance observed in the previous 
experiment has now disappeared. The absorbance at λmax 663 nm suggests that 9 has the 
highest affinity for c-myc, but this needs to be confirmed taking nucleic acid concentrations 
into account in the determination of the apparent affinities. The concentrations and apparent 
affinities of the ligand were determined (Table 3.22).        
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Table 3.22 presents the affinities of 9 for different nucleic acid sequences and confirms Table 
20. Compound 9 has the highest affinity toward (dGdC)12●(dGdC)12. The results are in 
agreement with the results from the UV-visible titrations as shown in Chapter 2 which gave 
Kbinding of (5.25 ± 7.79) ×106 M-1 with c-myc and Kbinding of (5.95 ± 7.64) ×104 M-1 with 22AG. 
Similarly, the result of Table 5.22 is also in reasonable agreement with Table 5.21. However, 
the control hole clearly shows a problem again; our control (Areservoir = 0.3954 and Abuffer hole = 
0.5922, i.e. 66 %).  This problem was later attributed to the fading of 9 as discussed in 
Chapter 2.  
Table 3.22: Equilibrium constants K for 9 a interacting with c-myc, (dAdT)12●(dAdT)12 , (22AG) 
and (dGdC)12●(dGdC)12 b   
  DNA c-myc 
(dAdT)12● 
(dAdT)12 22AG 
(dGdC)12● 
(dGdC)12 buffer 
[DNA]total / M 5.6×10-6 4.0×10-5 6.0×10-6 4.0×10-5 0 
unit conc. quadruplex bp quadruplex bp / 
bind. sites / unit conc. d,e 6 3.33×10-1 7 3.33×10-1 / 
[binding sites]total / M 3.36×10-5 1.33×10-5 4.20×10-5 1.33×10-5 / 
A663, end 1.1483 0.6717 0.8729 0.7153 0.5922 
Error 0.0156 0.0062 0.0172 0.0124 0.0165 
A663 bound 0.7529 0.2763 0.4775 0.3199 0.1968 
C bound / M 1.37×10-5 5.06×10-6 8.74×10-6 5.86×10-6 / 
[ligand]free / M 4.73×10-6 4.74×10-6 4.74×10-6 4.74×10-6 4.74×10-6 
[binding sites]free / M 1.98×10-5 8.27×10-6 3.33×10-5 7.48×10-6 / 
K / M-1 1.47×105 1.29×105 5.55×104 1.65×105 / 
a) Concentration of 9 was 7.7 µM. 
b) In buffer (25 mM MOPS, 50 mM  NaCl, 1 mM EDTA and pH=7),  at 25 °C.       
c) Abg, 0.0258,  Afree, 0.3696,  A663 reservoir was 0.3954, ε free = 78000 M-1 cm -1 and ε bound = 54618 M-1 
cm -1. 
d) We assume the binding site size in base pairs is 3.0. 
e) We know the binding sites per quadruplex of 22AG is seven and six for c-myc. 
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A recent study suggested that 9 interacts with quadruplex EAD2. We therefore repeated the 
competition dialysis of 9 in buffer (25 mM MOPS, pH 7.0, 100 mM KCl, and 1 mM EDTA) 
but using EAD2 instead of c-myc and in a buffer containing KCl instead of NaCl buffer 
because potassium chloride is widely accepted to stabilise G-quadruplex structures. 196, 197 198 
The spectra of 9 after equilibration with the different DNA structures are shown in Figure 
3.20.  
(A) (B) 
  
 
Figure 3.20 (A) UV-visible spectra for 9 after equilibration with 10 µM EAD2, 10 µM 
22AG, 39 µM (dAdT)12●(dAdT)12 and 32 µM (dGdC)12●(dGdC)12. (B) The absorbance of 9 
at 663 nm as a function of time for 10 µM (♦) EAD2, 10 µM 22AG (▲), 39 µM 
(dAdT)12●(dAdT)12 (●), 32 µM of (dGdC)12●(dGdC)12 (■) and buffer (■).         
Figure 3.20A shows the spectra of 9 and the highest absorbance is observed with EAD2. It is 
apparent from B that the equilibrium has been achieved after around 355 hours, but 
surprisingly the absorbance has gone through a maximum again.  
The concentrations and apparent affinities of 9 for the different nucleic acid structures were 
determined (Table 3.23).             
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Table 3.23 shows that 9 has very high affinity for (dAdT)12●(dAdT)12 with binding constant 
of 1.83×105 M-1, in agreement with the previous two experiments. Affinity for EAD2 was 
also high, albeit not as high as expected.  However, the absorbance of the control does not 
match with the absorbance of 9 in the reservoir (57% recovery). This problem was later 
attributed to the fading. 
 
 
Table 3.23: Equilibrium constants K for 9 a interacting with (dAdT)12●(dAdT)12 , 22AG, 
(dGdC)12●(dGdC)12, and EAD2 b   
  DNA 
(dAdT)12● 
(dAdT)12 22AG 
(dGdC)12● 
(dGdC)12 EAD2 buffer 
[DNA]total / M 3.9×10-5 1.0×10-5 3.2×10-5 1.0×10-5 0 
unit conc. bp quadruplex bp quadruplex / 
bind. sites / unit conc. d,e 3.33×10-1 7 3.33×10-1 3 / 
[binding sites]total / M 1.30×10-5 7.00×10-5 1.07×10-5 3.00×10-5 0 
A663, end 0.3985 0.5438 0.3402 0.6593 0.3344 
Error 0.0107 0.0121 0.01 0.0227 0.011 
A663 bound 0.2067 0.352 0.1484 0.4675 0.1426 
C bound / M 3.78×10-6 6.44×10-6 2.72×10-6 8.56×10-6 / 
[ligand]free / M 2.24×10-6 2.24×10-6 2.24×10-6 2.24×10-6 2.24×10-6 
[binding sites]free / M 9.22×10-6 6.36×10-5 7.95×10-6 2.14×10-5 / 
K / M-1                                                                      1.83×105 4.52×104 1.52×105 1.78×105 / 
a) Concentration of 9 was 3.2 µM. 
b) In buffer (25 mM MOPS, pH 7.0, 100 mM KCl, and 1 mM EDTA), at 25 °C.       
c) Abg, 0.0167,  Afree, 0.1751,  A663reservoir was 0.1918, ε free = 78000 M-1 cm -1 and ε bound = 54618 
M-1 cm -1. 
d) We assume the binding site size in base pairs is 3.0. 
e) We  know the binding sites per quadruplex of 22AG is seven and three for EAD2. 
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To find out whether the results are reproducible, we repeated the experiment, replacing 
(dGdC)12●(dGdC)12 with c-myc. The spectra of 9 after equilibration with different DNA 
sequences are shown in Figure 3.21.   
(A) (B) 
  
 
Figure 3.21 (A) UV-visible spectra for 9 after equilibration with EAD2, 22AG, c-myc and 
(dAdT)12●(dAdT)12 (B) The absorbance of 5.9 at 663nm as a function of time for 10 µM 
EAD2 (♦), 10 µM 22AG (▲), 10 µM c-myc (■), 39 µM (dAdT)12●(dAdT)12 (●), and buffer 
(■).    
Figure 3.21A shows the spectra of 9 following equilibration. A higher absorbance is observed 
with c-myc and 22AG. It is apparent from B that the equilibrium has been achieved after 
around 240 hours. The absorbance at λmax 663 nm of 9 suggests affinity toward quadruplexes 
sequences c-myc, 22AG and EAD2.  The concentrations and apparent affinities of 9 were 
determined (Table 3.24).                
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Table 3.24: Equilibrium constants K for 9 a interacting with 22AG, (dAdT)12●(dAdT)12, EAD2 
and c-mycb 
 DNA 22AG 
(dAdT)12● 
(dAdT)12 EAD2 c-myc buffer 
[DNA]total / M 1.0×10-5 3.9×10-5 1.0×10-5 1.0×10-5 0 
unit conc. Quadruplex bp quadruplex quadruplex / 
bind. sites / unit conc. d,e 7 3.33×10-1 3 6 / 
[binding sites]total / M 7.00×10-5 1.30×10-5 3.00×10-5 6.00×10-5 0 
A663, end 0.7107 0.5692 0.6810 0.7114 0.5773 
Error 0.0105 0.0088 0.0794 0.0113 0.011 
A663 bound 0.498 0.3565 0.4683 0.4987 0.3646 
C bound / M 9.11×10-6 6.53×10-6 8.57×10-6 9.13×10-6 / 
[ligand]free / M 2.44×10-6 2.44×10-6 2.44×10-6 2.44×10-6 2.44×10-6 
[binding sites]free / M 6.09×10-5 6.47×10-6 2.14×10-5 5.09×10-5 / 
K / M-1    6.13×104     4.13×105 1.64×105   7.35×104 / 
a) Concentration of 9 was 4.3 µM. 
b) In buffer (25 mM MOPS, pH 7.0, 100 mM KCl, and 1 mM EDTA), at 25 °C.           
c) Abg, 0.0221, Afree,  0.1906, A663 reservoir was 0.2127, ε free = 78000 M-1 cm -1 and ε bound = 54618 
M-1 cm -1. 
d) We assume the binding site size in base pairs is 3.0.        
e) We know the binding sites per quadruplex of 22AG is seven and three for EAD2 and six for c-
myc. 
 
From Table 3.24, it is still clear that 9 has high affinity for (dAdT)12●(dAdT)12. However, 
compound 9 also has high affinity for EAD2.  However, our control (Areservoir = 0.2127 and 
Abuffer hole = 0.5773 i.e. 36 %) shows us there is once more a problem with 9. This problem 
was later attributed to the fading of 9. 
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3.5 Conclusion 
The result of the traditional approach to dialysis methods for the quantification of affinities 
for FS-DNA produces results that are similar to those from UV-visible titrations. The average 
value for the equilibrium constant of 9 without co-solvent (Kbinding) is (8.5 ± 2.22) × 104 M-1. 
The result is in reasonable agreement with the results from the UV-visible titrations, as 
shown in Chapter 2, which gave Kbinding of (3.83 ± 0.78) ×105 M-1. The average equilibrium 
constant of 9 in the presence of 9 vol-% DMSO (Kbinding) is (4.42 ± 0.80) × 104 M-1. The 
result is in reasonable agreement with the results from the UV-visible titrations, as shown in 
Chapter 2, which gave Kbinding of (8.5 ± 1.35) ×104 M-1. It clearly shows that DMSO can affect 
the binding of hydrophobic compounds to DNA. However, use of 9 vol-% DMSO is 
sufficient to reduce any ligand precipitation as we have shown in Chapter 2. Therefore, we 
preferred more diluted solutions of compounds to avoid precipitation of the ligand.  
We have successfully developed a device that allows us to study affinities using dialysis in an 
easy way. The final test for our method and our device involves a compound that shows no 
binding to DNA, viz. anionic 3, with different concentrations of FS-DNA. The result is in 
agreement with the results from the UV-visible titrations as shown in chapter 4, which was 
(0.66 ± 2.34) ×102 M-1. The competition dialysis assay has been successfully used.  
We found optimal experimental conditions for the competition dialysis for promising ligands 
such as 5 and 10 for the quantification of affinities for quadruplex DNA c-myc and 22AG and 
specific sequences (dAdT)12●(dAdT)12 and (dGdC)12●(dGdC)12. Compound 5 has a high 
affinity toward c-myc 2.57×105 M-1. Moreover, 10 has the same affinities to duplex and 
quadruplex forming sequences which is ~ 104 M-1. On the other hand, problems with 
unpromising ligands such as 9 were later attributed to the fading. Compound 9 shows a 
higher affinity for (dAdT)12●(dAdT)12 gives a binding constant of 2.96×105 M-1 and binding 
to (dGdC)12●(dGdC)12 is accompanied by a binding constant of 1.65×105 M-1. The results are 
in agreement with the results from the UV-visible titrations as shown in Chapter 4 which 
gives Kbinding of (5.25 ± 7.79) ×106 M-1 with  c-myc  and Kbinding of (5.95 ± 7.64) ×104 M-1 with 
22AG. Moreover, our control shows that this device works well with promising compounds 
such as 5 and 10. However, our control shows us there is a problem related to the stability of 
the ligand of 9 as we mentioned that before.  
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3.6 Materials and Methods 
3.6.1 Buffer preparation 
All experiments were carried out in one of 3 buffers. Buffer A contained 25 mM MOPS, 50 
mM NaCl and 1 mM EDTA, pH 7.0; buffer B contained 25 mM MOPS, 50 mM NaCl, 1 mM 
EDTA and 9 vol-% of DMSO, pH 7.0; buffer C contained 25 mM MOPS, 100 mM KCl and 
1 mM EDTA, pH 7.0. The buffer components were purchased from Melford (CAS 1132-61-
2), NaCl was purchased from Fisher Scientific (CAS 7647-14-5), KCl was purchased from 
Sigma Aldrich (CAS 7447-40-7), EDTA was purchased from VWR (CAS 60-00-4) and 
DMSO from Fisher Scientific (CAS 67-68-5). Buffers were titrated with aqueous NaOH and 
KOH to the required pH. The pH of aqueous solutions was determined using a Hanna 
microprocessor pH 113 pH-meter equipped with a VWR 662-1382 glass electrode. Materials 
were weighed out on a Fisherbrand 4-decimal balance. De-ionised water was produced using 
an ELGA water purifier for all solutions. 
Buffer A, containing 25 mM MOPS (3-(N-morpholino) propanesulfonic acid) and 50 mM 
sodium chloride (NaCl) was prepared by dissolving MOPS and sodium chloride (NaCl) in 
distilled water and stirring at room temperature until the solid dissolved. The solution of 
sodium hydroxide (NaOH) was used for adjusting the pH to 7.0 and the buffer was made up 
to 2 liters. 
Buffer B containing 25 mM MOPS (3-(N-morpholino) propanesulfonic acid), 50 mM sodium 
chloride (NaCl) and 1 mM EDTA was prepared by dissolving MOPS, sodium chloride 
(NaCl) and EDTA in distilled water and stirring at room temperature until the solid dissolved. 
9 vol-% of DMSO was add to the buffer solution. Sodium hydroxide (NaOH) was used for 
adjusting the pH to 7.0 and the buffer was made up to 2 liters.  
Buffer C, containing 25 mM MOPS (3-(N-morpholino) propanesulfonic acid) and 100 mM 
potassium chloride (KCl) was prepared by dissolving MOPS and potassium chloride (KCl) in 
distilled water and stirring at room temperature until the solid dissolved. Potassium hydroxide 
(KOH) was used for adjusting the pH to 7.0 and the buffer was made up to 2 liters. 
3.6.2 DNA preparation 
Fish sperm DNA was purchased from Acros Organics (CAS 68938-01-2). The stock solution 
of fish sperm DNA was prepared by dissolving the DNA in buffer and then sonicating the 
suspension of FS-DNA for about 10 minutes to get a homogeneous solution. All DNA 
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solutions were dialysed against buffer. The dialysis process for the DNA solution was carried 
out by taking the DNA solution and placing it into the dialysis tube of appropriate pore size 
(3.5 kDa MWCO).189 The dialysis tube was suspended for 24 hours inside a beaker that 
contains the MOPS buffer until the impurities were completely diffused out. The DNA 
concentrations were determined from the absorbance using the extinction coefficient of FS-
DNA of 12800 M-1 cm-1 in terms of base pair molarity as recorded using UV-visible 
spectroscopy at  260 nm.190 
The concentration of c-myc (dTdGdA dGdGdG dTdGdG dGdTdT dGdGdG dTdGdG 
dGdTdAdA) was determined using UV-visible spectroscopy in terms of quadruplex molarity 
by using the extinction coefficient of 228700 M-1 cm-1 at 260 nm. The concentration of 22AG 
(dAdGdG dGdTdT dAdGdG dGdTdT dAdGdG dGdTdT dAdGdGdG) was determined using 
UV-visible spectroscopy in terms of quadruplex molarity using the extinction coefficient of 
228500 M-1 cm-1 at 260 nm.76 The concentration of EAD2 (CTG-GGA-GGG-AGG-GAG-
GGA) was determined using UV-visible spectroscopy in terms of quadruplex molarity by 
using the extinction coefficient of 189900 M-1 cm-1 at 260 nm.181 
For the double-stranded synthetic DNA, i.e. poly (dAdT) and poly (dGdC), we dissolve each 
sequence in 1 ml of buffer. Then, the dialysis process for the DNA solution was carried out 
by taking the DNA solution and placing it into dialysis tubing of sufficient pore size (3.5 kDa 
MWCO). The dialysis tube was suspended for 24 hours inside a beaker that contains the 
MOPS buffer until the impurities were completely diffused out. The DNA concentration was 
determined using UV-visible spectroscopy in terms of base pair molarity using the extinction 
coefficient of 14800 M-1 cm-1 at 254 nm for poly (dGdC) and of 12000 M-1 cm-1 at 260 nm for 
poly (dAdT).127 Then the DNA solutions were annealed placing each DNA solution into an 
Eppendorf and placing the Eppendorf in a beaker that contains water at 95 °C, allowing to 
cool down and finally determine the concentration of each solution.  
For single-stranded DNA such as poly (dA) and poly (dT), we dissolve each sequence in 1 ml 
of buffer in (25 mM MOPS, 50 mM NaCl, 1 mM EDTA and 9 vol-% of DMSO, pH 7.0, at 
25 °C). The dialysis process for the DNA solution was carried out by taking the DNA 
solution and placing it into the dialysis tube of sufficient pore size (3.5 kDa MWCO). The 
dialysis tube was suspended for 24 hours inside a beaker that contains the MOPS buffer until 
the impurities were completely diffused out. The DNA concentration was determined using 
UV-visible spectroscopy and using the extinction coefficient of 8600 M-1 cm-1 at 257 nm for 
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single-stranded (dA)24 and 8520 M-1 cm-1 at 264 nm for single stranded of (dT)24. We then 
mixed both sequences to have a 1:1 mixture of strands in an Eppendorf. The duplex was 
annealed by placing the Eppendorf in a beaker that contains water at 95 °C and allowing to 
cool down. Finally, the concentration of each solution was determined using UV-visible 
spectroscopy in terms of base pair molarity using the extinction coefficient of 12000 M-1 cm-1 
at 260 nm for poly (dA) ●poly (dT).127 
3.6.3 Dialysis units 
Dialysis using dialysis tubing was carried out by taking the DNA solution and placing it into 
the dialysis tube of sufficient pore size (3.5 kDa MWCO). The dialysis tube was suspended 
for 24 hours inside a beaker that contains the MOPS buffer until the impurities were 
completely diffused out.  The dialysis tubing was purchased from Medicell Membranes Ltd, 
MWCO 12-14000 Daltons. Dialysis membrane was also purchased from Medicell 
Membranes Ltd, (MWCO 3500 Daltons) and was used for the dialysis device, in the middle 
part of the device.124 
3.6.4 Competition dialysis data analysis. 
For duplex DNA, [DNA]total is the DNA concentration of FS-DNA, (dAdT)24 and (dGdC)24 in 
terms of base pairs. For quadruplex DNA, [DNA]total equals the concentration of quadruplex 
structures such as c-myc, 22AG and EAD2 (i.e. not in terms of quartets). Depending on the 
unit of DNA concentrations, we use a binding site size (if the concentrations are in units of bp 
for duplex DNA) or a stoichiometry in units of quadruplex-1 for the different quadruplexes.  
We expressed the binding site size in term of base pairs and this was typically set to 3.0, 
which means 1 ligand binds to 3 base pairs. For the quadruplexes we have typically assumed 
two binding sites per quadruplex structure. For 9, we knew the number of binding sites per 
quadruplex for c-myc, 22AG and EAD2 (Chapter 4). The stoichiometries are 6 ligands per 
quadruplex of c-myc, 7 ligands per quadruplex of 22AG and 3 ligands per quadruplex of 
EAD2.  
The total concentration of binding sites in solution is given as follows; 
[binding sites] total is defined as “binding sites per unit concentration” × the total concentration 
of DNA in the selected unit of concentration. 
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 A is the ligand absorbance observed at a specific wavelength (λmax) 
Abound is given by: 
Abound = Aobs-(Abg+Afree) 
Aobs = Abg+Afree+Abound 
Aobs= Abg+ ε free × c free × l + ε bound × c bound × l 
Aobs-(Abg+Afree) = ε bound × c bound × l 
Subsequently:  
Aobs-(Abg+Afree)  
Aobs is the observed signal for the ligand  
Abg is the background signal or the buffer absorbance  
Afree is the difference (Aobs - Abg) 
We can determine [ligand] bound from A bound / epsilonbound × pathlength 
ligand free = Afree / epsilonfree × pathlength 
 [binding site] free is given by: 
 [binding site size] free = [binding site size] total - [ligand] bound  
To calculate K value: 
K = [ligand]bound / [ligand]free × [binding sites] free 
The absorption is plotted against time to obtain the optimal approximation for signalend and 
kobs from the best fit of a pseudo-first-order kinetic rate model to the data 199 (Equation 1). 
  (signalstart -  signalend) × exp (- 1× kobs × time) + signalend    
(Δ#) e−%&'() × t + signalend                        Equation 1 
The terms in the equation are defined as follows.   
ΔA is the difference between the ligand absorbance and the buffer absorbance, kobs is the 
observed pseudo-first-order rate constant, t is defined as the time in hours.  
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3.7 Equipment 
3.7.1 Spectroscopic studies 
UV-visible spectra were recorded using a Jasco V-630BIO spectrophotometer with a Peltier 
temperature controller at 25 °C. All UV-visible absorbances were determined using a 1.0 cm 
path length cuvette at 25 °C, except for experiments involving 9 (in tables 5.1 and 5.2) where 
experiments were carried out in a 1 mm path length cuvette. The ligand concentrations were 
determined using the extinction coefficient.   
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Abstract 
In this Chapter, we explore how double competition dialysis allows simultaneous screening 
of two potentially competing ligands against an array of nucleic acids structures. We 
describe how couples of ligands are selected for screening based on selectivity, optical 
emission, absorption and stability. The use of a control buffer allows facile identification of 
problematic experiments. Several of the tested compounds [TF1 (8), methylene blue (9), 
thiazole orange (12) and DODC (13)] fade upon exposure to light and we show that our 
assay deals with this reasonably well unless fading progresses to the extent that absorbances 
become too low to measure reliably. Although we have identified individual compounds with 
interesting affinity profiles, even in the presence of a second binder, we have not yet 
identified a couple of binders with the orthogonal selectivity profile required for construction 
of a self-assembled nanostructure.   
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4.1 Introduction  
 The G-Quadruplex structures are able to protect the internal sequences of the 
chromosomes.200 Research of functions and structure of G-quadruplexes intensified since 
discovery of G-quadruplexes and G-tetraplexes telomeric DNA.201 This is due to the fact that 
these structures are substrates for telomerase, therefore stabilizers of quadruplex can 
antitumor action as shown in Chapter 1.202, 203 
Scientists have explored the use of small ligands which target the nucleic acids for example 
as future therapeutic agents. In a sequence-specific manner, duplex groove binding molecules 
can recognize DNA during the binding process. On the side of quadruplex-binding ligands, 
some molecules show a degree of selectivity between G-quadruplex and duplex DNA.204, 
205,206  
 
4.1.1 Competition dialysis  
Competition dialysis is a powerful tool for studying ligand binding selectivity.125 We explore 
how double competition dialysis allows screening of two ligands against an array of nucleic 
acids structures.  
4.1.2 Double competition dialysis as a high throughput tool for identifying orthogonal 
host-guest pairs. 
Double competition dialysis is very similar to competition dialysis but we will use multiple 
ligands simultaneously. A few examples of simultaneous binding to nucleic acid structures 
have been reported in the literature. These will be discussed briefly. 
4.1.2a Simultaneous binding of a groove binder and an intercalator to a duplex DNA.  
Hoechst 33258 (H33258) and ethidium bromide (EtBr) are widely used fluorescent 
cytological stains.207 The literature suggests that resonance energy transfer (FRET) could 
occur between H33258 (donor) and EtBr (acceptor). H33258 and ethidum bromide area 
minor groove binder and an intercalator, respectively. H33258 and EtBr bind to DNA.205, 208, 
209 the application of X-ray crystallography, NMR analysis, Raman and spectroscopy in 
combination with theoretical calculations have shown that the specific binding of the 
molecules are very much sensitive to the polarity environment.210 Simultaneous binding 
ligands to DNA may find application in drug design because it provides an opportunity to 
maintain molecular weights low (thus fitting with Lipinski’s rules).  FRET has been used to 
study the distance between the bound ligand, H33258 (donor) and EtBr (acceptor) in genomic 
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DNA. To explain more, the minor groove binding of the H33258 and the intercalation by the 
EtBr have the capability to take place independently in a particular site of the dodecamer. 
When bound to DNA H33258 and ethidum bromide have their transition dipoles oriented at 
an angle of about 66 degrees. The majority of the acceptor molecules are placed at a distance 
of around 0.92nm from the donor in the central position of the DNA. A smaller number of 
acceptors are intercalated in the end of the dodecamer at a distance of 1.92nm. Different 
types of DNA offer binding sites of binding nature. The two types of genomic DNA are 
separated with the help of the base pair with a persistence length or a formation of a loop at a 
distance of 3.3nm. The calculated value of the orientation parameter of 0.04 is very important 
for the estimation of the distance between the donor and the acceptor which are bound to the 
dodecamer. 211 The application of the value of the orientation parameter allows for the 
random distribution of an acceptor. At the same time it can be concluded that DNA partially 
restricts the effective distribution of the acceptors and these restrictions can lead to different 
kinds of errors in the final analyses.211  
 
4.1.2b System combining a groove binder and a quadruplex binder.  
To provide more direct evidence for the existence of quadruplex structures, fluorescent signal 
detection with potential G-quadruplex targeting fluorophores can be used to make the 
structures visible under fluorescence microscopy. The fluorescent image detection method is 
popular because of its convenience and visibility. For this method, it is important to have a 
good G-quadruplex stabilizer or recognizer with fluorescent emission in the visible region. 
Researchers have found that the G-quadruplex structure of the human telomere (TTAGGG)4 
can be stabilized with the help of the organic small molecule BMVC .212 In addition, 
fluorescence yield and the distinct fluorescence properties of BMVC bound to various DNA 
structures has been increased as a result of binding. This has been allowing the mapping of 
the G-quadruplex structure within the choromosomes of human metaphase. The 
distinguishable properties have also allowed observing the bright fluorescence spots from 
BMVC in the cancer cell nucleus in comparison to the weak fluorescence as observed within 
the normal cell BMVC. Furthermore, a simple handheld device incorporating the BMVC 
molecule was designed for low cost point-of-care screening of cancer cells (a). Athough 
BMVC is a potent quadruplex recognizing fluorophore, its fluorescent signal cannot be 
detected by microscopy due to interference with duplex structures, which are in excess in 
chromosomes. Additionally, the emission wavelength comes to a difference in nature when 
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BMVC binds with duplex and, as a result, the quadruplex is observed to be less than 20 nm 
shift in fluorescence wavelength. It means that the fluorescent color assortment sandwiched 
between quadruplex and duplex is imperceptible when BMVC stains the chromosome. 
Therefore, a strategy has been developed to increase the color contrast of the image using 
FRET to resolve this challenge in the molecular imaging of quadruplexes. This is why 
researchers have chosen Hoechst and propidium iodide (PI) as duplex-binding fluorophores 
and present the predictable results with suitable staining procedure. 
To summarize, based on FRET studies, it can be said that the binding modes of duplex-
binding molecules are intercalation or groove binding, while the binding modes of 
quadruplex-binding molecules are stacking or groove binding. Furthermore, the number of 
quadruplex structures is very low with respect to the duplexes in the chromosome. Hence, 
research has shown that the duplex structures spread everywhere around the quadruplex 
structure unit in chromosome. Based on the results it has been proposed that the FRET of 
quadruplex binding molecule might occur with Hoechst, which binds to the same quadruplex 
structure unit with different binding modes and the free Hoeschst that binds to duplex 
structures around the quadruplex structures. Thus, the research proves that the experiment 
results in increasing the contrast of the fluorescent colors.  
 4.1.3 Summary and objectives 
Our self-selection approach uses different types of nucleic acid structures such as single-
stranded and double–stranded DNA; quadruplex and triplex, each of those structures have its 
own functionalities associated with them. The other types of hybrid duplexes involve PNA 
and RNA. A specific type of technique such as the orthogonal recognition are applied so that 
the multiple nucleic acid structures are differentiated and evaluated.   
The importance of different in structures of the types of nucleic acids and the selectivity of 
the structure is very much different for each properties such as the optoelectronic properties. 
Some examples for the different types of opto-electronic properties are tetra substituted 
phenanthrolines, and berberine have a selectivity for the quadruplex. Another example, 
neomycin has selectivity for triplex structures. 
Glenn Burley’s optical gradient was the photonic waveguide described in Chapter 1.123 In this 
waveguide, the routing of FRET is unidirectional and lateral to a track of a double-stranded 
DNA. It is very important that the duplex-binding fluorophore recognizes specific sequence 
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in this approach. Hence, PAs were the minor groove binding molecular ligands that provided 
control. The PAs bind within the minor groove of the duplex DNA, and enable targeting of 
sequences of 6 to 10 base pairs. Binding for these systems has high affinity and effectively 
modulates the efficiency of FRET by fluorophores which have been supramolecularly 
organised laterally to the double-stranded DNA. The enhancement of the FRET that is uni-
directional evidences the whole association of all the integral parts, leading to the discerning 
routing of light along DNA duplexes that are simple as the three-way junction. As they 
mentioned in their report the designing of the experiments for the testing of the PAs was done 
to check the programmable nature of the PAs for programming FRET processes that are uni-
directional along DNA duplex and a 3-way junction. The base stacking of the Cy3.5 dye is 
possible. There may be unfavourable orientations but the observed FRET results from the 
average orientations and is relatively efficient, even though this may not be applicable to the 
other dyes.122  
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4.1.4 Aims 
Our aim is to identify couples of compounds displaying orthogonal selectivity for nucleic 
acids structures such as duplex, triplex and quadruplex DNA. The mutually orthogonal 
interaction pairs are required for the construction of self-assembled functional nanostructures. 
We will, for example, use common redox indicators and fluorescent molecules such as 6 and 
8 (orange and blue dots) as illustrated in Figure 4.1. 
 
Figure 4.1. Schematic illustration of the double competition dialysis process involving three 
nucleic acid structures, viz. quadruplex (Q), triplex (T) and duplex (D) and two ligands 
(orange and blue dots). 
The reason to use these compounds in this process is that they have been reported to have 
selectivity127 toward nucleic acid structures while their optoelectronic properties will allow us 
to confirm assembly formation by FRET. In this case, we will see if 6 and 8 selectively bind 
with different nucleic acid structures. To explain further, in the hypothetical example shown 
in Figure 4.1, 8 (blue dots) has a high affinity and selectivity for the quadruplex DNA, 6 
(orange dots) has a high affinity and selectivity for the duplex DNA, while 6 and 8 both bind 
to the triplex. Therefore, the quadruplex192 and the duplex will provide high affinity and 
selectivity binding sites for 6 and 8, respectively. However, the triplex DNA has affinity for 
both ligands and binds with both ligands 6 and 8. Therefore, in this hypothetical example we 
would select the quadruplex and duplex DNA based on the dialysis results because each 
nucleic acid structure uniquely binds with one binder only. We would then use the duplex 
DNA and the quadruplex DNA as building blocks for a template (or scaffold) for self-
assembly. The template will place 6 and 8 in a pre-determined arrangement. We will then use 
FRET to measure the energy which is transferred from 6 on the duplex DNA to 8 on the 
Double competition dialysis studies 
 
189 
 
quadruplex DNA.196 The observation of energy transfer would therefore provide the evidence 
that the self-assembled nanostructure has been formed successfully. In order to select pairs of 
binders for testing, we require an overview of spectroscopic properties and binding 
selectivities for optoelectronically active nucleic acid binders (Table 4.1). 
 
Table 4.1 shows properties like optical emission, absorption and selectivity for nucleic acids 
for the chosen ligands. We chose basic yellow and methylene blue because it has been shown 
that methylene blue can bind by several modes to nucleic acids. Optical emission and 
absorption for the basic yellow and methylene blue are highly important in the selection of 
the competition because the emission of the donor needs to overlap with the absorption of the 
acceptor.  
The primary aim of this system is to direct the opto-electronically active compound into a 
judicious sequence alongside a chain of nucleic acid structures. The feasibility of the 
transportation of the electrons and/or excitation energy are focused in this system. Our system 
is applied only forunidirection transport of excitation energy. Other potential uses involve 
Table 4.1:  Optical emission, absorption and nucleic acid targets for optoelectronically 
active nucleic acid binders. 
ligand Solubility Nucleic acid target 
λex 
/nm 
λem 
/nm 
Ref. 
basic yellow (thioflavin) Soluble Quadruplex  22AG 330 450 191 
H33258 Soluble Duplex 
A·T 
338 454 62 
methylene blue Soluble 
Telomere G-quadruplex 
DNA 
663 / 124 
ethidium bromide Soluble 
polyA • polyT 
Triplex 
481 616 125,126 
DAPI Soluble 
AT- rich duplex 
c-myc quadruplex 
342 470 125 
thiazole orange Soluble Duplex DNA 500 527 213 
DODC 
 
Soluble 
Quadruplex and Triplex 
DNA 
576 603 127 
coralyne 
Slightly 
soluble 
Poly(A) 
Quadruplex 
Triplex DNA 
423 565 158 
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self-assembled catalytic systems which involves the redirection of the reactivity with the help 
of the nucleic acid structures. The main determinants of this step is the positioning of the 
reactants. Careful reaction design will be used in this system in order to prevent multivalency. 
The application of our systems will help in the having a perception about the self-selection 
approach considering the different structures of the nucleic acids. The self-selection criteria 
of the orthogonal and modified completion dialysis approach can be implemented to yield 
more accurate results. 
Our system shows how orthogonal pairs of recognition elements can be made to self-select 
using a modified competition dialysis approach. We have targeted nucleic acid structures to 
take advantage of the relative ease of identifying selective binders, that means that different 
nucleic acids can have very different shapes so that a duplex binder does not necessarily bind 
to quadruplex DNA. Identification of the selective binders is an important ability of our 
device as the selection of the nucleic acid structures is vital for this research.  
A modified competition dialysis approach can be implemented. The prime purpose of this 
device is to compare the current use of the different structures of the nucleic acid in the 
competition and double competition dialysis. Measuring the affinities of nucleic acid binders 
individually and in combination is challenging. This is because some binders have two types 
of binding i.e. stronger and weaker binding and this can have a significant impact on the 
apparent affinity. 
Glenn Burley’s gradient focus on only one shape of nucleic acid structure which is duplex 
DNA. The application Glenn Burley’s gradient was just to transfer the energy from one place 
to another place. On the other hand, our gradient can make a big difference due to different 
nucleic acid structures e.g. single-stranded, duplex, triplex, quadruplex DNA, DNA•PNA and 
DNA•RNA hybrid duplexes. In addition, our gradient can be applicable to the other dyes (see 
chapter 2). 
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 4.2 Results and discussion  
This section is divided into two parts. Sections 4.2.1a – 4.2.1b deal with compounds which 
lack stability and in particular with fading compounds. Sections 4.2.2a and 4.2.2b report on 
studies on stable compounds. At the time of carrying out these experiments, we had not yet 
established the fact that these compounds fade on exposure to light.  
4.2.1a Validation of the double competition dialysis method for the simultaneous 
quantification of affinities of basic yellow (5) and methylene blue (9) for different 
sequences of duplex DNA.  
It is essential that the ligands used in the proposed assay are carefully chosen, based on 
their optoelectronic properties, such as optical emission and absorption. The first experiment 
was a test run performed to investigate the affinity and selectivity of two ligands, basic 
yellow (5) and methylene blue  (9), against an array of nucleic acids structures.166 Compouds 
5 and 9 have a high selectivety to different nucleic acid structures. 
Ligands 5 and 9 were exposed to FS-DNA and different sequences of duplex DNA, viz. 
(dGdC)12●(dGdC)12, (dAdT)12●(dAdT)12 and (dA)24 (dT)24 in buffer (25 mM MOPS, pH 7.0, 
50 mM NaCl, and 1 mM EDTA), at 25 °C. The equilibration kinetics and the spectra of 5 and 
9 after equilibration with the different DNA structures are reported in Figure 4.2.   
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Figure 4.2 (A) UV-visible spectra for  basic yellow (5) and methylene blue (9) following 
equilibration in the presence of FS-DNA, (dA)24 (dT)24, (dGdC)12●(dGdC)12 and 
(dAdT)12●(dAdT)12  (B) free and bound ligands at 412 nm and 663 nm (also see Section 
4.2.1e and 4.2.1i in Chapter 2 (C) the absorbance at 663 nm (mainly 9) as a function of 
equilibration time and (D) the absorbance at 412 nm (mainly 5)  as a function of equilibration 
time for 75 µM FS-DNA (♦), 70 µM (dA)24 (dT)24 (●), 72µM (dGdC)12●(dGdC)12 (▲), 77 
µM (dAdT)12●(dAdT)12 (■)  and buffer (■). 
Figure 4.2A presents the final spectra for the solutions in the 5 holes of the device after 
equilibration. For reference, Figure 4.2B shows the spectra for the free and bound forms of 
both, both in the free and bound forms. Figures 4.2C and D show the changes in absorbance 
at 412 nm and 663 nm as a function of time. Figure 4.2 shows that the absorbances at 412 nm 
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and 663 nm remain constant after approximately 100 hours. Therefore, Figures 4.2C and D 
show that equilibrium has been achieved after around 100 hours. Figure 4.2C shows that the 
absorbance at 663 nm, which is mainly caused by 9, is highest with (dGdC)12●(dGdC)12 (▲). 
On the other hand, Figure 4.2D shows that the absorbance at 412 nm, which is mainly caused 
by 5, is similar for all sequences and for the buffer, suggesting that 5 has low affinity and 
selectivity for the different DNA sequences. The concentrations and apparent affinities of the 
ligands at equilibrium were determined (Table 4.2).           
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Table 4.2: Apparent equilibrium constants K for 5 and 9 a interacting with FS-DNA, (dGdC)12●(dGdC)12, (dAdT)12●(dAdT)12  and 
(dA)24 (dT)24 b 
DNA (dA)24 (dT)24 
(dGdC)12● 
(dGdC)12 
(dAdT)12● 
(dAdT)12 
FS-DNA buffer 
[DNA]total /  µM 70 72 77 75 / 
unit conc. bp / 
bind. sites / unit conc. i 3.33×10-1 / 
[binding sites]total / M 2.33×10-5 2.40×10-5 2.57×10-5 2.50×10-5 / 
Ligand 9 5 9 5 9 5 9 5 9 5 
A663nm,end(9); A412nm,end(5) 0.291 0.116 0.441 0.111 0.359 0.111 0.357 0.115 0.231 0.104 
Error 0.003 0.001 0.005 0.001 0.003 0.001 0.003 0.001 0.002 0.001 
A663nm,bound ; A412nm,bound 0.083 0.023 0.233 0.018 0.152 0.018 0.149 0.022 0.023 0.011 
Cbound / µM 1.52 1.32 4.28 1.04 2.79 1.04 2.73 1.27 / / 
[ligand]free / µM 33 28 33 28 33 28 33 28 33 28 
[binding sites]free / µM 21 22 19 23 22 24 22 23 / / 
K / M-1 2.07×104 2.14×104 6.40×104 1.61×104 3.59×104 1.51×104 3.62×104 1.91×104 / / 
e) Concentrations of 5 = 8.5 µM  and 9 = 8.1 µM.  
f) In buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 25 °C.     
g) A412nm,bg= 0.0256, A412nm,free = 0.0676 and A412nm,reservoir was 0.0932, εfree = 24073 M-1 cm -1and εbound = 18073 M-1 cm -1. 
h) A663nm,bg= 0.0227, A663nm,free =  0.1851 and A663nm,reservoir was 0.2078, εfree = 78000 M-1 cm -1 and εbound = 54618 M-1 cm -1.  
i) We assume the number of binding site size in base pairs is 3.0. 
j) The absorbances of the solution in the reservoir at the beginning of the experiment were 0.2312 (A412 nm) and 0.6565 (A663 nm). 
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As shown in Table 4.2, 9 has the highest affinity for (dGdC)12●(dGdC)12, giving a binding 
constant of 6.40×104 M-1. Nevertheless, there was no significant difference between the 
calculated affinities for DNA and equilibrium constants of 5 and 9 for all sequences are 
almost equal. Moreover, the fact that the absorbance in the hole containing the buffer is also 
slightly higher than in the reservoir indicates that some of the increases observed for the 
nucleic acid solutions may be within the error of the experiment. 
At the end of the experiment, the absorbances in the reservoir and in the buffer control hole 
for 5 and 9 are similar, suggesting good equilibration. However, comparison with the 
absorbances at the beginning of the experiments show that both compounds faded a lot. 
Overall, the experiment is working well if fading is ignored.  
To explore the reproducibility of the data, we repeated the experiment involving 5 and 9 and 
the same DNA sequences. The spectra of 5 and 9 after equilibration with different DNA 
seuences and the absorbances at 412 and 663 nm are shown in Figure 4.3.  
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Figure 4.3 (A) UV-visible spectra for 5 (basic yellow) and 9 (methylene blue) following 
equilibration in the presence of DNA (B) free and bound ligands at 412 nm and 663 nm also 
see Section 4.2.1e and 4.2.1i in Chapter 2. (C) the absorbance at 412 nm (mainly 5) as a 
function of equilibration time and (D) the absorbance at 663 nm (mainly 9) as a function of 
equilibration time for 75 µM FS-DNA (♦), 70 µM (dA)24 (dT)24 (●), 72µM 
(dGdC)12●(dGdC)12 (▲), 77 µM (dAdT)12●(dAdT)12 (■) and buffer (■). 
Figure 4.3A presents the final spectra for the solutions in the 5 holes of the device after 
equilibrium. For reference, Figure 4.3B shows the spectrafor the free and bound forms of 
both ligands. Figures 4.3C and D show that the changes in absorbance at 412 nm and 663 nm 
as a function of time. Figure 4.3 shows that the absorbance at 412 nm and 663 nm remain 
constant after approximately 150 hours. Therefore, Figures 4.3B and C show that equilibrium 
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has been achieved after around 150 hours.   Figure 4.3B shows the absorbance at 412 nm of 
5, this suggests that 5 has the same affinity for all different DNA sequences. Figure 6.3D the 
absorbance at 663 nm, which is mainly caused by 9, which is highest with 
(dGdC)12●(dGdC)12 (▲). 
The concentrations and apparent affinities of the ligands at equilibrium were determined 
(Table 4.3). 
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Table 4.3: Apparent equilibrium constants K for 5 and 9 a interacting with FS-DNA, (dGdC)12●(dGdC)12, (dAdT)12●(dAdT)12 and 
(dA)24 (dT)24 b 
DNA FS-DNA 
(dGdC)12● 
(dGdC)12 
(dAdT)12● 
(dAdT)12 
(dA)24 (dT)24 buffer 
[DNA]total /  µM 75 72 77 70 / 
unit conc. bp / 
bind. sites / unit conc. e 3.33×10-1 / 
[binding sites]total /M 2.50×10-5 2.40×10-5 2.57×10-5 2.33×10-5 / 
Ligand 9 5 9 5 9 5 9 5 9 5 
A663nm,end(9); A412nm,end(5) 0.323 0.233 0.388 0.216 0.308 0.219 0.265 0.228 0.215 0.204 
Error 0.006 5.15×10-3 0.004 3.8×10-3 0.007 3.9×10-3 0.003 0.004 0.003 3.9×10-3 
A663nm,bound; A412nm,bound 0.137 0.053 0.202 0.036 0.122 0.039 0.079 0.048 0.029 0.024 
Cbound /µM 2.52 2.9 3.7 2.06 2.24 2.21 1.46 2.69 / / 
[ligand]free  /µM 2.98 6.3 2.98 6.3 2.98 6.3 2.98 6.3 2.98 6.3 
[binding sites]free  /µM 22. 22 20. 21 23. 23 21. 20 / / 
K / M-1 3.77×104 2.12×104 6.15×104 1.48×104 3.21×104 1.48×104 2.24×104 2.05×104 / / 
a) Concentrations of 5 = 25 µM  and 9 = 7.1 µM.  
b) In buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 25 °C.     
c) A412nm,bg= 0.0271 A412nm, free = 0.153 and A412nm, reservoir was 0.1801, εfree = 24073 M-1 cm -1and εbound = 18073 M-1 cm -1. 
d) A663nm,bg= 0.0232 A663nm, free =  0.1625 and A663nm, reservoir was 0.1857, εfree = 78000 M-1 cm -1 and εbound = 54618 M-1 cm -1. 
e) We assume the number of binding site size in base pairs is 3.0. 
f) The absorbances of the solution in the reservoir at the beginning of the experiment were 0.6431 (A412 nm) and 0.5817 (A663 nm). 
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Table 4.3 is in good agreement with Table 4.2 and confirms that 9 has a higher affinity for 
(dGdC)12●(dGdC)12 than for other types of DNA. However, these data also confirm that 5 has 
no selectivity for one of the four different types of duplex DNA because affinities are 
very similar.  Finally, comparison of the absorbances of the solution in the reservoir at the 
beginning and the end of the experiment and the buffer in the control hole still show us that 
fading of both 5 and 9 occurred during this experiment.  
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4.2.1b Double competition dialysis methods for the quantification of affinities of 9 and 
11 for duplex and quadruplex DNA.  
In Chapter 3 we have seen that 11 binds to quadruplex structures such as c-myc and 22AG. 
As mentioned before, 9 has already shown fading in competition dialysis.  
In order to estimate the affinities of methylene blue  (9) and DAPI (11) for duplex-forming 
sequences (dGdC)12●(dGdC)12, (dAdT)12●(dAdT)12, and quadruplex-forming sequences214 
22AG and c-myc, the two compounds were dialysed against these structures in our device in 
buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 25 °C.  The spectra for 
11 and 9 after equilibration with different types of DNA are reported in Figure 4.4.  
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Figure 4.4 (A) UV-visible spectra for 9 and 11 following equilibration in the presence of 
DNA (B) free and bound ligands at 342 nm and 663 nm also see Section 4.2.4e and 4.2.1i in 
Chapter 2. (C) the absorbance (mainly 9) at 663 nm as a function of equilibration time and 
(D) the absorbance at 342 nm (mainly 11) as a function of equilibration time for 9.7 µM 
22AG (♦), 9.3 µM c-myc (●), 38 µM (dGdC)12●(dGdC)12 (▲), 37 µM (dAdT)12●(dAdT)12 
(■) and buffer (■). 
Figure 4.4A shows the final spectra for the solutions in the 5 holes of the device after 
equilibration. For reference, Figure 4.4B shows the spectra for the free and bound forms of 
both ligands. Figure 4.4C show that changes in absorbance at 342 nm and 663 nm as a 
function of time.  Figure 4.4 shows that the absorbances at 342 nm and 663 nm remain 
constant after approximately 100 hours. Therefore, Figures 4.4 C and D show the equilibrium 
has been achieved after around 100 hours. Figure 4.4C shows the absorbance at 342 nm, 
which is dominated by 11 which shows 11 has affinity toward 22AG (♦).  
The concentrations and apparent affinities of the ligands at equilibrium were determined 
(Table 4.4).    
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Table 4.4: Apparent equilibrium constants K for 9 and 11a simultaneously interacting with 22AG, (dAdT)12●(dAdT)12 , (c-myc) and 
(dGdC)12●(dGdC)12 b 
DNA 22AG 
(dAdT)12● 
(dAdT)12 
c-myc 
(dGdC)12● 
(dGdC)12 
buffer 
[DNA]total /  µM 9.7 37 9.3 38 / 
unit conc. quadruplex bp quadruplex bp / 
Ligand 9 11 9 11 9 11 9 11 9 11 
bind. sites / unit conc. 7 11 3.33×10-1 6 4 3.33×10-1 / 
[binding sites]total /M 6.7×10-5 1.07×10-4 1.1×10-5 1.23×10-5 5.5×10-5 3.7×10-5 1.2×10-5 1.27×10-5 / 
A663nm,end(9); A342nm,end(11) 0.4280 0.3865 0.2927 0.3078 0.5200 0.3745 0.3516 0.3070 0.31716 0.2458 
Error 0.0051 0.0046 0.0043 0.0042 0.0096 0.0069 0.0032 0.0057 0.0079 0.0065 
A663nm,bound A342nm, bound 0.1669 0.2084 0.0316 0.1297 0.2589 0.1964 0.0905 0.1289 0.0560 0.0677 
Cbound /µM 3.05 17 0.57 10 4.74 16 1.66 10 / / 
[ligand]free /µM 4.32 7.1 4.32 7.1 4.32 7.1 4.32 7.1 4.32 7.1 
[binding sites]free /µM 64.8 89 11.8 1.68 51.1 21.1 11 2.08 / / 
K / M-1 1.09×104 2.6×104 1.14×104 8.9×105 2.15×104 1.08×105 3.48×104 7.1×105 / / 
a) Concentrations of 11 = 22 µM  and 9 = 8.0 µM. 
b) In buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA)), at 25 °C. 
c) A663nm,bg= 0.0249 A663nm,free =  0.2113 and A663nm, reservoir was 0.2362, εfree = 78000 M-1 cm -1 and εbound = 54618 M-1 cm -1. 
d) A342nm,bg= 0.0107 A342nm,free = 0.1567 and A342nm, reservoir was 0.1674, εfree = 23570 M-1 cm -1 and εbound = 12180 M-1 cm -1. 
e) We assume the number of binding site size in base pairs is 3.0, which means 1 ligand binds to 3 base pairs. 
f) For 9 and 11, we know  the number of binding sites per quadruplex of c-myc are six, four and  for 22AG are seven and eleven, respectively.   
g) The absorbances of the solution in the reservoir at the beginning of the experiment were 0.578(A342 nm) and 0.6568 (A663 nm). 
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Table 4.4 presents the affinities of 9 and 11 for different types of nucleic acid structures. The 
affinity of 9 toward (dGdC)12●(dGdC)12 was confirmed. DAPI (11) has affinity toward 
(dAdT)12●(dAdT)12. Unfortunately, our control shows us and there is a problem related to the 
fading of both 9 and 11. Table 6.4 shows useful affinity differences for 11, but for this couple 
to become an applicable system in a self-assembled nanostructure, 9 should have a higher 
affinity for one of the structures as well.  
4.2.1C Double competition dialysis methods for the quantification of affinities of 11 and 
12 for duplex and quadruplex DNA. 
We became interested in testing other ligands like 12 and to compare it with previous 
competition experiments. we decided to find out whether DAPI (11) and thiazole orange (12) 
have the required relative affinities toward duplex-forming sequences, (dGdC)12●(dGdC)12, 
(dAdT)12●(dAdT)12, and quadruplex-forming sequences 22AG and c-myc, in buffer (25 mM 
MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 25 °C. The spectra of 11 and 12 at 
equilibrium, as well as the changes in absorbance as a function of time during equilibration 
for the different types DNA are shown in Figure 4.5.  
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Figure 4.5 (A) UV-visible spectra for 11 and 12 exposed to DNA sequences (B) free and 
bound ligands at 342 nm and 500 nm also see Section 4.2.1e and 4.2.4g in Chapter 2. (C) the 
absorbance at 342 nm (primarily 11) as a function of equilibration time and (D) the 
absorbance at 500 nm (primarily 12) as a function of equilibration time for 12 µM 22AG (♦), 
11 µM c-myc (●), 40 µM (dGdC)12●(dGdC)12 (▲), 40 µM (dAdT)12●(dAdT)12 (■) and buffer 
(■).  
Figure 4.5 presents the final spectra for the solutions in the 5 holes of the device after 
equilibration. For reference, Figure 4.5B shows the spectra for the free and bound forms of 
both ligands. Figures 4.5C and D show the changes in absorbance at 342 nm and 500 nm as a 
function of time. Figure 4.5 shows that the absorbances at 342 nm and 500 nm remain 
constant after approximately 200 hours. Therefore, Figures 4.5C and D show that equilibrium 
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has been achieved after around 200 hours. Figure 4.5C shows that the absorbance at 342 nm, 
which is mainly caused by 11, is highest with c-myc (●). Figure 4.5D shows that the 
absorbance at 500 nm, which is mainly caused by 12, is also highest c-myc (●). Therefore, 11 
and 12 both have their highest affinity for c-myc (●). The concentrations and apparent 
affinities of the ligands at equilibration were determined (Table 4.5).              
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Table 4.5: Apparent equilibrium constants K for 11 and 12 a  interacting with c-myc, (dAdT)12●(dAdT)12 , (22AG) and 
(dGdC)12●(dGdC)12 b 
DNA c-myc 
(dAdT)12● 
(dAdT)12 
22AG 
(dGdC)12● 
(dGdC)12 
buffer 
[DNA]total /  µM 11 40 12 40 / 
unit conc. quadruplex bp quadruplex bp / 
Ligand 11 12 11 12 11 12 11 12 11 6.12 
bind. sites / unit conc. 4 12 3.33×10-1 11 10 3.33×10-1 / 
[binding sites]total / M 4.4×10-5 1.3×10-4 1.3×10-5 1.3×10-5 1.3×10-4 1.2×10-4 1.3×10-5 1.3×10-5 / 
A342nm,end(11);A500,end(12) 0.4289 0.3289 0.2318 0.0679 0.2832 0.1297 0.2249 0.1512 0.1084 0.0505 
Error 0.0173 0.0059 0.0035 0.0027 0.0098 0.0024 0.0040 0.0025 0.0024 0.1038 
A342nm,boud; A500nm,bound 0.3184 0.2932 0.1213 0.0322 0.1727 0.0940 0.1144 0.1155 / / 
Cbound /  µM 6.9 6.7 2.6 0.74 3.7 2.1 2.5 2.6 / / 
[ligand] free /  µM 1.05 0.034 1.05 0.034 1.05 0.034 1.05 0.034 1.05 0.034 
[binding sites] free /  µM 37 120 10 12 128 118 10 10 / / 
K / M-1 1.7×105 1.5×106 2.3×105 1.7×106 2.7×104 5.3×105 2.1×105 7.3×106 / / 
a) Concentrations of 11 = 13 µM  and 12 = 1.8 µM. 
b) In buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 25 °C.                
c) A342nm, bg= 0.0430 A342nm, free =  0.0675 and A342nm, reservoir was 0.1105, εfree = 64095 M-1 cm -1 and εbound = 45826 M-1 cm -1. 
d) A500nm, bg= 0.0335 A500nm, free = 0.0022 and A500nm, reservoir was 0.0357, εfree = 46095 M-1 cm -1 and εbound = 43185 M-1 cm -1. 
e) We assume the number of binding site size in base pairs is 3.0, which means 1 ligand binds to 3 base pairs. 
f) For 11 and 12, we know  the number of binding sites per quadruplex of c-myc are four, twelve and  for 22AG are eleven and ten, 
respectively.  
g) The absorbances of the solution in the reservoir at the beginning of the experiment were 0.3633(A342 nm) and 0.1386 (A500 nm). 
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Our control shows us that 12 has faded almost entirely during the experiment, meaning that 
concentrations of remaining 12 are very low. This makes our data difficult to interpret 
because error margins on affinities are high. This observation suggests that 11 and 12 are not 
a useful couple for a nanostructure, because of fading.  
4.2.2 Double competition dialysis with stable ligands.   
In this section, we present examples of compounds that are stable when exposed to light. We 
chose the compounds in this section based on properties such as emission and absorption and 
known affinities for nucleic acid structures.  
4.2.2a Double competition dialysis for the quantification of affinities of 5 and 10 for 
duplex- and quadruplex-forming DNA  
Compounds 5 and 10 are promising based on their know affinities, stability as well as optical 
emission and absorption. Both of them are soluble in water and stable. Compounds 5 and 10 
can bind to different nucleic acid structures. Compound 5 has a high affinity to binds to 
quadruplex-forming sequences 22AG. However, Compound 10 binds to poly A●polyT and 
triplex.   
We employed basic yellow (5) and ethidium bromide (10) in combination with duplexes 
(dGdC)12●(dGdC)12, (dAdT)12●(dAdT)12, and quadruplexes 22AG and c-myc, in buffer (25 
mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 25 °C.  The spectra of 5 and 10 after 
equilibration were determined and are shown in Figure 4.6. Similarly, the evolution of the 
absorbance at 412 nm and 481 nm is shown in Figure 4.6.  
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Figure 4.6 (A) UV-visible spectra for 5 and 10 following equilibration in the presence of 
DNA (B) spectra for free and bound ligands also see Section 4.2.1e and 4.2.4d in Chapter 2. 
(C)the absorbance at 412 nm (mainly 5) as a function of equilibration time and (D) the 
absorbance at 481 nm (mainly 10) as a function of equilibration time for 8.7 µM 22AG (♦), 
8.9 µM c-myc (●), 34 µM (dGdC)12●(dGdC)12 (▲), 34 µM (dAdT)12●(dAdT)12 (■) and 
buffer (■).  
Figure 4.6A presents the final spectra for the solutions in the 5 holes of the device after 
equilibration. For reference, Figure 4.6B shows the spectra for the free and bound forms of 
both ligands. Figures 4.6C and D show the changes in absorbance at 412 nm and 481 nm as a 
function of time. Figure 4.6 shows that the absorbances at 412 nm and 481 nm remain 
constant after approximately 100 hours. Therefore, Figures 4.6C and D show that equilibrium 
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has been achieved after around 100 hours. Figure 4.6C shows that the absorbance at 412 nm, 
which is mainly caused by 5, is highest with c-myc (●). Figure 4.6D shows that the 
absorbance at 481 nm, which is mainly caused by 10, suggests that 10 has a high affinity for 
c-myc (●). The concentrations and apparent affinities of the ligands after equilibration were 
determined (Table 4.6). 
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Table 4.6: Apparent equilibrium constants K for 5 and 10 a  interacting with 22AG, (dAdT)12●(dAdT)12 , c-myc and 
(dGdC)12●(dGdC)12b 
DNA 22AG 
( dAdT)12● 
(dAdT)12 
c-myc 
(dGdC)12● 
(dGdC)12 
buffer 
[DNA]total /  µM 8.7 34 8.9 34 / 
unit conc. quadruplex bp quadruplex bp / 
Ligand 5 10 5 10 5 6.10 5 10 5 10 
bind. sites / unit conc. e,f,g 2 3.33×10-1 2 3 3.33×10-1 / 
[binding sites]total / M 1.7×10-5 1.7×10-5 1.1×10-5 1.1×10-5 1.7×10-5 2.6×10-5 1.1×10-5 1.1×10-5 / 
A412nm,end(5); A481nm,end(10) 0.3544 0.1217 0.3043 0.1235 0.5416 0.1715 0.3256 0.1286 0.3031 0.1046 
Error 0.0027 0.00181 0.0001 0.0005 0.0006 0.002 0.0060 0.0009 0.0017 0.00162 
A412nm, bound;A481nm,bound 0.067 0.0244 0.0169 0.0262 0.2542 0.07424 0.0382 0.0313 0.01577 0.00731 
Cbound /  µM 3.76 5.48 0.949 5.91 14.2 1.67 2.14 7.04 / / 
[ligand] free /  µM 11.1 11.7 11.1 11.7 11.1 11.7 11.1 11.7 11.1 11.7 
[binding sites]free /  µM 13.6 11.9 10.4 5.43 3.56 10 9.19 4.29 / / 
K / M-1 2.4×104 3.9×104 8.2×103 9.3×104 3.5×105 1.4×105 2.09×104 1.4×105 / / 
a) Concentrations of 5 = 28 µM  and 10 = 28 µM. 
b) In buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 25 °C.                
c) A412nm, bg= 0.0191 A412nm, free = 0.2683 and A412nm, reservoir was 0.2874, εfree = 24073 M-1 cm -1 and εbound = 17850 M-1 cm -1. 
d) A481nm, bg= 0.0191 A481nm, free =  0.0782 and A481nm,  reservoir was 0.0973, εfree = 6696 M-1 cm -1 and εbound = 4450 M-1 cm -1. 
e) We assume the binding site size in base pairs is 3.0. 
f) For 5 and 10,  we assume the number of binding sites per quadruplex of 22AG are two and for 5  of c-myc is two.  
g) For 10, we know the number of binding sites per quadruplex of c-myc is three.  
h) The absorbances of the solution in the reservoir at the beginning of the experiment were 0.7081(A412 nm) and 0.2131 (A481 nm). 
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Table 4.6 shows that both 5 has the highest affinity toward c-myc while 10 has the highest 
affinities for c-myc and (dGdC)12●(dGdC)12. Equilibration has been successful considering 
the similar absorbance in the reservoir and in the control hole containing the buffer. However, 
there is a big different between the absorbance in the reservoir at the beginning and the end of 
the experiment. Because these compounds should be stable upon exposure to light, the 
decrease is not attributed to fading but may represent either precipitation of these compounds 
or the compounds stick to the materials used in the device. The affinity for 5 is in reasonable 
agreement with the results from the UV-visible titrations as shown in Chapter 2 which gave 
(Kbinding) of of (1.18 ± 0.21) ×104 M-1. The affinity for 10 is in reasonable agreement with the 
results from the UV-visible titrations as shown in Chapter 2 which gave (Kbinding) of (4.01 ± 
2.60) ×105 M-1. 
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We wanted to evaluate the affinities and selectivities of H33258 (6) and ethidium bromide 
(10) for duplex-forming (dAdT)12●(dAdT)12 and (dGdC)12●(dGdC)12 and quadruplex-
forming 22AG and c-myc in buffer (25 mM MOPS, pH 7.0, 100 mM KCl, and 1 mM 
EDTA), at 25 °C using double competition dialysis. The spectra of 6 and 10 after 
equilibration with the different DNA sequences are shown in Figure 4.7.  Figure 4.7 also 
shows the evolution of the absorbance at 338 nm and at 481 nm. 
 
Figure 4.7 (A) UV-visible spectra for 6 and 10 following equilibration in the presence of 
DNA (B) spectra for the free and bound forms of both ligands (also see Section 4.2.1f and 
4.2.4d in Chapter 2).  (C) the absorbance at 338 nm (mainly 6) as a function of equilibration 
time and (D) the absorbance at 481 nm (mainly 10) as a function of equilibration time for 10 
µM 22AG (♦), 10 µM c-myc (●), 32 µM (dGdC)12●(dGdC)12 (▲), 39 µM 
(dAdT)12●(dAdT)12 (■) and buffer (■). 
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Figure 4.7A presents the final spectra for the solutions in the 5 holes of the device after 
equilibration. For reference, Figure 4.7B shows the spectra the free and bound forms of both 
ligands. Figures 4.7C and D show the changes in absorbance at 338 nm and 481 nm as a 
function of time. Figure 4.7 shows that the absorbances at 338 nm and 481 nm remain 
constant after approximately 300 hours. Therefore, Figures 4.7C and D show that equilibrium 
has been achieved after around 300 hours. Figure 4.2C shows that the absorbance at 338 nm, 
which is mainly caused by 6, is highest with c-myc (●). Figure 4.7D shows that the 
absorbance at 481 nm, which is mainly caused by 10, also suggests the highest for c-myc (●). 
The concentrations and apparent affinities of the ligands at equilibrium were determined 
(Table 4.7). 
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Table 4.7: Apparent equilibrium constants K for 6 and 10 a interacting with 22AG, (dGdC)12●(dGdC)12, c-myc and 
(dAdT)12●(dAdT)12  b 
DNA 22AG 
(dGdC)12● 
(dGdC)12 
c-myc 
(dAdT)12● 
(dAdT)12 
buffer 
[DNA]total /  µM 10 32 10 39 / 
unit conc. quadruplex bp quadruplex bp / 
Ligand 6 10 6 10 6 10 6 10 6 10 
bind. sites / unit conc. e,f 2 2 3.33×10-1 3 3 3.33×10-1 / 
[binding sites]total /  µM 20 10.7 30 13 / 
A338nm,end(6); A481nm,end(10) 0.3278 0.1248 0.3397 0.123 0.5083 0.1406 0.3027 0.1244 0.2012 0.10207 
Error 0.0073 0.0016 0.0078 0.0016 0.0097 0.0021 0.0063 0.0012 0.0046 0.0018 
A338nm,bound ;A481nm,bound 0.15 0.0209 0.17 0.0191 0.34 0.0367 0.13 0.0205 0.0331 0.00183 
Cbound /  µM 6.14 4.7 6.5 4.2 13 8.2 5.17 4.6 / / 
[ligand]free /  µM 2.99 11.1 2.99 11.1 2.99 11.1 2.99 11.1 2.99 11.1 
[binding sites]free /  µM 13.9 15 4.07 6.3 16.9 21 7.83 8.3 / / 
K / M-1 1.4×105 2.77×104 5.4×105 6.07×104 2.5×105 3.4×104 2.2×105 4.9×104 / / 
a)  Concentrations of 6 = 9.2 µM  and 10 = 27 µM. 
b)  In buffer (25 mM MOPS, pH 7.0, 100 mM KCl, and 1 mM EDTA), at 25 °C.                
c)  A338nm, bg= 0.0427 A338nm, free = 0.1254 and A338nm, reservoir was 0.1681,  εfree = 42000 M-1 cm -1 and εbound = 26030 M-1 cm -1. 
d)  A481nm, bg= 0.0296  A481nm, free =  0.0743 and A481nm, reservoir was 0.1039, εfree = 6696 M-1 cm -1 and εbound = 4450 M-1 cm -1. 
e)  we assume the binding site size in base pairs is 3.0.  
f) For 10,  we know the number of binding sites per quadruplex of c-myc is three and for 6 and 10 we assume the number of binding 
sites per   quadruplex of 22AG are two. 
g) The absorbances of the solution in the reservoir at the beginning of the experiment were 0.4209(A338 nm) and 0.2006 (A481 nm). 
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Table 4.7 indicates that 6 and 10 have similar affinities toward all nucleic acids with 6 
consistently binding a bit more strongly than 9. On other hand, Table 4.7 shows that the 
absorbance of the buffer as a control and the absorbance of ligands in the reservoir at the end 
are relatively similar, but both differ significantly from the absorbances of the ligands in the 
reservoir at the start of the experiment. Therefore, 6 and 10 faded a lot. That might be related 
to fading or to precipitation, because we keep the solutions inside the device for long time.  
The result of 10 is in agreement with the results from the UV-visible titrations as shown in 
Chapter 3 which gave Kbinding of (4.01 ± 2.60) × 105 M-1.  
4.2.2b Double competition dialysis for the quantification of affinities of 6 and 14 for 
duplex and quadruplex.  
Compounds H33258 (6) and coralyne (14) might form a useful couple of compounds that 
have different affinity to different sequences and also display the required stability.  
Consequently, to explore whether 6 and 14 have the required relative affinities toward nucleic 
acids structures, this experiment involved 6 and 14 in combination with duplex-forming and 
quadruplex-forming sequences c-myc, (dAdT)12●(dAdT)12, 22AG, and (dGdC)12●(dGdC)12 
in buffer (25 mM MOPS, pH 7.0, 100 mM KCl, and 1 mM EDTA), at 25 °C. The spectra of 
6 and 14 after equilibration are shown in Figure 4.8. Figure 4.8 also shows the evolution of 
the absorbance at 338 nm and 423 nm.  
 
Figure 4.8 (A) UV-visible spectra for 6 and 14 following equilibration in the presence of 
DNA. (C) the absorbance at 338 nm as a function of equilibration time and (D) the 
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absorbance at 423 nm as a function of equilibration time for 10 µM 22AG (♦), 10 µM c-myc 
(●), 32 µM (dGdC)12●(dGdC)12 (▲), 39 µM (dAdT)12●(dAdT)12 (■) and buffer (■). 
Figure 4.8A presents the final spectra for the solutions in the 5 holes of the device after 
equilibration. For reference, Figure 4.8B and C show the changes in absorbance at 338 nm 
and 423 nm as a function of time. Figure 4.8B shows that the absorbance at 338 nm is highest 
with c-myc, suggesting that 6 has highest affinity toward c-myc (●) while Figure 4.8C shows 
the higest final absorbance with 22AG, suggesting that 14 has the highest affinity toward 
22AG.  Figures 4.8B and C also show that the absorbance as a function of time shows a lot of 
scatter. We are unsure what caused this scatter.  Unfortunately, we cannot analyse this data to 
find the apparent affinities of the ligands after equilibration. We cannot recorded the UV-
visible titration because the poor solubility of coralyne (14) in buffer. 58, 59, 188 
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4.2.2c Double competition dialysis methods for the quantification of affinities of 10 and 
11 for duplex and quadruplex DNA.  
We select 10 (ethidium bromide) and 11 (DAPI) because of the stability of these compounds. 
To know whether 10 and 11 have different affinities toward duplexes (dAdT)12●(dAdT)12, 
(dGdC)12●(dGdC)12 and quadruplex DNA c-myc and 22AG in buffer (25 mM MOPS, pH 
7.0, 100 mM KCl, and 1 mM EDTA), at 25 °C we carried out a double competition dialysis 
experiment.  The spectra of 10 and 11 after equilibration with different DNA structures are 
shown in Figure 4.9. Figure 4.9 also shows the evolution of the absorbance at 342 nm and 
481 nm.  
(A) (B) 
  
(C) (D) 
  
 
Figure 4.9 (A) UV-visible spectra for 10 and 11 following equilibration in the presence of 
DNA (B) spectra for the free and bound forms of both ligands (also see Section 4.2.4d and 
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4.2.4e in Chapter 2). (C) the absorbance at 342 nm (mainly 11) as a function of time and (D) 
the absorbance at 481 nm (mainly 10) as a function of equilibration time for 10 µM 22AG 
(♦), 10 µM c-myc (●), 32 (dGdC)12●(dGdC)12 (▲), 39 µM  (dAdT)12●(dAdT)12 (■) and  
buffer (■). 
Figure 4.9A presents the final spectra for the solutions in the 5 holes of the device after 
equilibration. Figures 4.9C and D show that equilibrium has been achieved after around 300 
hours. Figure 4.9C shows the absorbance at 342 nm is also similar to the hole containing 
buffer only, this suggests that 11 has negligible affinity for the different DNA sequences. 
Figure 4.9D shows that the absorbance at 481 nm is more or less the same for all sequences 
and for buffer only. This suggests no affinity of 10 for these sequences. The concentrations 
and apparent affinities of the ligands after equilibration were nevertheless determined (Table 
4.8).              
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Table 4.8: Apparent equilibrium constants K for 10 and 6.11a  interacting with 22AG, c-myc, (dGdC)12●(dGdC)12 and 
(dAdT)12●(dAdT)12 b 
DNA 22AG c-myc 
(dGdC)12● 
(dGdC)12 
( dAdT)12● 
(dAdT)12 
buffer 
[DNA]total /  µM 10 10 32 39 / 
unit conc. quadruplex quadruplex bp bp / 
Ligand 10 11 10 11 10 11 10 11 10 11 
bind. sites / unit conc. e,f,g 2 11 3 4 3.33×10-1 3.33×10-1 / 
[binding sites]total / M 2.0×10-5 1.1×10-4 3.0×10-5 4.0×10-5 1.07×10-5 1.30×10-5 / 
A481nm,end(10); A342nm,end(11) 0.1192 0.3223 0.1189 0.3703 0.1198 0.34255 0.1274 0.32221 0.1177 0.33198 
Error 0.0014 0.0052 0.0014 0.0157 0.0010 0.01084 0.00088 0.00978 0.0024 0.0070 
A481nm,bound ;A342nm,bound 0.0157 0.13585 0.0154 0.1838 0.0163 0.1560 0.0239 0.1357 0.0142 0.1454 
Cbound /  µM 3.54 11 3.47 15 3.68 12 5.37 11 / / 
[ligand]free /  µM 12 6.87 12 6.87 12 6.87 12 6.87 12 6.87 
[binding sites]free /  µM 16 98.8 26 24 6.99 2.15 7.63 1.86 / / 
K / M-1 1.7×104 1.6×104 1.09×104 8.8×104 4.3×104 8.6×105 5.8×104 8.7×105 / / 
a) Concentrations of 10 = 29 µM  and 11 = 14 µM. 
b) In buffer (25 mM MOPS, pH 7.0, 100 mM KCl, and 1 mM EDTA), at 25 °C.                
c) A481nm, bg= 0.0228 A481nm, free = 0.0807 and A481nm, reservoir was 0.1035, εfree = 6696 M-1 cm -1 and εbound = 4450 M-1 cm -1. 
d) A342nm, bg= 0.0245  A342nm, free =  0.162 and A342nm,  reservoir was 0.1865, εfree = 64095 M-1 cm -1 and ε bound = 45826 M-1 cm -1. 
e) We assume the binding site size in base pairs is 3.0. 
f) For 10 and 11, we know that the number of binding sites per quadruplex of c-myc is three and four, respectively.  
g) for 11 we also know the number of binding sites per quadruplex of 22AG is eleven, but we assume the number of binding 
sites per quadruplex of 22AG is two for 10.  
h) Absorbances of the solution in the reservoir at the beginning of the experiment were 0.3683(A342 nm) and 0.2191 (A481 nm). 
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It appears from Table 4.8 that the 10 has a high affinity toward to (dAdT)12●(dAdT)12 and 
(dGdC)12●(dGdC)12.  However, 11 has no affinity toward DNA. There is a big difference 
between the absorbance of the reservoir and the absorbance in the control hole for ligand 11. 
The control therefore shows us that there is a problem with 11. Therefore, these two ligands 
are not useful for the double competition dialysis.  
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4.3 Conclusion 
We show data for a series of nucleic acid binders, comparing selectivity and affinity obtained 
using double competition dialysis. We show that the assay works well and the results are in 
agreement with the results from the UV-visible titrations (Chapter 2).  The quantification of 
affinities of 5 and 10 for duplex- and quadruplex-forming DNA shows that 5 has affinity 
toward c-myc and 10 has affinity to c-myc and (dGdC)12●(dGdC)12. Equilibration has been 
successful considering the similar absorbance in the reservoir and in the control hole 
containing the buffer. The result for 5 is in reasonable agreement with the results from the 
UV-visible titrations as shown in Chapter 2 which gave (Kbinding) of of (1.18 ± 0.21) ×104 M-1. 
The result for 10 is in reasonable agreement with the results from the UV-visible titrations as 
shown in Chapter 2 which gave (Kbinding) of (4.01 ± 2.60) ×105 M-1. However, the affinities of 
10 and 11 for duplex and quadruplex DNA are not a successful example for the double 
competition dialysis. This is because a big difference between the absorbance of the reservoir 
and the absorbance in the control hole for ligand 11. On the other hand, the control buffer can 
identify problems in this experiment. The typical problem in these experiments is the fading 
of compounds such as methylene blue, thiazole orange and coralyne upon the exposure of 
light. Therefore, stability for the compounds is a very important selection criterion when 
selecting compounds for the competition.  
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4.4 Materials and Methods 
4.4.1 Buffer preparation 
All experiments were carried out in one of 2 buffers, viz. (25 mM MOPS, 50 mM NaCl and 1 
mM EDTA, pH 7.0) or (25 mM MOPS, 100 mM KCl and 1 mM EDTA, pH 7.0). The buffer 
components were purchased from Melford (CAS 1132-61-2), NaCl was purchased from 
Fisher Scientific (CAS 7647-14-5), KCl was purchased from Sigma Aldrich (CAS 7447-40-
7), EDTA was purchased from VWR (CAS 60-00-4). Buffers were titrated with aqueous 
NaOH and KOH. The pH of aqueous solutions was determined using a Hanna 
microprocessor pH 113 pH-meter equipped with a VWR 662-1382 glass electrode. Materials 
were weighed out on a Fisherbrand 4-decimal balance. De-ionised water was produced using 
an ELGA water purifier for all solutions. 
A buffer containing 25 mM MOPS (3-(N-morpholino) propanesulfonic acid) and 50 mM 
sodium chloride (NaCl) was prepared by dissolving MOPS and sodium chloride (NaCl) in 
distilled water and stirring at room temperature until the solid dissolved. A solution of 
sodium hydroxide (NaOH) is used for adjusting the pH to 7.0 and the buffer was made up to 
2 liters in a volumetric flask. 
A buffer containing 25 mM MOPS (3-(N-morpholino) propanesulfonic acid) and 100 mM 
potassium chloride (KCl) was prepared by dissolving MOPS and potassium chloride (KCl) in 
distilled water and stirring at room temperature until the solid dissolved. Potassium hydroxide 
(KOH) was used for adjusting the pH to 7.0 and the buffer was made up to 2 liters in a 
volumetric flask. 
4.4.2 DNA preparation 
Fish sperm DNA was purchased from Acros Organics (CAS 68938-01-2). The stock solution 
of fish sperm DNA was prepared by placing the DNA in buffer and then sonicating the 
suspension of FS-DNA for about 10 minutes to get a homogeneous solution. All DNA 
solutions were dialysed against buffer. The dialysis process for the DNA solution was carried 
out by taking the DNA solution and placing it into dialysis tubing of appropriate pore size 
(3.5 kDa MWCO).189 The dialysis tube was suspended for 24 hours inside a beaker that 
contains the MOPS buffer until the impurities were completely diffused out. The DNA 
concentrations were determined from the absorbance using the extinction coefficient of FS-
DNA of 12800 M-1 cm-1 in terms of base pair molarity as recorded using UV-visible 
spectroscopy at  260 nm.190 
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 The concentration of quadruplex DNA c-myc (dTdGdA dGdGdG dTdGdG dGdTdT 
dGdGdG dTdGdG dGdTdAdA) was determined using UV-visible spectroscopy in terms of 
quadruplex molarity by using the extinction coefficient of 228700 M-1 cm-1 at 260 nm. The 
concentration of 22AG (dAdGdG dGdTdT dAdGdG dGdTdT dAdGdG dGdTdT 
dAdGdGdG) was determined using UV-visible spectroscopy in terms of quadruplex molarity 
by using the extinction coefficient of 228500 M-1 cm-1 at 260 nm.76 The concentration of 
EAD2 (CTG-GGA-GGG-AGG-GAG-GGA) was determined using UV-visible spectroscopy 
in terms of quadruplex molarity by using the extinction coefficient of 189900 M-1 cm-1 at 260 
nm.181 
For the preparation of double-stranded DNA solutions of poly (dAdT) and poly (dGdC), we 
dissolve each sequence in 1 ml of buffer. Then the dialysis process for the DNA solution was 
carried out by taking the DNA solution and placing it into dialysis tubing of sufficient pore 
size (3.5 kDa MWCO). The dialysis tube was suspended for 24 hours inside a beaker that 
contains the MOPS buffer until the impurities were completely diffused out. The DNA 
concentration was determined using UV-visible spectroscopy in terms of base pair molarity 
using the extinction coefficient of 14800 M-1 cm-1 at 254 nm for poly (dGdC) and 12000 M-1 
cm-1 at 260 nm for poly (dAdT).127 Duplexes were then annealed by placing the each DNA 
solution into an eppendorf and placing the eppendorf in a beaker that contains water at 95°C 
allowing to cool down. Finally, we determine the concentration of each solution.  
For single stranded DNA such as poly (dA) and poly (dT), we dissolve each sequence in 1ml 
of buffer in (25 mM MOPS, 50 mM NaCl and 1 mM EDTA, pH 7.0). The dialysis process 
for the DNA solution was carried out by taking the DNA solution and placing it into the 
dialysis tubing of sufficient pore size (3.5 kDa MWCO). The dialysis tube was suspended for 
24 hours inside a beaker that contains the MOPS buffer until the impurities were completely 
diffused out. The DNA concentration was determined using UV-visible spectroscopy and 
using the extinction coefficient of 8600 M-1 cm-1 at 257 nm for single-stranded (dA)24 and 
8520 M-1 cm-1 at 264 nm for single stranded of (dT)24. We then mixed both sequences to form 
one solution in an eppendorf that was then placed in a beaker that contains water at 95°C 
allowing to cool down to room temperature. Finally, the concentration of each solution was 
determined using UV-visible spectroscopy in terms of base pair molarity using the extinction 
coefficient of 12000 M-1 cm-1 at 260 nm for poly (dA) ●poly (dT).127 
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4.4.3 Dialysis units 
Dialysis using dialysis tubing was carried out by taking the DNA solution and placing it into 
the dialysis tube of sufficient pore size (3.5 kDa MWCO). The dialysis tube was suspended 
for 24 hours inside a beaker that contains the MOPS buffer until the impurities were 
completely diffused out.  The dialysis tubing was purchased from Medicell Membranes Ltd, 
MWCO 12-14000 Daltons. Dialysis membrane was also purchased from Medicell 
Membranes Ltd, (MWCO 3500 Daltons) and was used for the dialysis device (double 
competition dialysis), in the middle part of the device.124 
 4.4.4 Competition dialysis data analysis. 
For duplex DNA, [DNA]total is the DNA concentration of FS-DNA, (dAdT)12●(dAdT)12 and 
(dGdC)12●(dGdC)12 in terms of base pairs. For quadruplex DNA, [DNA]total equals the 
concentration of quadruplex structures such as c-myc, 22AG and EAD2 (i.e. not in terms of 
quartets). Depending on the unit of DNA concentrations, we use a binding site size (if the 
concentrations are in units of bp for duplex DNA) or a stoichiometry in units of quadruplex-1 
for the different quadruplexes.  
We expressed the binding site size in term of base pairs and this was typically set to 3.0, 
which means 1 ligand binds to 3 base pairs. For the quadruplexes we have typically assumed 
two binding sites per quadruplex structure. For 9, we knew the number of binding sites per 
quadruplex for c-myc, 22AG and EAD2 (Chapter 2). The stoichiometries are 6 ligands per 
quadruplex of c-myc, 7 ligands per quadruplex of 22AG and 3 ligands per quadruplex of 
EAD2.  
The total concentration of binding sites in solution is given by [binding sites] total. 
[binding sites] total is defined as “binding sites per unit concentration” × the total concentration 
of DNA in the selected unit of concentration. 
 A is the ligand absorbance observed at a specific wavelength (λmax) 
Abound is given by: 
Abound = Aobs-(Abg+Afree) 
Aobs = Abg+Afree+Abound 
Aobs = Abg+ ε free × c free × l + ε bound × c bound × l 
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Aobs-(Abg+Afree) = ε bound × c bound × l 
Subsequently:  
Aobs-(Abg+Afree)  
Aobs is the observed signal for the ligand  
Abg is the background signal or the buffer absorbance  
Afree is the difference (Aobs - Abg) 
We can determine [ligand] bound from A bound / epsilonbound × pathlength 
ligand free = Afree / epsilonfree × pathlength 
 [binding site] free is given by: 
 [binding site size] free = [binding site size] total - [ligand]bound  
To calculate K value: 
K = [ligand]bound / [ligand]free × [binding sites] free 
The absorption is plotted against time to obtain the optimal approximation for signalend and 
kobs from the best fit of a pseudo-first-order kinetic rate model to the data 199 (Equation 1). 
  (signalstart -  signalend) × exp (- 1× kobs × time) + signalend    
(Δ!) e−#$%&' × t + signalend                        Equation 1 
 
The terms in the equation are defined as follows.   
ΔA is the difference between the ligand absorbance and the buffer absorbance, kobs is the 
observed pseudo-first-order rate constant and t is defined as the time in hours. 
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4.5 Equipment 
4.5.1 Spectroscopic studies 
UV-visible spectra were recorded using a Jasco V-630BIO spectrophotometer with a Peltier 
temperature controller. All concentrations were determined in a 1.0 cm cuvette path length at 
25 °C. Ligands concentrations were determined using the extinction coefficient. The stock 
solutions of different ligands were added into 2500 µl of buffer in a 1.0 cm cuvette path 
length at 25 °C. UV-visible spectra in the range 200 - 600 nm were recorded. The absorption 
was kept in the range of 0.1-0.8 a.u. to avoid any non-linearity of signals and precipitation or 
self-aggregation of ligand. The absorptions at selected wavelength λmax were plotted against 
time. The evolution of absorbances as a function of time were analysed in terms of a first-
order kinetics model using Origin 9. 
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Abstract 
This chapter presents an overview and general conclusions of the work described in this 
thesis and an outlook for future work. 
5.1 General conclusions 
The main objective of this project was the development of a custom competition dialysis 
device that allows us to carry out double competition dialysis assays conveniently.                                    
Chapter 2 of this thesis describes our work to determine the extinction coefficients for 
selected optolectronically active π-conjugated molecules in our aqueous buffer solutions. 
These studies also established that eosin b, ponceau s, sulforhodamine, basic fuchsin, basic 
yellow (thioflavin T), ethidium bromide and DAPI are sufficiently stable and soluble in 
aqueous solutions. The extinction coefficients were determined successfully are summarised 
in Table 5.1. 
  
TF1, methylene blue, thiazole orange and DODC were found to fade significantly upon 
exposure to light. We found that different buffers do not affect significantly the sensitivity to 
light, indicating that the buffer does not affect the fading.  Because of limited solubility, we 
also determined the extinction coefficient of TF1 (8) in pure DMSO and pure acetonitrile and 
in aqueous mixtures containing these cosolvents. The extinction coefficients for TF1 (8) in 
aqueous acetonitrile and aqueous DMSO are similar.  
In addition, we describe the binding studies of a series of potential nucleic acid binders from 
a library of available (commercial and in-house synthesised) ligands to double-stranded FS-
DNA and to different quadruplex-forming sequences (c-myc, 22AG and EAD2).                                                                                                                                         
According to UV-visible spectroscopy titrations, eosin b, ponceau s and sulforhodamine 
Compound Extinction coefficients / M-1 cm-1 
eosin b  (57063 ± 457) 
ponceau s  (36355 ± 581) 
Sulforhodamine (84469 ± 563) 
basic fuchsin (79644 ± 192) 
basic yellow (thioflavin T) (24073 ± 135) 
ethidium bromide (6645 ± 65.27) 
DAPI (23570 ± 786) 
H33258 42000 
GB01 33000 
Coralyne 14500 
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show no binding affinity for duplex FS-DNA. For these compounds, the lack of binding is 
because the negative charge of the sulphonate group leads to increase in electrostatic 
repulsion between ligand and DNA. On the contrary, compounds methylene blue (9) with a 
high affinity of 9 duplex FS-DNA with a binding constant of ~ 105 M-1 and TF1 (8) shows a 
moderate affinity for duplex FS-DNA with a binding constant of ~ 103 M-1. At the same time, 
basic fuchsin (4) and basic yellow (thioflavin T) (5) have a high affinity (~ 104 M-1) for DNA.                          
We also investigated the effect of added cosolvents on affinities and we show decreasing 
binding affinity of methylene blue (9) for DNA in the presence of DMSO comparing with 
only buffer. Moreover, the DNA-binding affinity of compound 8 in the presence of DMSO is 
higher (~ 105 M-1) than in the presence of acetonitrile (~ 103 M-1).                                                           
Moreover, compounds 9-11 bind to a specific quadruplex-forming sequences such as c-myc, 
22AG and EAD2. Compound 9 has a higher affinity for c-myc than for 22AG and EAD2. 
The binding stoichiometry for 9 with c-myc was found to be 6 ligands per quadruplex. 
Compound 11 also binds more strongly to c-myc than to 22AG. The binding stoichiometry 
for 11 with c-myc was found to be 4 ligands bind per quadruplex.                                                                            
To investigate the binding mode of 3, 4 and 7 with FS-DNA, we used circular dichroism 
spectroscopy. The interaction of 3 with FS-DNA does not result in an important induced 
circular dichroism signal, which suggests that 3 does not interact strongly with DNA. 
However, we found that the binding modes for 4 and 7 with FS-DNA are intercalation and 
groove binding, respectively.  Finally, ITC shows the affinity of 7 for FS-DNA and suggests 
the presence of at least one binding event.                                                                                               
In Chapter 3, we describe the creation of a dialysis device that works very well and gives 
good affinity data for ligands interacting with nucleic acid structures as evidenced by 
agreement with affinities from UV-visible spectroscopy. Furthermore, we used competition 
dialysis as a test for affinity and selectivity of ligands for nucleic acid structures such as 
quadruplex, c-myc, 22AG and specific duplex-forming sequences such as, 
(dAdT)12●(dAdT)12 and (dGdC)12●(dGdC)12.  We compare the results with the results from 
UV-vis titration (as shown in Chapter 2) and conclude that the results are in reasonable 
agreement.                                                                                                      
Finally, in Chapter 4, we show data for couples of nucleic acid binders, comparing selectivity 
and affinity obtained using double competition dialysis. We show that the assay works well 
and   the results are in agreement with the results from the UV-visible titrations (Chapter 2).  
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On the other hand, the control buffer identifies problems in this experiment. The typical 
problem in these experiments is the fading of compounds such as methylene blue, thiazole 
orange and DODC upon the exposure to light for the long duration of these experiments. 
Therefore, stability for the compounds is very important in order to select compounds for the 
competition.   
5.2 Suggestion and future work 
Important future goals include modifications to the competition dialysis device, such as 
keeping the device inside a closed box during the experiment to reduce exposure of the 
binders to light. Alternatively, we could explore using a less transparent material to construct 
the device. It is also a good idea to test individual dyes and pairs of dyes in the device with 
just buffer in all holes. This experiment will allow us to identify problematic dyes, but will 
also give us a quantitative understanding of intrinsic variability in post equilibration 
absorbances. Moreover, we should understand the fading more. This can be achieved by 
studying fading kinetics and determining the reaction mechanisms of fading of these 
compounds (such as TF1, methylene blue and DODC)  
In addition, other important future goals include the double competition dialysis. We should 
try more compounds with selectivity for different sequences of quadruplex, duplex and 
DNA● PNA hybrid duplexes. We should identify more candidate compounds and potential 
target sequences to enhance the chances of identifying orthogonal recognition couples. A 
further way by which this may be achieved is through further development of the dialysis 
device to hold more different solutions of nucleic acid solutions than the current four (with 
the fifth hole used for the buffer control solution).  
In addition, we have to repeat experiments more than one time to determine the affinity of 
H33258 for quadruplex sequences such as c-myc and 22AG and duplex sequences, such as 
(dAdT)12●(dAdT)12 and (dGdC)12●(dGdC)12.  
Once orthogonal recognition elements have been identified, the self-assembled nanostructure 
can be created. 
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This Appendix to Chapter 2 
 
 
A1 UV-visible titration of compound of 1 
 
 
 
 
 
Table A1 UV-visible titration of 0.015 mM 1 upon addition of 0 – 4.17 mM FS-DNA in 
buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA), at 25 °C. [DNA]stock = 16.1 
mM, [Ligand]stock = 1.2 mM 
Cumulative added 
volume DNA (µL) 
Added 
volume 
ligand 
(µL) 
Total 
volume 
(µL) 
[DNA] 
(M) 
[ligand] 
(x10-5 M) 
A520 nm 
0 0 0 0 0 0.024963 
0 30 2405 0 1.51 0.860931 
10 30 2415 6.67E-05 1.5 0.854969 
20 30 2425 0.000133 1.49 0.851524 
35 30 2440 0.000231 1.49 0.847892 
55 30 2460 0.00036 1.47 0.841878 
85 30 2490 0.00055 1.46 0.833937 
125 30 2530 0.000796 1.43 0.8212 
175 30 2580 0.001093 1.4 0.807157 
240 30 2645 0.001462 1.37 0.790369 
315 30 2720 0.001866 1.33 0.770511 
400 30 2805 0.002298 1.29 0.747155 
495 30 2900 0.00275 1.25 0.725424 
600 30 3005 0.003217 1.21 0.702668 
715 30 3120 0.003692 1.16 0.67644 
840 30 3245 0.004171 1.12 0.651607 
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A2UV-visible titration of compound of 2 
 
 
 
 
 
 
Table A2UV-visible titration of 0.016 mM. 2 upon addition of 0 – 4.26 mM FS-DNA in buffer (25 
mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA), at 25 °C. [DNA]stock = 16.1 mM, [Ligand]stock = 
0.9 mM. 
Cumulative added 
volume DNA (µL) 
Added volume ligand 
(µL) 
Total volume 
(µL) [DNA] (M) 
[ligand] (x10-5 
M) A520 nm 
0 0 0 0 0 0.0295219 
0 40 2415 0 1.639 0.608532 
10 40 2425 6.64412E-05 1.632 0.607947 
15 40 2430 9.94568E-05 1.628 0.607103 
30 40 2445 0.000197693 1.618 0.606371 
45 40 2460 0.000294732 1.609 0.601195 
65 40 2480 0.00042229 1.596 0.598383 
90 40 2505 0.000578874 1.580 0.593598 
120 40 2535 0.000762698 1.561 0.591259 
155 40 2570 0.000971735 1.540 0.582787 
195 40 2610 0.00120377 1.516 0.575538 
240 40 2655 0.001456452 1.490 0.56534 
290 40 2705 0.001727349 1.463 0.555694 
345 40 2760 0.002014 1.434 0.546512 
405 40 2820 0.002313957 1.403 0.53702 
470 40 2885 0.002624832 1.372 0.527928 
540 40 2955 0.002944325 1.339 0.51264 
615 40 3030 0.003270257 1.306 0.504382 
695 40 3110 0.003600592 1.272 0.490638 
780 40 3195 0.003933446 1.238 0.481089 
870 40 3285 0.004267105 1.204 0.46755 
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A3 UV-visible titration of compound of 3 
 
Table A3 UV-visible titration of 0.0097 mM 3 upon addition of 0 – 3.70 mM FS-DNA in 
buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA), at 25 °C. [DNA]stock = 16.1 
mM, [Ligand]stock = 0.58 mM. 
Cumulative added 
volume DNA (µL) 
Added 
volume 
ligand 
(µL) 
Total 
volume 
(µL) 
[DNA] 
(M) 
[ligand] 
(x10-6 M) A563 nm 
0 0 0 0 0 0.0230762 
0 40 2415 0 9.74 0.845436 
5 40 2420 3.33E-05 9.72 0.844315 
20 40 2435 0.000132 9.66 0.839522 
50 40 2465 0.000327 9.54 0.82932 
95 40 2510 0.00061 9.37 0.817463 
150 40 2565 0.000942 9.17 0.799077 
225 40 2640 0.001373 8.91 0.779044 
320 40 2735 0.001885 8.6 0.753538 
435 40 2850 0.002459 8.25 0.725201 
570 40 2985 0.003077 7.88 0.694903 
720 40 3135 0.0037 7.5 0.663657 
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A4 UV-visible titration of compound of 4 
 
 
 
 
 
 
 
 
 
 
Table A4 UV-visible titration of 0.0080 mM 4 upon addition of 0 – 4.25 mM FS-DNA in 
buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA), at 25 °C. [DNA]stock = 16.1 mM, 
[Ligand]stock = 0.9 mM. 
Cumulative added 
volume DNA (µL) 
Added 
volume 
ligand (µL) 
Total volume 
(µL) [DNA] 
[ligand] 
(x10-6 M) A539 nm 
0 0 0 0 0 0.027419 
0 20 2395 0 8.021 0.957865 
5 20 2400 3.35667E-05 8.004 0.922753 
10 20 2405 6.69938E-05 7.987 0.898413 
15 20 2410 0.000100282 7.971 0.884886 
25 20 2420 0.000166446 7.938 0.85869 
35 20 2430 0.000232066 7.905 0.848627 
45 20 2440 0.000297148 7.873 0.842011 
60 20 2455 0.000393776 7.825 0.831079 
95 20 2490 0.000614715 7.715 0.807193 
160 20 2555 0.001008971 7.518 0.78183 
310 20 2705 0.001846477 7.101 0.739657 
460 20 2855 0.002595979 6.728 0.70928 
610 20 3005 0.003270656 6.392 0.680763 
860 20 3255 0.004256934 5.901 0.636237 
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A5 UV-visible titration of compound of 5 
 
Table A5 UV-visible titration of 0.011 mM 5 upon addition of 0 – 0.74 mM FS-
DNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA), at 25 °C. 
[DNA]stock = 11 mM, [Ligand]stock = 0.070 mM. 
Cumulative 
added 
volume 
DNA (µL) 
Added volume 
ligand (µL) 
Total 
volume 
(µL) 
[DNA] [ligand] (x10
-5 
M) A412 nm 
0 0 0 0 0 0.017465 
0 400 2400 0 1.1709 0.29165 
1 400 2401 4.58E-06 1.170 0.28866 
2 400 2402 9.16E-06 1.170 0.297099 
3 400 2403 1.37E-05 1.169 0.286899 
4 400 2404 1.83E-05 1.169 0.284639 
5 400 2405 2.29E-05 1.168 0.286469 
7 400 2407 3.2E-05 1.167 0.280367 
10 400 2410 4.56E-05 1.166 0.27812 
14 400 2414 6.38E-05 1.164 0.273843 
19 400 2419 8.64E-05 1.161 0.268764 
29 400 2429 0.000131 1.157 0.262926 
39 400 2439 0.000176 1.152 0.252965 
54 400 2454 0.000242 1.145 0.245867 
74 400 2474 0.000329 1.135 0.23909 
124 400 2524 0.00054 1.113 0.222239 
174 400 2574 0.000744 1.091 0.212333 
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A6 UV-visible titrations of compound of 6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table A6 UV-visible titration of 0.018 mM 6 upon addition of 0 – 0.17 mM FS-
DNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA), at 25 °C. 
[DNA]stock = 16 mM, [Ligand]stock = 0.44 mM. 
Cumulative 
added 
volume 
DNA (µL) 
Added 
volume 
ligand 
(µL) 
Total 
volume 
(µL) 
[DNA] [ligand] (x10-5 M) A338 nm 
0 0 0 0 0 0.052425 
0 100 2400 0 1.87 0.839554 
1 100 2401 6.66E-06 1.87 0.707175 
2 100 2402 1.33E-05 1.87 0.657087 
3 100 2403 2E-05 1.87 0.606835 
4 100 2404 2.66E-05 1.87 0.585521 
5 100 2405 3.33E-05 1.87 0.570176 
6 100 2406 3.99E-05 1.87 0.558692 
8 100 2408 5.32E-05 1.86 0.546678 
11 100 2411 7.3E-05 1.86 0.551399 
16 100 2416 0.000106 1.86 0.548176 
26 100 2426 0.000171 1.85 0.548244 
Appendix 
 
238 
 
 
 
 
 
 
 
 
 
 
Table A6.1 UV-visible titration of 0.017 mM 6 upon addition of 0 – 0.65 mM FS-
DNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA), at 25 °C. 
[DNA]stock = 10 mM, [Ligand]stock = 0.43 mM. 
 
Cumulative 
added 
volume 
DNA (µL) 
Added 
volume 
ligand 
(µL) 
Total 
volume 
(µL) 
[DNA] [ligand] (x10-5 M) A338 nm 
0 0 0 0 0 0.038435 
0 100 2400 0 1.8 0.794067 
1 100 2401 4.1649E-06 1.8 0.730034 
2 100 2402 8.3264E-06 1.79 0.665407 
3 100 2403 1.2484E-05 1.79 0.616172 
4 100 2404 1.6639E-05 1.79 0.580509 
5 100 2405 2.079E-05 1.79 0.556638 
7 100 2407 2.9082E-05 1.79 0.533729 
9 100 2409 3.736E-05 1.79 0.519196 
12 100 2412 4.9751E-05 1.79 0.512089 
17 100 2417 7.0335E-05 1.78 0.508502 
27 100 2427 0.00011125 1.78 0.510529 
42 100 2442 0.00017199 1.76 0.520502 
62 100 2462 0.00025183 1.75 0.519449 
87 100 2487 0.00034982 1.73 0.516946 
122 100 2522 0.00048374 1.71 0.518197 
167 100 2567 0.00065056 1.68 0.514737 
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A7 UV-visible titration of compound of 7 
 
Table A7 UV-visible titration of 0.028 mM 7 upon addition of 0 – 2.90 mM FS-DNA in 
buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA), at 25 °C. [DNA]stock = 17 
mM, [Ligand]stock = 0.98 mM. 
Cumulative 
added volume 
DNA (µL) 
Added 
volume 
ligand 
(µL) 
Total 
volume 
(µL) 
[DNA] [ligand] (x10-5 M) A331 nm 
0 0 0 0 0 0.033005 
0 70 2445 0 2.83 0.966682 
5 70 2450 3.61E-05 2.82 0.7262 
10 70 2455 7.21E-05 2.82 0.725121 
15 70 2460 0.000108 2.81 0.735498 
20 70 2465 0.000144 2.81 0.749349 
30 70 2475 0.000215 2.8 0.763345 
40 70 2485 0.000285 2.78 0.772927 
50 70 2495 0.000355 2.77 0.780035 
65 70 2510 0.000458 2.76 0.785839 
80 70 2525 0.000561 2.74 0.792399 
105 70 2550 0.000729 2.71 0.796304 
130 70 2575 0.000894 2.69 0.798039 
165 70 2610 0.001119 2.65 0.799567 
200 70 2645 0.001339 2.62 0.799893 
245 70 2690 0.001612 2.57 0.793153 
290 70 2735 0.001877 2.53 0.789441 
340 70 2785 0.002161 2.48 0.781579 
405 70 2850 0.002516 2.43 0.769321 
480 70 2925 0.002905 2.37 0.757858 
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A7.1 ITC of compound of 7 
 
Table A7.1 Thermodynamic parameters for diluting of  7 into MOPS 
buffer, pH 7.0, at 25 °C 
variable initial change? avoid 0? fit value 
att. 
changes 
DHdil -1.00E+03 1 y -9.39E+02 196696 
offset 0.00E+00 0 n 0.00E+00 0 
Kdim 0.00E+00 0 n 0.00E+00 0 
DHdim 0.00E+00 0 n 0.00E+00 0 
Kagg 1.00E+04 1 y 1.48E+03 196922 
DHagg -6.00E+03 1 y -9.02E+03 196382 
KA1 0.00E+00 0 y 0.00E+00 0 
DHA1 0.00E+00 0 y 0.00E+00 0 
nA1 0.00E+00 0 y 0.00E+00 0 
KA2 0.00E+00 0 n 0.00E+00 0 
DHA2 0.00E+00 0 n 0.00E+00 0 
nA2 0.00E+00 0 n 0.00E+00 0 
KB1 0.00E+00 0 n.d. 0.00E+00 0 
DHB1 0.00E+00 0 n.d. 0.00E+00 0 
nB1 0.00E+00 0 n.d. 0.00E+00 0 
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Table A7.2 Thermodynamic parameters for binding of 7 to DNA in 
MOPS buffer, pH 7.0, at 25 °C 
 
variable initial change? avoid 0? fit value att. changes 
DHdil -9.39E+02 0 n -9.39E+02 0 
offset 0.00E+00 0 n 0.00E+00 0 
Kdim 0.00E+00 0 n 0.00E+00 0 
DHdim 0.00E+00 0 n 0.00E+00 0 
Kagg 1.48E+03 0 n 1.48E+03 0 
DHagg -9.02E+03 0 n -9.02E+03 0 
KA1 5.00E+04 1 y 4.48E+05 196696 
DHA1 2.00E+03 1 y -6.45E+03 196922 
nA1 3.00E-01 1 y 8.48E-01 196382 
KA2 0.00E+00 0 n 0.00E+00 0 
DHA2 0.00E+00 0 n 0.00E+00 0 
nA2 0.00E+00 0 n 0.00E+00 0 
KB1 0.00E+00 0 n.d. 0.00E+00 0 
DHB1 0.00E+00 0 n.d. 0.00E+00 0 
nB1 0.00E+00 0 n.d. 0.00E+00 0 
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Figure 1 normalised Ʃdev2/dof for a stepwise self-aggregation model fitted to ITC data for 
dilution of a 0.95 mM solution of 7 into a 25 mM MOPS, 50 mM NaCl, pH 7, 1 mM EDTA 
at 25 °C as a function of ∆Hagg. 
 
 
Figure 2 normalised Ʃdev2/dof for a stepwise self-aggregation model fitted to ITC data for 
dilution of a 0.95 mM solution of 7  into a 25 mM MOPS, 50 mM NaCl, pH 7, 1mM EDTA 
at 25 °C as a function of ΔHdil.                                                                                           
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Figure 3 normalised Ʃdev2/dof for a stepwise self-aggregation model fitted to ITC data for 
dilution of a 0.95 mM solution of 7  into a 25 mM MOPS, 50 mM NaCl, pH 7, 1 mM EDTA 
at 25 °C as a function of Kgg.  
 
Figure 4 normalised Ʃdev2/dof for a stepwise self-aggregation model fitted to ITC data for 
dilution of a 0.95 mM solution of 7  into a 25 mM MOPS, 50 mM NaCl, pH 7, 1 mM EDTA 
at 25 °C as a function of ΔGagg. 
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A8 UV-visible titration of compound of 8 
 
 
 
 
 
 
Table A8UV-visible titration of 0.0029 mM 8 in presence of 1.04 % of acetonitrile 
upon addition of 0 – 1.04 mM FS-DNA in buffer (25 mM MOPS, pH 7.0, 50 mM 
NaCl, 1 mM EDTA), at 25 °C. [DNA]stock1 = 17 mM and  [DNA]stock2 = 1.7 mM, 
[Ligand]stock = 0.28 mM. 
Cumulative 
added volume 
DNA (µL) 
Added 
volume 
ligand 
(µL) 
Total 
volume 
(µL) 
[DNA] [ligand] (x10-6 M) A476 nm 
0 0 2375 0 0 0.027701 
0 25 2400 0 2.93 0.178401 
1 25 2401 7.08E-07 2.93 0.163616 
2 25 2402 1.42E-06 2.93 0.157205 
3 25 2403 2.12E-06 2.93 0.148839 
5 25 2405 3.53E-06 2.93 0.143132 
8 25 2408 5.65E-06 2.92 0.134969 
12 25 2412 8.46E-06 2.92 0.125868 
17 25 2417 1.2E-05 2.91 0.120721 
22 25 2422 1.54E-05 2.91 0.122923 
27 25 2427 1.89E-05 2.9 0.118094 
7.7 25 2432 5.61E-05 2.89 0.109457 
12.7 25 2437 9.23E-05 2.89 0.120128 
22.7 25 2447 0.000164 2.88 0.128531 
32.7 25 2457 0.000236 2.86 0.136591 
47.7 25 2472 0.000342 2.85 0.143664 
72.7 25 2497 0.000515 2.82 0.153688 
107.7 25 2532 0.000753 2.78 0.160581 
152.7 25 2577 0.001049 2.73 0.162239 
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Table A8.1 UV-visible titration of 0.0008 mM 8 upon addition of 0 – 0.44 mM FS-
DNA in buffer (25 mM MOPS, pH 7.0, 100 mM KCl, 9 vol-% DMSO and 1 Mm 
EDTA), at 25 °C. [DNA]stock = 15 mM, [Ligand]stock = 0.0031 mM 
Cumulative 
added 
volume 
DNA (µL) 
Added 
volume 
ligand 
(µL) 
Total 
volume 
(µL) 
[DNA] [ligand] (x10-7 M) A476 nm 
0 0 0 0 0 0.026018 
0 800 2800 0 8.897 0.071762 
1 800 2801 5.36594E-06 8.893 0.070785 
2 800 2802 1.07281E-05 8.890 0.067611 
3 800 2803 1.60863E-05 8.887 0.066927 
5 800 2805 2.67914E-05 8.881 0.066881 
8 800 2808 4.28205E-05 8.871 0.064229 
11 800 2811 5.88154E-05 8.862 0.063979 
15 800 2815 8.00888E-05 8.849 0.063239 
20 800 2820 0.000106596 8.834 0.062852 
25 800 2825 0.000133009 8.818 0.062423 
35 800 2835 0.000185556 8.787 0.06248 
45 800 2845 0.000237733 8.756 0.06083 
55 800 2855 0.000289545 8.725 0.062236 
70 800 2870 0.000366585 8.680 0.060135 
85 800 2885 0.000442825 8.635 0.059629 
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Table A8.2 UV-visible titration of 0.0015 mM 8 upon addition of 0 – 0.45 
mM FS-DNA in buffer (25 mM MOPS, pH 7.0, 100 mM KCl, 9 vol-% 
DMSO and 1 mM EDTA), at 25 °C. [DNA]stock = 15 mM, [Ligand]stock 
= 0.0060 mM 
Cumulative 
added 
volume 
DNA (µL) 
Added 
volume 
ligand 
(µL) 
Total 
volume 
(µL) 
[DNA] [ligand] (x10-6 M) A476 nm 
0 0 0 0 0 0.02038 
0 700 2700 0 1.57 0.10083 
1 700 2701 5.56E-06 1.56 0.09741 
2 700 2702 1.11E-05 1.56 0.09466 
3 700 2703 1.67E-05 1.56 0.09417 
5 700 2705 2.78E-05 1.56 0.09334 
8 700 2708 4.44E-05 1.56 0.08948 
11 700 2711 6.1E-05 1.56 0.08936 
15 700 2715 8.3E-05 1.56 0.08796 
20 700 2720 0.000111 1.55 0.08722 
25 700 2725 0.000138 1.55 0.08718 
35 700 2735 0.000192 1.55 0.08565 
45 700 2745 0.000246 1.54 0.08345 
55 700 2755 0.0003 1.53 0.08337 
70 700 2770 0.00038 1.53 0.08255 
85 700 2785 0.000459 1.52 0.08213 
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A9 UV-visible titrations of compound of 9 
 
Table A9UV-visible titration of 0.0035 mM 9 upon addition of 0 – 4.6 mM 
FS-DNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA), at 
25 °C. [DNA]stock = 14 mM, [Ligand]stock = 1.4 mM 
Cumulative 
added 
volume 
DNA (µL) 
Added 
volume 
ligand 
(µL) 
Total 
volume 
(µL) 
[DNA] [ligand] (x10-6 M) A663 nm 
0 0 2000 0 0 0.02248 
0 5 2005 0 3.57 0.30085 
1 5 2006 7.33E-06 3.57 0.269774 
3 5 2008 2.2E-05 3.56 0.252462 
5 5 2010 3.66E-05 3.56 0.240762 
7 5 2012 5.12E-05 3.56 0.232359 
9 5 2014 6.57E-05 3.55 0.228138 
11 5 2016 8.03E-05 3.55 0.22493 
16 5 2021 0.000116 3.54 0.222443 
21 5 2026 0.000152 3.53 0.220084 
26 5 2031 0.000188 3.52 0.218901 
31 5 2036 0.000224 3.51 0.215157 
36 5 2041 0.000259 3.51 0.21633 
46 5 2051 0.00033 3.49 0.214286 
66 5 2071 0.000469 3.46 0.212827 
116 5 2121 0.000805 3.37 0.211435 
166 5 2171 0.001125 3.3 0.208606 
316 5 2321 0.002003 3.08 0.198093 
516 5 2521 0.003011 2.84 0.184381 
716 5 2721 0.003871 2.63 0.174674 
916 5 2921 0.004613 2.45 0.165187 
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Table A9.2 UV-visible titration of 0.0037 mM 9 upon addition of 0 – 0.006 
mM c-myc in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), 
at 25 °C. [c-myc]stock = 0.43 mM, [Ligand]stock = 0.37 mM 
Cumulative 
added 
volume 
DNA (µL) 
Added 
volume 
ligand 
(µL) 
Total 
volume 
(µL) 
[DNA] [ligand] (x10-6 M) A663 nm 
0 0 0 0 0 0.025621 
0 50 2550 0 7.3 0.595289 
1 50 2551 1.69E-07 7.3 0.547168 
2 50 2552 3.37E-07 7.3 0.514325 
3 50 2553 5.05E-07 7.29 0.482571 
5 50 2555 8.41E-07 7.29 0.434554 
7 50 2557 1.18E-06 7.28 0.397027 
10 50 2560 1.68E-06 7.27 0.357836 
13 50 2563 2.18E-06 7.27 0.338535 
17 50 2567 2.85E-06 7.26 0.3342 
22 50 2572 3.68E-06 7.24 0.340724 
27 50 2577 4.51E-06 7.23 0.350041 
37 50 2587 6.15E-06 7.2 0.367759 
Table A9.1UV-visible titration of 0.004 mM 9 upon addition of 0 – 0.19 mM 
FS-DNA in buffer (25 mM MOPS, pH 7.0, 100 mM KCl, 9 vol-% DMSO and 
1 mM EDTA), at 25 °C. [DNA]stock = 19 mM, [Ligand]stock = 0.14 mM 
Cumulative 
added 
volume 
DNA (µL) 
Added 
volume 
ligand 
(µL) 
Total 
volume 
(µL) 
[DNA] [ligand] (x10-6 M) A663 nm 
0 0 2000 0 0 0.019418 
0 70 2070 0 4.88 0.400304 
1 70 2071 9.24E-06 4.88 0.385613 
3 70 2073 2.77E-05 4.88 0.365823 
5 70 2075 4.61E-05 4.87 0.351676 
7 70 2077 6.45E-05 4.87 0.342728 
9 70 2079 8.29E-05 4.86 0.343271 
11 70 2081 0.000101 4.86 0.336805 
16 70 2086 0.000147 4.85 0.327029 
21 70 2091 0.000192 4.83 0.322373 
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Table A9.3 UV-visible titration of 0.0038 mM 9 upon addition of 0 – 0.035 
mM 22AG in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM 
EDTA), at 25 °C. [22AG]stock = 0.37 mM, [Ligand]stock = 0.38 mM 
Cumulative 
added 
volume 
DNA (µL) 
Added 
volume 
ligand 
(µL) 
Total 
volume 
(µL) 
[DNA] [ligand] (x10-6 M) A663 nm 
0 0 0 0 0 0.024336 
0 25 2525 0 3.81 0.321684 
1 25 2526 1.46E-07 3.81 0.317579 
3 25 2528 4.39E-07 3.81 0.311755 
6 25 2531 8.77E-07 3.8 0.298048 
10 25 2535 1.46E-06 3.8 0.2904 
15 25 2540 2.19E-06 3.79 0.283499 
25 25 2550 3.63E-06 3.77 0.271128 
35 25 2560 5.06E-06 3.76 0.262249 
50 25 2575 7.18E-06 3.74 0.255163 
70 25 2595 9.98E-06 3.71 0.248022 
120 25 2645 1.68E-05 3.64 0.2391 
170 25 2695 2.33E-05 3.57 0.233499 
270 25 2795 3.57E-05 3.44 0.223599 
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Table A9.4 UV-visible titration of 0.0051 mM 9 upon addition of 0 – 0.0069 
mM EAD2 in buffer (25 mM MOPS, pH 7.0, 100 mM KCl, and 1 mM 
EDTA), at 25 °C. [EAD2]stock = 0.089 mM, [Ligand]stock = 0.26 mM 
Cumulative 
added 
volume 
DNA (µL) 
Added 
volume 
ligand 
(µL) 
Total 
volume 
(µL) 
[DNA] [ligand] (x10-6 M) A663 nm 
0 0 0 0 0 0.02317 
0 50 2550 0 5.17 0.426721 
5 50 2555 1.74E-07 5.16 0.415568 
10 50 2560 3.48E-07 5.15 0.405448 
15 50 2565 5.2E-07 5.14 0.393989 
20 50 2570 6.93E-07 5.13 0.383441 
25 50 2575 8.64E-07 5.12 0.374234 
30 50 2580 1.03E-06 5.11 0.367119 
40 50 2590 1.37E-06 5.09 0.351191 
50 50 2600 1.71E-06 5.07 0.337987 
60 50 2610 2.05E-06 5.05 0.328734 
70 50 2620 2.38E-06 5.04 0.320336 
80 50 2630 2.71E-06 5.02 0.313191 
90 50 2640 3.03E-06 5 0.307767 
105 50 2655 3.52E-06 4.97 0.300127 
120 50 2670 0.000004 4.94 0.294553 
135 50 2685 4.47E-06 4.91 0.291214 
150 50 2700 4.94E-06 4.89 0.287755 
170 50 2720 5.56E-06 4.85 0.284336 
190 50 2740 6.17E-06 4.81 0.278467 
215 50 2765 6.92E-06 4.77 0.274208 
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      A10 UV-visible titration of compound of 10        
 
  
 
 
 
 
 
Table A10 UV-visible titration of 0.027 mM 10 upon addition of 0 – 0.023 
mM c-myc in buffer (25 mM MOPS, pH 7.0, 100 mM KCl, and 1 mM 
EDTA), at 25 °C. [ c-myc ]stock = 0.34 mM, [Ligand]stock = 0.37 mM 
Cumulative 
added 
volume 
DNA (µL) 
Added 
volume 
ligand 
(µL) 
Total 
volume 
(µL) 
[DNA] [ligand] (x10-5 M) A481 nm 
0 0 0 0 0 0.037602 
0 200 2700 0 2.76 0.221167 
2 200 2702 2.52E-07 2.75 0.213641 
7 200 2707 8.79E-07 2.75 0.21181 
12 200 2712 1.5E-06 2.74 0.207669 
17 200 2717 2.13E-06 2.74 0.204787 
27 200 2727 3.37E-06 2.73 0.197448 
37 200 2737 4.6E-06 2.72 0.191412 
47 200 2747 5.82E-06 2.71 0.185026 
57 200 2757 7.03E-06 2.7 0.179755 
72 200 2772 8.83E-06 2.68 0.172849 
87 200 2787 1.06E-05 2.67 0.166421 
102 200 2802 1.24E-05 2.66 0.162605 
122 200 2822 1.47E-05 2.64 0.156249 
142 200 2842 1.7E-05 2.62 0.15702 
162 200 2862 1.92E-05 2.6 0.154009 
182 200 2882 2.15E-05 2.58 0.149465 
202 200 2902 2.37E-05 2.56 0.153578 
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A11 UV-visible titrations of compound of 11 
 
Table A11 UV-visible titration of 0.019 mM 11 upon addition of 0 – 0.007mM 
22AG in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), at 
25 °C. [22AG]stock = 0.37 mM, [Ligand]stock = 0.7 mM 
Cumulative 
added 
volume 
DNA (µL) 
Added 
volume 
ligand 
(µL) 
Total 
volume 
(µL) 
[DNA] [ligand] (x10-5 M) A342 nm 
0 0 0 0 0 0.028171 
0 70 2570 0 1.95 0.488855 
1 70 2571 1.44E-07 1.95 0.477623 
3 70 2573 4.31E-07 1.95 0.461553 
5 70 2575 7.18E-07 1.95 0.445539 
7 70 2577 1.01E-06 1.95 0.432206 
9 70 2579 1.29E-06 1.95 0.419181 
11 70 2581 1.58E-06 1.95 0.406492 
13 70 2583 1.86E-06 1.94 0.395623 
15 70 2585 2.15E-06 1.94 0.389088 
18 70 2588 2.57E-06 1.94 0.376518 
21 70 2591 3E-06 1.94 0.369977 
26 70 2596 3.71E-06 1.93 0.358677 
36 70 2606 5.11E-06 1.93 0.338019 
46 70 2616 6.51E-06 1.92 0.330084 
56 70 2626 7.89E-06 1.91 0.327357 
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Table A11.1 UV-visible titration of 0.019 mM 11 upon addition of 0 – 
0.025mM c-myc in buffer (25 mM MOPS, pH 7.0, 100 mM KCl, and 1 mM 
EDTA), at 25 °C. [c-myc]stock = 0.34 mM, [Ligand]stock = 2.4 mM 
Cumulative 
added 
volume 
DNA (µL) 
Added 
volume 
ligand 
(µL) 
Total 
volume 
(µL) 
[DNA] [ligand] (x10-5 M) A342 nm 
0 0 0 0 0 0.047873 
0 20 2520 0 1.96 0.510126 
2 20 2522 2.69627E-07 1.96 0.497406 
4 20 2524 5.38827E-07 1.96 0.481601 
6 20 2526 8.07601E-07 1.96 0.47021 
8 20 2528 1.07595E-06 1.95 0.457545 
13 20 2533 1.74497E-06 1.95 0.433789 
18 20 2538 2.41135E-06 1.95 0.411758 
23 20 2543 3.07511E-06 1.94 0.390788 
33 20 2553 4.39483E-06 1.94 0.355235 
43 20 2563 5.70425E-06 1.93 0.324969 
53 20 2573 7.0035E-06 1.92 0.304024 
68 20 2588 8.93354E-06 1.91 0.289233 
83 20 2603 1.08413E-05 1.9 0.282941 
98 20 2618 1.27273E-05 1.89 0.281062 
118 20 2638 1.52085E-05 1.87 0.282079 
138 20 2658 1.76524E-05 1.86 0.276557 
158 20 2678 2.00597E-05 1.85 0.272735 
183 20 2703 2.30189E-05 1.83 0.270489 
208 20 2728 2.59238E-05 1.81 0.26825 
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A12UV-visible titrations of compound of 12 
Table A12 UV-visible titration of 0.0061 mM 12 upon addition of 0 – 
0.0027mM c-myc in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM 
EDTA), at 25 °C. [c-myc]stock = 0.24 mM, [Ligand]stock = 0.7 mM 
Cumulative 
added 
volume 
DNA (µL) 
Added 
volume 
ligand 
(µL) 
Total 
volume 
(µL) 
[DNA] [ligand] (x10-6 M) A500 nm 
0 0 0 0 0 0.022018 
0 20 2520 0 6 0.418617 
1 20 2521 9.52E-08 6.1 0.392908 
2 20 2522 1.9E-07 6.1 0.363493 
3 20 2523 2.85E-07 6.09 0.343658 
4 20 2524 3.8E-07 6.09 0.319716 
5 20 2525 4.75E-07 6.09 0.303139 
7 20 2527 6.65E-07 6.08 0.280882 
9 20 2529 8.54E-07 6.08 0.271141 
14 20 2534 1.33E-06 6.07 0.263451 
19 20 2539 1.8E-06 6.06 0.268503 
24 20 2544 2.26E-06 6.04 0.277617 
29 20 2549 2.73E-06 6.03 0.284707 
 
Table A12.1 UV-visible titration of 0.0083 mM 12 upon addition of 0 – 0.0066 
mM c-myc in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), 
at 25 °C. [c-myc]stock = 0.4 mM, [Ligand]stock = 0.42 mM 
Cumulative 
added 
volume 
DNA (µL) 
Added 
volume 
ligand 
(µL) 
Total 
volume 
(µL) 
[DNA] [ligand] (x10-6 M) A500 nm 
0 0 0 0 0 0.022866 
0 50 2550 0 8.33 0.564345 
1 50 2551 1.57E-07 8.33 0.509113 
2 50 2552 3.13E-07 8.32 0.463323 
3 50 2553 4.7E-07 8.32 0.43757 
4 50 2554 6.26E-07 8.32 0.423453 
6 50 2556 9.39E-07 8.31 0.391805 
8 50 2558 1.25E-06 8.3 0.374462 
10 50 2560 1.56E-06 8.3 0.374582 
13 50 2563 2.03E-06 8.29 0.385841 
18 50 2568 2.8E-06 8.27 0.391768 
33 50 2583 5.11E-06 8.22 0.398861 
43 50 2593 6.63E-06 8.19 0.396215 
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Table A12.2 UV-visible titration of 0.0048 mM 12 upon addition of 0 – 0.003 
mM 22AG in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl, and 1 mM EDTA), 
at 25 °C. [22AG]stock = 0.28 mM, [Ligand]stock = 0.61 mM 
Cumulative 
added 
volume 
DNA (µL) 
Added 
volume 
ligand 
(µL) 
Total 
volume 
(µL) 
[DNA] [ligand] (x10-6 M) A500 nm 
0 0 0 0 0 0.021377 
0 20 2520 0 4.88 0.338487 
1 20 2521 1.11E-07 4.88 0.310966 
2 20 2522 2.22E-07 4.87 0.285808 
3 20 2523 3.33E-07 4.87 0.285808 
4 20 2524 4.44E-07 4.87 0.252222 
5 20 2525 5.54E-07 4.87 0.244721 
7 20 2527 7.76E-07 4.87 0.239943 
9 20 2529 9.96E-07 4.86 0.240551 
14 20 2534 1.55E-06 4.85 0.24065 
19 20 2539 2.1E-06 4.84 0.242608 
24 20 2544 2.64E-06 4.83 0.245497 
29 20 2549 3.19E-06 4.82 0.249563 
 
Table A13 the absorbance of 13 and the time exposed to light and oxygen in buffer (25 
mM MOPS, pH 7.0, 50 mM NaCl, 1 mM EDTA), at 25 °C. 
 
 
 
 
 
 
Time (min) Absorbance 
0 0.1355 
2 0.1343 
5 0.1261 
10 0.1127 
15 0.0936 
20 0.0790 
60 0.0598 
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